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Abstract
This thesis begins with an introduction to Vitamin E and the Jocic reaction. Chapter 1
provides a review of the biological activity of vitamin E and related compounds and
the synthesis, both racemic and asymmetric, of vitamin E compounds. Also discussed
in this chapter is the Jocic reaction and the synthesis of trichloromethyl alcohol
compounds.
Chapter 2 describes the asymmetric total syntheses of both α- and β-tocopherol, where 
an intramolecular Jocic reaction was used to provide a high enantiomeric excess.
Difficulties encountered during the synthesis, and how these were overcome, are
detailed.
Chapter 3 describes the novel use of hydride as a nucleophile in the Jocic reaction with
tertiary polychloromethyl alcohols. This one-carbon homologation procedure was
improved by the use of dichloro- rather than trichloromethyl alcohols. The scope of
the reaction, mechanisms and stereochemical implications are discussed.
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Chapter 1: Introduction to Vitamin E and the Jocic
Reaction
1.1 Discovery of Vitamin E
Vitamin E is the name given to a class of naturally occurring antioxidants consisting
of eight different compounds. These eight compounds are divided into the tocopherols
and the tocotrienols (Figure 1), which differ only in unsaturation of the phytyl side
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chain. Depending on the extent and position of methylation around the aromatic ring
these compounds are further designated α, β, γ or δ. 
Figure 1. Naturally occurring vitamin E compounds.
In 1922, Evans and Bishop reported that rats which were fed an unnatural diet
consisting mainly of milk, cornstarch and adequate vitamin A, B and C were infertile,
and that fertility was restored by the feeding of lettuce leaves.1 They had demonstrated
that natural foods contained a substance essential for reproduction. Other groups
reported the same results from similar experiments and the substance was first termed
“Vitamin E” since vitamins A, B, C and D were already known.2-4 Much of the early
studies on the antioxidant activity of vitamin E were carried out by Mattill5-10 and
Evans.11 Mattill and co-workers were one of the first groups to suggest that vitamin E
acted as an antioxidant; they did this by measuring the uptake of oxygen from a variety
of vegetable and animal fats and noted that uptake of oxygen was considerably slower
in the presence of wheat germ oil (the best source of vitamin E at the time).12, 13 Evans
et al. isolated α-tocopherol in pure form from wheat germ oil in 193614 and shortly
after its chemical structure was fully elucidated.15 Olcott and Emerson then
demonstrated the antioxidant activity of α, β and γ-tocopherols towards unsaturated 
fats definitively for the first time.16
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1.2 Mechanism of Action
Lipid autoxidation (Scheme 1) is the process by which long chain fatty acids undergo
oxidation under mild conditions, leading to rancidity.17-19 In biological systems, the
process is referred to as peroxidation and can result in the modification of low density
lipoprotein (LDL)20 and tissue damage.21-23
Scheme 1. Lipid autoxidation free radical chain reaction.
In order to measure the kinetics of lipid autoxidation using equations 1-4 (Scheme 1),
the rate of initiation needs to be controlled and this is most commonly achieved using
thermally-labile azo compounds as initiators.24-26 Within biological systems initiators
such as Fe+ ions,27-30 organic hydroperoxides,31-33 CCl434, 35 and ethanol36, 37 have all
been described. The alkyl radicals (L•) generated are highly reactive and will react
quickly with oxygen to form lipid peroxy radicals (LOO•), which react with further
lipids to form lipid hydroperoxides (LOOH) and L• radicals which propagate the
chain. Termination via dimerisation takes place when almost all of the lipids LH have
been consumed.
Phenols are well known to act as inhibitors in radical chain reactions.38-41 This is
primarily due to their ability to donate a hydrogen atom to a propagating radical, thus
terminating the chain. Therefore the antioxidant activity of vitamin E can be described
by equations 5 and 6 (Scheme 2), where the phenol hydrogen atom (TOH) is donated
to a lipid peroxy radical, forming a chromanoxyl radical (TO•).
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Scheme 2. Inhibition of free radical propagation by tocopherols.
The chromanoxyl radical (TO•) will undergo radical-radical coupling to form adducts.
Depending on whether the other radical is carbon-based or oxygen-based, the adduct
will tend to be formed at the chromanoxyl oxygen42 or at the 8a43, 44 position
respectively (Scheme 3).
Scheme 3. Reactions of α-tocopherol with peroxyl radicals. 
The tocopherones 10-13 are then hydrolysed to the corresponding quinones by
opening of the chromane ring. According to equations (5) and (6), one tocopherol
molecule is therefore theoretically able to neutralise two lipid peroxy radicals.
1.3 Influence of Substituents on Activity
Vitamin E components have been the topic of a number of studies into antioxidant
activity.45-56 This antioxidant activity is primarily due to the ability of the tocopherols
to terminate free radical chain reactions as discussed previously (Schemes 1 and 2).
Therefore, in order to be an effective chain-breaking antioxidant the rate constant for
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reaction (5) must be much greater than that for (3), k5 >> k3 (Schemes 1 and 2), which
implies a high reactivity towards peroxy radicals. Howard and Ingold measured k5 for
a range of phenolic antioxidants with various substitution patterns, a selection of
which are shown in Table 1.41, 57
R1 R2 R3 10-5k5 (M-1s-1)
H OCH3 H 94
H OCH3 CH3 130
CH3 OCH3 CH3 39
CH3 CH3 CH3 36
CH3 CH3 H 11
H CH3 H 8.5
Table 1. k5 values for selected o-alkylated phenols at 30 °C.
structure 10-4 k5 (M-1s-1) structure 10-4 k5 (M-1s-1)
α-tocopherol 320 γ-tocopherol 140
β-tocopherol 130 δ-tocopherol 44
Table 2. k5 values for the natural tocopherols at 30 °C.
They found that the greatest k5 values were obtained with a p-methoxy substituent,
and with three methyl groups in the other positions. From the data it was concluded
that for simple phenols, k5 is dependent both on the radical stabilising effect of groups
in the ortho and para positions and on steric hindrance preventing the approach of the
peroxy radical. For example, in the same study they found that 2,6-di-tert-butyl
phenols were less reactive than the corresponding 2,6-dimethyl phenols due to the
increased steric bulk of the tert-butyl group.
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The k5 values for the natural tocopherols were also measured under the same
conditions and found to be in the order α > β ≈ γ > δ (Table 2), which has also been 
reported by others in vitro.58 Due to their structural similarities it might be expected
that p-methoxy-2,3,5,6-tetramethyl phenol should have a comparable antioxidant
activity to α-tocopherol, but instead it was found that α-tocopherol was much more 
active. Given that there is no difference in steric hindrance in the positions ortho to
the phenol group, the authors concluded that there must be a difference in the stability
of the radicals formed.
If the group in the para position has lone pairs available these can overlap with the π 
system of the aromatic ring, which stabilises the phenoxyl radical by delocalisation
(Scheme 4).
Scheme 4. Stabilisation of phenoxyl radicals by delocalisation.
In order for the lone pair electrons to overlap effectively they need to be perpendicular
to the aromatic plane, and the extent of overlap will depend on the dihedral angle (θ) 
between the lone pair orbital on oxygen 1 and the p orbitals in the aromatic ring.
Therefore a dihedral angle closer to 0 ° maximises the orbital overlap while an angle
closer to 90 ° represents a minimum overlap. In p-methoxy-2,3,5,6-tetramethyl phenol
the methoxy group can twist out of the plane in order to reduce steric clashing,
resulting in a dihedral angle of 89 ° (Figure 2).57, 59, 60 Orbital overlap is at a minimum
and the oxygen lone pair is not able to stabilise the radical.
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Figure 2. Newman projection of 4-methoxy-2,3,5,6-tetramethyl phenoxyl radical.
On the other hand, pentamethyl-6-hydroxy chromane is not able to twist out of the
plane to the same extent due to its bicyclic nature, resulting in a dihedral angle of
17 ° and better orbital overlap (Figure 3).57, 59, 60 Consequently, the chromane
compound is able to stabilise the radical to a greater extent resulting in a larger k5
value. This appears to be the fundamental reason for high vitamin E antioxidant
activity compared to phenols which lack the fused ring system.
Figure 3. Newman projection of pentamethyl-6-hydroxy chromanoxyl radical.
Burton et al. investigated the effect of substitution on the chromane ring in an attempt
to find a compound with greater antioxidant activity than α-tocopherol (Table 3).61 An
increase in k5 was seen when the phytyl side chain was substituted for a CH3 group,
due to a decrease in puckering of the chromane ring resulting in a dihedral angle closer
to 0 ° than in α-tocopherol. When R2 = CO2H or CO2CH3 (compounds 15d and 15e) a
decrease in activity is seen. The authors attribute this to an electron-withdrawing effect
which reduces the ability of oxygen (X = O, Table 3) to donate its lone pair,
consequently lowering the stability of the radical. Compound 15d had previously been
shown to be a more potent antioxidant than α-tocopherol in fats.62, 63
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Table 3. The effect on k5 of substitution around the chromane ring.
It might be expected that the compound with X = NCH2CH3 (tetrahydroquinoline,
15h) should have higher activity than compounds with X = O due to the greater ability
of nitrogen to stabilise neighbouring radical centres.64, 65 However, a decrease in
activity relative to α-tocopherol was measured. The reason for this is suggested to be 
that the N-ethyl group occupies the axial position in order to reduce steric clashing
with the C-8 methyl group, preventing the nitrogen lone pair from overlapping with
the π system (Figure 4).  
Figure 4. Presumed conformation of compound 15h, with the nitrogen lone pair perpendicular to the
π system. 
compound n R1 R2 X 10-4 k5 (M-1s-1)
a 2 CH3 C16H33 O 324
b 2 CH3 CH3 O 377
c 2 H H O 267
d 2 CH3 CO2H O 110
e 2 CH3 CO2CH3 O 183
f 2 CH3 CH2CO2H O 187
g 2 H H NC(O)CH3 12
h 2 H H NCH2CH3 197
i 1 H CH3 O 539
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However, this conclusion was drawn from space-filling models as the authors were
unable to grow crystals for X-ray crystallography. Compound 15i with n = 1 (2,3-
dihydrobenzofuran) showed the greatest k5 value in the study, and this has been shown
to be due to the small dihedral angle of 6 ° which increases radical stability as
discussed previously.57, 60 Other groups have carried out similar structure activity
relationship (SAR) studies of this type.66, 67
Studies of the type by Burton et al. above are typically carried out by measuring the
inhibited autoxidation of styrene in non-polar, organic solvent. Mukai et al.
investigated the reaction of an ArO•  radical with α-, β-, γ-, and δ-tocopherols, together 
with a selection of structurally related phenols, in a micellar solution designed to
mimic cell membranes (Table 4).58
The data they obtained showed that the activity of the tocopherols is in the order α > 
β ≈ γ > δ in both micellar and ethanol solutions. The increase in rate constant seen in 
micellar solution is due to the lipophilicity of the compounds. They will be localised
within the micelles and since the ArO• radicals are also lipid soluble, the reaction will
take place inside the micelle. This close association is responsible for the large
increase in rate. Tocol was shown to be around 90% less reactive towards radicals and
this is due to a lack of electron donating groups ortho to the phenol.
Ubiquinol-0 and ubiquinol-10 are known to act as lipid antioxidants in cell
membranes.68-70 The rate constant k5 in micelles measured in this study was found to
be comparable to vitamin E and a “regenerative” mechansim has been observed in
vitro, whereby ubiquinol-10 donates an H atom to the Toc• radical (Scheme 5).58, 71, 72
This type of synergistic relationship has been directly observed with ascorbic acid
(vitamin C).73-76
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solvent
antioxidant ethanol k5 (M-1s-1) micelle k5 (M-1s-1)
α-tocopherol 5.12 x 103 5.12 x 105
β-tocopherol 2.24 x 103 1.05 x 105
γ-tocopherol 2.42 x 103 1.00 x 105
δ-tocopherol 1.00 x 103 1.49 x 104
tocol 0.56 x 103 3.53 x 103
ubiquinol-10 4.70 x 103 1.25 x 105
ubiquinol-0 2.90 x 103 2.29 x 104
hydroquinone 3.35 x 102 2.68 x 103
Table 4. Measurement of k5 values for vitamin E and related phenolic antioxidants at 25 °C, in both
micellar (Triton X-100) and ethanol solution.
Scheme 5. Regeneration of tocopherol by UQ10H2 (Ubiquinol-10).
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1.4 Comparison Between α-, β-, γ- and δ- forms 
1.4.1 In Vitro
In vitro studies have shown α-tocopherol to be the most active form of vitamin E and 
δ-tocopherol to be the least active, with the β- and γ- forms in between.50, 52, 57-59, 77
This must be primarily due to the greater extent of methylation of α-tocopherol around 
the aromatic ring, as discussed previously, since the dihedral angles imply a greater
orbital overlap between the ring oxygen and the arene π system in γ- and δ- 
tocopherol.78-80 In addition, a greater number of electron donating groups would be
expected to stabilise a radical to a greater extent. However, studies of this type appear
to be highly dependent on a number of experimental factors. For example, Cillard et
al. studied the autoxidation of linoleic acid with and without tocopherols. They found
that the antioxidant activities were in the reversed order, with δ-tocopherol most 
potent.81 This has also been reported by other authors when measuring the relative
antioxidant activities in fats.82-84 Due to the reactive nature of radicals a number of
side reactions can take place which may be dependent on the substrate being studied,85,
86 temperature,86 light,86 concentration87-89 or solvent.90, 91 This wide range of variables
may explain the contradictory nature of the reports in the literature and makes it
difficult to compare results from different authors.
1.4.2 In Vivo
Whilst the relative antioxidant activities of the four tocopherols are all within an order
of magnitude in vitro, in biological systems α-tocopherol is by far the most important 
antioxidant. Leth and Sondergaard used a rat resorption-gestation assay to determine
the relative biological activities of the tocopherols (Table 5).92 They found that δ-
tocopherol had < 0.4% activity relative to so-called (all-rac)-α-tocopheryl acetate and 
similar results have been reported elsewhere in the literature.93-97
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substrate biological activity (%)a α-TTP binding affinity (%)b
(R,R,R)-α-tocopherol 80 100
(R,R,R)-β-tocopherol 45 38.1 ± 9.3
(R,R,R)-γ-tocopherol 13 8.9 ± 0.6
(R,R,R)-δ-tocopherol < 0.4 1.6 ± 0.3
(R,R,R)-α-tocopheryl acetate - 1.7 ± 0.1
(S,R,R)-α-tocopherol - 10.5 ± 0.4
Table 5. Comparison of natural tocopherols. a Relative to (2RS,4’RS,8’RS)-α-tocopheryl acetate 
(=100%). b Measured by calculating the relative IC50 values.
Given that this difference cannot be explained by the relative chemical reactivity of
the tocopherols alone, other factors relating to their distribution, transport or
bioavailability in cell tissues must be governing the measured relative activity. The
most important factor appears to be recognition by the α-tocopherol transfer protein 
(α-TTP), which is the protein responsible for maintaining plasma α-tocopherol 
concentrations.98-100
Hosomi et al. measured the relative binding affinities for tocopherols and tocopherol
analogues to α-TTP (Table 5).101 They found that (R,R,R)-α-tocopherol displayed the 
highest binding affinity and δ-tocopherol displayed the lowest, which correlates well 
with the relative biological activities in vivo. In addition, they also studied the effect
of stereochemistry on the binding affinity. From their results it can be seen that α-
tocopherol with the (2R)-configuration has an almost 10-fold higher binding affinity
to α-TTP than α-tocopherol with the (2S) configuration. Both of these results and
similar studies by other groups102-105 suggest that (R,R,R)-α-tocopherol is the optimal 
substrate for α-TTP and therefore it will be preferentially transported into cell 
membranes.
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The metabolism of vitamin E provides an additional explanation for the differences in
observed potency. It has been shown that the non-α-tocopherols are preferentially 
metabolised to the 2’-carboxyethyl-6-hydroxychromane (CEHC) forms by
cytochrome P450s (Scheme 6).106, 107
Scheme 6. Pathway of metabolism of γ-tocopherol to its γ-CEHC form. 
The fate of non-α-tocopherols is of importance given that the North American intake 
of γ-tocopherol exceeds that of α-tocopherol by a factor of 2-4.108, 109 Soybean oil is
thought to be the primary source of ingestion of vitamin E in the US diet, and this oil
has been shown to contain 3-4 fold higher quantity of γ-tocopherol compared to α-
tocopherol.110 γ-Tocopherol may also have different reactivity due to the potentially 
nucleophilic C-5 site which is blocked in α-tocopherol. Cooney et al. showed that the
41
reaction of γ-tocopherol with low levels of NO2 yielded 2,7,8 trimethyl-2-(4’,8’,12’-
trimethyldecyl)-5-nitro 6-chromanol 16 and 2,7,8-trimethyl-2-(4’,8’,12’-
trimethyltridecyl)-5,6-chromaquinone 19 (Scheme 7).111, 112 Other groups have
demonstrated the ability of γ-tocopherol to trap mutagenic electrophiles.110, 113 It has
also been suggested that γ-tocopherol may play a specific role in the prevention of 
heart disease and cancer.114
16 33 16 33 16 33
16 33 16 33
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Scheme 7. Proposed mechanism for the trapping of NO2 radicals by γ-tocopherol. 
1.5 Vitamin E Deficiency in Humans
Patients with symptoms caused by vitamin E deficiency were first reported in the
1960s.115, 116 This has been shown to be not due to lack of vitamin E in the diet, but
due to either a defect in the gene for α-TTP,117-120 or malabsorption of fatty acids,121
resulting in a lack of α-tocopherol at cell membranes and therefore increased lipid 
peroxidation. An increased oxidative stress on tissue cells can result in
neurodegenerative disease,122 cardiovascular disease,123 myopathy,124, 125 or peripheral
neuropathy.126 The reason for this is attributed to a dying back of sensory nerves.127
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1.6 Potential Non-antioxidant Applications
A number of roles not associated with antioxidant activity have been proposed for the
tocopherols, including regulation of protein kinase C128-130 and inhibition of cell
proliferation.131, 132 This conclusion was based largely on the fact that α-tocopherol 
had an effect on the signalling pathways whilst non-α forms did not. However, it has 
been suggested that these signalling pathways may in fact be dependent on the
oxidative stress of the cell or tissue in question rather than being directly controlled
by α-tocopherol.133 Therefore, the apparent regulation of signalling pathways and
other roles suggested for vitamin E may come back to its primary antioxidant function.
Vitamin E and analogues such as α-tocopheryl succinate (α-TOS) and α-tocopherol 
ether-linked acetic acid (α-TEA) have been shown to have potent anticancer properties 
in some cell types.134-139 Chen et al. synthesised a number of related vitamin E
analogues for anticancer functions (Table 6).140 The data in table 6 shows that the
highest anticancer activity was obtained with ether-linked analogues 21 and 22. Chen
et al. speculated that this may be due to the ether increasing the hydrophilicity of the
compound and increasing uptake in the cells, but the mechanism is unknown.
Pharmaceutical compounds incorporate fluorine in order to increase bioavailability,
lipophilicity or binding with a target protein.141 It has also been shown that fewer
methyl groups on the chromane head group may increase anticancer activity.136
Therefore, the authors synthesised 20 and 23, which are fluorinated at the C-7 position
and unsubstituted at C-5 and C-8. These compounds were found to exhibit similar
anticancer activity to α-TEA. However, given the considerable difference observed 
between the in vitro and in vivo antioxidant activity of the tocopherols due to their
differing bioavailability, similar effects may be observed with anticancer activity.
Therefore in vivo studies are potentially more useful.
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Table 6. EC50 values (µM) for vitamin E analogues.
1.7 Tocotrienols
In comparison to the tocopherols, much less work has been done on the tocotrienols,
which only differ in the phytyl side chain unsaturation (Figure 1). In vivo studies
showed that α-tocotrienol has 30% of the biological activity of α-tocopherol and β-
tocotrienol has only 5% of the activity of β-tocopherol, as determined by the rat 
resorption-gestation assay.142 This can be attributed to discrimination by the α-TTP 
which specifically recognises a saturated phytyl chain.143, 144 Consequently, the
tocotrienol forms of vitamin E are not retained in tissues and membranes to the same
extent as the tocopherols, resulting in lower biological activity.
Studies suggest that α-tocotrienol has a higher antioxidant activity than α-tocopherol 
in vitro.145, 146 Suzuki et al. found α-tocotrienol to have greater reactivity towards 
peroxy radicals in membrane systems, whilst both tocopherol and tocotrienol forms
cancer cell line α-TEA 20 21 22 23
MDA-MB-231 35 34 16 18 27
MCF-7 31 60 29 21 35
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were identical in hexane solution.147 Since the only structural difference between the
two is in the side chain, this suggests that differing arrangements in the membrane
could be affecting the reactivity. From their results Suzuki et al. suggested that α-
tocotrienol is located closer to the membrane surface than α-tocopherol, allowing for 
greater interaction with peroxy radicals. However, work by Yoshida et al. yielded
contrary results to those above, where they found very little difference in antioxidant
activity between α-tocopherol and α-tocotrienol in membrane systems.148
1.8 Vitamin E Synthesis in Industry
(R,R,R)-α-Tocopherol is the most biologically relevant form of vitamin E due to its 
higher activity. However a mixture of all eight stereoisomers, so-called (all-rac)-α-
tocopherol 26, is the most important compound commercially. The first synthesis of
α-tocopherol was reported by Karrer et al. in 1938, by the acid-catalysed condensation
of trimethylhydroquinone 24 with phytyl bromide 25 (Scheme 8).149, 150
Scheme 8. First reported synthesis of α-tocopherol. 
Note that phytyl bromide 25 was derived from natural (enantiomerically enriched)
phytol, since this was the only available source of the compound at the time.
The current industrial-scale synthesis of (all-rac)-α-tocopherol and (all-rac)-α-
tocopheryl acetate consists of the acid-catalysed condensation of
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trimethylhydroquinone and (all-rac)-isophytol 27 (Scheme 9). Considerable effort has
gone into the development of alternative catalysts to replace the conventional Lewis
acids (ZnCl2, AlCl3, BF3 among others), in order to increase selectivity and yield with
a lower catalyst loading.151-153 Trimethylhydroquinone is accessible on an industrial
scale from mesitol, isophorones or diethyl ketone.152, 154 (All-rac)-isophytol 27 is
accessible using isoprenoid chemistry, in particular the acid-catalysed Carroll155 and
Saucy/Marbet156 reactions for C3 elongations. The starting materials are acetone,
ethyne and hydrogen (Scheme 10).
Scheme 9. Industrial synthesis of (all-rac)-α-tocopherol 28 and its acetate 29.
Scheme 10. Industrial synthesis of (all-rac)-isophytol 27.
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Given the increased biological activity of specifically (R,R,R)-α-tocopherol compared 
to the lower homologues and other stereoisomers, access to this compound on an
industrial scale is important for pharmaceutical applications. Currently this is achieved
by the processing of natural materials, such as soya beans and vegetable oil, which are
rich in (R,R,R)-α-tocopherol. However, these materials also contain the lower 
homologues and so a “semi-synthetic” approach is used. All the tocopherols are first
isolated by extraction, and then upgraded to the α-form using halo-,157 amino-,158 or
hydroxy-159 alkylation-reduction sequences (Scheme 11).
Scheme 11. Representative procedure for the upgrading of γ-tocopherol to α-tocopherol. 
Netscher et al. have optimised procedures of this type using morpholine as the
Mannich reagent in a variety of ratios with formaldehyde.160 By adjusting the
stoichiometry to 1:1-1.2 [δ-tocopherol:morpholine] they were also able to 
monoalkylate δ-tocopherol to the β- form, due to the higher reactivity of the C-5 
position compared to the C-7 position. The reduction step is typically carried out using
H2 and Pd/C and the authors screened a considerable number of hydride reductants in
an attempt to find alternative reagents. They found that NaCNBH3 or NaBH4/NaOH
in i-BuOH were effective in the reduction of 5-(aminomethylated)-γ-tocopherol, but 
less effective when bis(aminomethylated)-δ-tocopherol was used as the substrate.  
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Relatively recent advances in catalytic asymmetric hydrogenation, based on the
pioneering work of Noyori and co-workers, have allowed construction of the enantio-
and diastereomerically enriched side-chain component 32 on an industrial scale
(Scheme 12).
Scheme 12. Asymmetric hydrogenation of olefins using Ru and Ir catalysts.
Conditions developed by Noyori et al.161, 162 were used at Roche to convert 30 into
(R,R)-hexahydrofarnesol 32, on a pilot scale with substrate:catalyst ratios of up to
150000:1.163 Pfaltz et al. developed an Ir catalyst capable of the asymmetric
hydrogenation of unfunctionalised, trialkyl substituted olefins with > 90% d.e. and >
99% e.e.164, 165 In this way farnesol, 31, was converted directly into (R,R)-
hexahydrofarnesol 32. One disadvantage of this route is that ligand 34 is not
commercially available, unlike the BINAP derived ligands used for Noyori-type
asymmetric hydrogenations.
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1.9 α-Tocopherol Asymmetric Total Synthesis 
The asymmetric total synthesis of (R,R,R)-α-tocopherol has been reported a number 
of times in the literature. Most of the syntheses to date can be categorised into: 1) those
which feature a C1’-C2’ coupling; 2) those which feature a stereospecific ring closing
reaction; and 3) those which feature a stereoselective ring closing reaction. The
syntheses in category 1 are the most abundant and generally consist of the asymmetric
construction of a chromane aldehyde (for example 35 or 36), followed by a Wittig
coupling with a side chain component (for example 37 or 38, Scheme 13).
Scheme 13. C1’-C2’ coupling route towards α-tocopherol. 
Given the importance of the chromane moiety in vitamin E chemistry, some
asymmetric approaches to their syntheses are also discussed below.
1.9.1 C1’-C2’ Coupling Approach
The first reported asymmetric total synthesis of α-tocopherol 1 was reported by Mayer
et al. in 1963.166 Their synthesis was the first example of the Wittig coupling method
shown in Scheme 13. They used chiral resolution to obtain aldehyde 36 (Scheme 14).
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Scheme 14. Chiral resolution of racemic aldehyde (±)-36.
The authors were unable to resolve aldehyde (±)-36 directly so it was converted into
the carboxylic acid 39, from which both enantiomers could be resolved using quinine.
Conversion into the enantiomerically enriched aldehyde 36 from the desired
enantiomer 40 was achieved over four steps; this compound was then subjected to a
Wittig coupling with phosphonium bromide 37, followed by hydrogenation over
palladium to yield (R,R,R)-α-tocopherol. 
Chiral resolutions of this type are common in the asymmetric syntheses of (R,R,R)-α-
tocopherol. Scott et al. used chiral resolution to synthesise precursor aldehyde 46, from
which the synthesis was completed using a Wittig coupling (Scheme 15).167
Construction of the chromane ring was achieved using a Wadsworth-Emmons reaction
and hydrolysis of the resulting ester gave the acid (±)-44. Resolution with (S)-α-
methylbenzylamine gave the enantiomerically enriched acid 45 in 34% yield. The side
chain component was derived from natural phytol as the (R,R)-diastereoisomer.
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Scheme 15. Synthesis of aldehyde 46 by chiral resolution.
Schmid et al. demonstrated a synthetic route to the phytyl side chain component and
used this in the total synthesis of α-tocopherol.168, 169 This synthesis was based on the
multiple Grignard coupling of chiral C5 components, derived from the
enantiomerically enriched lactone 47 (Scheme 16).170
Scheme 16. Synthesis of (3R,7R)-1-bromo-3,7,11-trimethyldodecane 56. Some steps have been
omitted for clarity.
The bromide fragment 48 was obtained with an e.e. of > 97% based on 1H NMR
analysis with the chiral shift reagent Eu(hfc)3. (3R,7R)-1-Bromo-3,7,11-
trimethyldodecane 56 was synthesised in 11 linear steps with an overall yield of 36%,
based on the lactone 47. Completion of the synthesis of α-tocopherol was achieved 
using the method of Mayer et al.
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A chiral γ-butyrolactone 57 was also used as a starting material in a synthesis by Cohen
et al. (Scheme 17).171 In this work the lactone 57 was elaborated into diketone 58 over
a number of steps, followed by annulation and oxidation to generate the p-
benzoquinone 59. This compound was cyclised in aqueous HCl and methanol to yield
the bridged ketal 60, which could be reduced with H2 and Pd/C to give the (S)-
chroman-2-methanol 61. None of the alternative seven-membered ring product was
detected in the final reduction step, and only one enantiomer was observed by chiral
shift 1H NMR spectroscopy. Completion of the synthesis was carried out using the
method of Mayer et al. to yield α-tocopherol in a total of 13 steps and with an overall 
yield of 6.5%.
Scheme 17. Synthesis of (S)-chroman-2-methanol 61
An alternative approach was demonstrated by Chan et al. in which the side chain was
built directly onto the chromane head group (Scheme 18).172, 173 The key steps in this
synthesis were a stereospecific Claisen rearrangement and a coupling with the
enantiomerically enriched Grignard reagent 67.
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Scheme 18. Synthesis of α-tocopheryl acetate. 
The chromane aldehyde 46 was prepared as described by Scott et al.167 (Scheme 15).
The required diastereomerically pure acetylenic carbinol 62 could be separated as a
mixture of 3,5-dinitrobenzoates, followed by hydrolysis. Johnson-Claisen
rearrangements are known to be highly stereoselective.174 Treatment of allylic alcohol
63 with triethylorthoacetate and propionic acid at 140 °C yielded the (2R,4’R)-ester
64, with an e.e. of 99%. Completion of the synthesis was achieved by the coupling of
tosylate 66 with the enantiomerically enriched Grignard reagent 67, analogous to the
route of Schmid et al. (Scheme 16), in a total of ten linear steps (from aldehyde 46)
and an overall yield of 8.5%.
1.9.2 Other Approaches to Enantiomerically Enriched Chromanes
As can be seen above, the synthesis of enantiomerically enriched chromane structures
commonly involves an optical resolution of a related racemic acid, often using chiral
nitrogen bases such as quinine or (S)-α-methylbenzylamine. Enzymatic kinetic 
resolutions have also been shown to provide very high e.e. values.175, 176 Asymmetric
syntheses are less common. Solladie and Moine reported the use of an
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enantiomerically enriched sulfoxide in the synthesis of chromane aldehyde 35
(Scheme 19).177
Scheme 19. Synthesis of chromane aldehyde 35 via an enantiomerically enriched sulfoxide.
Vinyl sulfoxide 69 was prepared in six steps (34% yield), and its addition to aldehyde
68 at -78 °C provided the allylic alcohol as a single diastereoisomer. Heating in
NaOMe/MeOH at reflux temperature furnished the chromene compound 72 by SN2’
ring closure, with no racemisation observed by 1H NMR spectrometry using a chiral
shift reagent. A further three steps (desulfurisation, benzylation and acetal hydrolysis)
yielded (S)-aldehyde 35 in six steps from 68, with an overall yield of 28%.
Uozumi et al. used palladium catalysis and a bisoxazoline (BOXAX) ligand to
synthesise both chromane and dihydrobenzofuran structures with high e.e. (Scheme
20).178 The reaction was tolerant of various substituents around the phenol ring with
e.e. values of 90-97% obtained under the optimised conditions. The (R,S,S)
diastereomer of the bisoxazoline ligand 74 gave poor selectivity (18% e.e.). Although
a good e.e. of 97% was achieved for the chromane compound (n = 1), with the (S,S,S)-
ligand, high catalyst loading (25 mol%) was required and 25% of unreacted starting
material was recovered even under these conditions.
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Scheme 20. Asymmetric Wacker-type cyclisation.
Trost et al. examined the asymmetric O-alkylation of phenols as a route towards the
synthesis of Canolides A and B, and the chromane core of vitamin E (Scheme 21).179
The aryl ether 79 was obtained with 98:2 regioselectivity and 77% e.e., despite the
tendency for phenols to attack the less hindered carbon in π-allylpalladium 
complexes.180 Hydroboration of the double bond, followed by activation as the
tosylate which underwent spontaneous intramolecular alkylation, yielded the
chromane 80 in an overall yield of 42% over three steps.
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Scheme 21. Chromane synthesis using an asymmetric O-alkylation.
Trost et al. later improved on these moderate e.e. values by employing an
intramolecular procedure (Scheme 22).181, 182 Much improved e.e. values were
obtained using this method and the issue of regioselectivity was also removed. This
procedure also offered an improvement over similar work by Mizuguchi et al. and
Labrosse et al. where only moderate e.e. values (up to 54%) were obtained.183, 184
Scheme 22. Intramolecular O-alkylation.
The leaving group was again chosen to be carbonate. Despite good e.e. values, the
lengthy synthesis of the starting material 81 (13% over 11 steps) represents the biggest
drawback to this procedure.
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Tietze et al. used a Sharpless dihydroxylation and a palladium cross-coupling to
synthesise the enantiomerically enriched chromane 92 (Scheme 23).185, 186 Protection
followed by dihydroxylation of the commercially available alcohol 84 provided diol
86 with an e.e. of 96%, and a yield of 93%. It was found that using a benzyl ether
protecting group (R = Bn) gave a much lower e.e. of 53%. Conversion to the iodide
89 was achieved over three steps, followed by coupling to aryl iodide 90 using
Zn/Cu/Pd system.
Scheme 23. Synthesis of chromanes using a Sharpless dihydroxylation.
Conversion to the enantiomerically enriched chromane 92 from the acetonide 91 was
previously reported.171 This work represents a slight improvement on earlier work by
Tietze et al. where the dihydroxylation of an enyne was used to generate the same
precursor acetonide 91, but with a lower e.e. of 84%.187 Takabe et al. and Mizuguchi
et al. also applied asymmetric epoxidations and dihydroxylations of this type in the
synthesis of enantiomerically enriched chromanes.188, 189
1.9.3 Stereospecific Ring Closure Approach
The majority of the syntheses discussed up to this point have involved the C-C
coupling of side chain components to an enantiomerically enriched chromane.
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Another important approach to vitamin E synthesis is by a stereospecific ring closure,
where the desired stereochemistry is defined beforehand.
Due to their high selectivity, asymmetric epoxidation and dihydroxylation reactions
have seen considerable use in natural product synthesis.190 Inoue et al. used a
sulfoxide-mediated phenol alkylation and an asymmetric epoxidation in the total
synthesis of α-tocopherol.191 Phenoxy- and azasulfonium ylids such as 96 are known
to undergo [2,3] sigmatropic rearrangements to yield o-alkylated products 97 (Scheme
24).192-194
Scheme 24. o-Alkylation of phenols with dialkyl sulphides.
Scheme 25 shows the synthesis carried out by Inoue et al. Epoxide 98 was obtained in
enantiomerically pure form by the Sharpless epoxidation195 of the corresponding
allylic alcohol, with the sulfide 100 generated over a further four transformations.
Treatment of sulfide 100 with sulfuryl chloride, triethylamine and phenol 101 at
-40 °C yielded the alkylated compound 102. The synthesis was completed by
desulfurisation, reduction of the acetyl groups and acid-catalysed cyclisation as
described by Cohen et al.196 The reported yield of α-tocopherol was 81% from sulfide 
99, with the e.e. at C-2 determined to be 96%.
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Scheme 25. Total synthesis of α-tocopherol 1.
Takano et al. reported the synthesis of α-tocopherol via an enantiomerically enriched
3-hydroxyacetylene (Scheme 26).197
Scheme 26. Synthesis of known benzoquinone intermediate 108.
The epoxide 98 was obtained from the Sharpless epoxidation of natural phytol. Takano
et al. had previously shown that enantiomerically enriched chloroepoxides such as 104
could be converted into the corresponding 3-hydroxyacetylenes without
racemisation.198 Thus, treatment of epoxide 104 with n-butyllithium furnished the
propargyl alcohol 105. Cross-coupling with the aryl iodide 90 and subsequent
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hydrogenation yielded alcohol 106, which was converted into the known p-
benzoquinone 108. Completion of the synthesis from this compound was previously
reported,191 and α-tocopherol was obtained in nine steps and 24% overall yield from 
natural phytol.
Hübscher and Barner reported the synthesis of α-tocopherol using several epoxide 
ring-opening reactions (Scheme 27).199 Diol 109 was obtained by the initial Sharpless
epoxidation of 2-methylprop-2-en-1-ol, in 81% overall yield over two steps and 98%
e.e. Treatment with NaH and alkyllithium 111 yielded the diol 112.
Scheme 27. Synthesis of α-tocopherol 1 by Hübscher and Barner.
Activation of the primary alcohol by tosylation allowed the formation of epoxide 113,
which was subsequently ring-opened by an enantiomerically enriched Grignard
reagent. Completion of the synthesis from alcohol 107 was carried out using the
method of Takano et al.,197 to yield α-tocopherol 1 in an overall yield of 17% over
eight steps (from 2-methylprop-2-en-1-ol).
Woggon et al. employed a similar approach, where an epoxide ring opening was used
to directly synthesise the chromane ring (Scheme 28).200
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Scheme 28. Synthesis of α-tocopherol using a stereoselective Shi epoxidation. 
Alkene 114 was synthesised from trimethylhydroquinone and phytyl bromide using
a four step sequence. Shi epoxidation gave the epoxide 115 in a d.e. of 97%, where
the bulky TBDPS (tert-butyldiphenylsilyl) protecting group was required to give good
selectivity. Subsequent deprotection and cyclisation in 2M HCl/Et2O gave the
chromane 117 in 93% d.e. Note that the 6-exo-tet cyclisation is formally disfavoured
according to Baldwin’s rules, and the authors found that the 5-exo-tet benzofuran
product was formed as a by-product in 19% yield. The slight decrease in d.e. is due to
the extent of carbenium ion formation during the reaction. The chromane 117 was then
converted into α-tocopherol, with an overall yield of 20% over 11 steps.  
Rein et al. reported a synthesis where the key steps were construction of a chromane
ring by stereospecific ring closure, and an o-DPPB (o-diphenylphosphanyl benzoate)
-directed syn substitution (Scheme 29).201 Synthesis of the chromane ring began with
the coupling of aryl iodide 118 with alcohol 119, derived from an enzymatic
hydrolysis. Subsequent hydrogenation yielded the acetonide 120 from which the
conversion into chromane 61 had been described by Cohen et al.171, 196 A further six
steps furnished the iodide precursor 122. o-DPPB has been shown to act as a directing
group in the addition of organic cuprates with excellent selectivity; furthermore, a
single equivalent of organometallic reagent can be used in contrast to the two or more
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equivalents commonly required.202 Thus, the Grignard reagent 123 was coupled to
alkene 124 in syn fashion. Hydrogenation furnished α-tocopherol in an overall yield 
of 30% over 13 steps. The coupling fragment 124 was synthesised in ten steps with an
overall yield of 18%, where the stereochemistry was introduced by a rhodium-
catalysed hydroformylation reaction, with a d.e. of 91%.
Scheme 29. α-Tocopherol synthesis using a directed cuprate addition. 
Woggon et al. used the Mitsunobu reaction with an α-hydroxy ester to obtain the 
required stereochemistry at the C-2 position, and subsequent cyclisation yielded the
chromane structure (Scheme 30).203
Epoxide 127 was prepared from the corresponding methylallyl alcohol by a Sharpless
epoxidation protocol and treatment with EtMgCl. The key Mitsunobu reaction
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between monoprotected hydroquinone 130 and α-hydroxy ester 129 was achieved
with 94% d.e. and complete inversion of configuration. Alcohol 133 was then obtained
following olefination and rhodium-catalysed hydroboration. Oxidation to the aldehyde
followed by acid-catalysed cyclisation yielded the chromene 135, which after
hydrogenation and demethylation yielded α-tocopherol 1 in a yield of 18% over 13
steps. The d.e. of the Mitsunobu reaction (94%) was retained throughout the synthesis.
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Scheme 30. α-Tocopherol synthesis using a Mitsunobu reaction. 
1.9.4 Stereoselective Ring Closure Approach
In contrast to the syntheses discussed above, approaches to the synthesis of
tocopherols where the chromane ring system is constructed in stereoselective fashion
are relatively scarce. Tietze et al. used a palladium-catalysed cyclisation to yield
chromanes 139 and 140 with good enantioselectivity (Scheme 31).204
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Scheme 31. Synthesis of chromanes via palladium-catalysed cyclisation.
A proposed mechanism is shown in scheme 32. The chirality is generated during the
enantiofacial coordination of 136 to the palladium complex, where Ln = (S,S,S)-iPr-
BOXAX.205, 206
Scheme 32. Domino Wacker-type oxidation and Heck reaction.
Insertion of acrylate 137 gave the chromane 139 in 84% yield and with an e.e. of 96%;
however, when R = CH3 (138) the yield and e.e. of chromane 140 were 54% and 84%
respectively. Dihydroxylation of the unsaturated ester 139 followed by oxidative
cleavage with sodium periodate gave an aldehyde which could be converted into α-
tocopherol 1 by known methods.173
Woggon et al. employed a diastereoselective aldol/oxa-Michael addition reaction as
the key step in the total synthesis of both (2R,4’R,8’R)-α-tocopherol and (2S,4’R,8’R)-
α-tocopherol (Scheme 33).207 Diarylprolinol-derived catalysts are known to provide
good selectivity in a variety of addition reactions.208-211 Therefore, the reaction
between aldehydes 144 and 145, derived from trimethylhydroquinone and natural
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phytol respectively, gave hemiacetal 147 in 58% yield and 97% d.e. A proposed
mechanism is shown in scheme 34. A number of proline derivatives were screened
and (R)/(S)-146 was found to give the best selectivity under the optimised conditions,
although a fairly high catalyst loading (30 mol%) was required. The lactone 148 was
readily hydrogenated to the carboxylic acid 149, which could be converted into α-
tocopheryl methyl ether 150 using a Barton decarboxylation.212
Scheme 33. Synthesis of α-tocopherol using a domino aldol/Michael addition. 
Removal of the methyl ether protecting group using BF3.SMe2/AlCl3 furnished
(R,R,R)-α-tocopherol and (S,R,R)-α-tocopherol in yields of 29% and 26% respectively, 
over eight steps starting from phytol. Diastereomeric excess was measured at 93% and
94% respectively.
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Scheme 34. Proposed mechanism for the aldol/oxa-Michael addition.
Woggon et al. also used chiral proline derivatives in a biomimetic synthesis inspired
by a tocopherol cyclase enzyme (Schemes 35 and 36).213, 214 The chiral auxiliary D-
Pro-D-Asp was installed using a Mannich reaction with N-methylene-D-proline,
followed by coupling with Fm-protected D-aspartate. Note that the use of a bulky R1
substituent was required to force the peptide into a conformation that is close enough
to the C-8 double bond. The key cyclisation of amide 153 follows an analogous
mechanism to that of the cyclase enzyme (Scheme 36). In this way the chromane 154
was furnished, which after removal of the chiral auxillary and the camphanate ester
gave α-tocotrienol in 65% e.e. Conditions developed by Pfaltz et al.165, 215 enabled the
catalytic hydrogenation of the side chain double bonds in an R/S ratio of > 99:1,
eventually yielding α-tocopherol 1 in an overall yield of 1% over 16 steps.
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Scheme 35. Biomimetic synthesis of α-tocopherol 1.
Scheme 36. Reaction mechanism of tocopherol cyclase.213
An alternative approach was explored by Termath et al. where the Ni-catalysed 1,4-
addition of a methyl anion equivalent onto chromenone intermediate, 159, was
anticipated to yield an enantiomerically enriched chromane when chiral ligands were
employed (Scheme 37).216
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Scheme 37. Synthesis of α-tocopherol by 1,4-addition.
Acetophenone building block 155 was synthesised from trimethylhydroquinone in a
yield of 85% over four steps, whilst carboxylic acid 156 was elaborated from (R,R)-
hexahydrofarnesol in 96% yield. Treatment of ester 157 with KOt-Bu yielded the
chromanone 158 in a Baker-Venkatamaran rearrangement,217, 218 and subsequent
dehydration with AcCl/MeOH gave the key chromenone 159. Termath et al. had
previously reported work on metal-catalysed, enantioselective 1,4-additions to
cyclohexanone;219, 220 however, treatment of chromenone 159 with AlMe3 in the
presence of a chiral Ni complex failed to provide any stereoselectivity. A maximum
d.e. of 2% was observed across all the ligands screened. (2RS,4’R,8’R)-α-Tocopherol 
was obtained in an overall yield of 60% over 11 steps (longest linear sequence).
Colobert et al. synthesised (2R,4’RS,8’RS)-α-tocopherol using a sulfoxide-directed 
allylation as the key step (Scheme 38).
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Scheme 38. Stereoselective synthesis of a chromane compound.
The treatment of the chroman-2-one 162 with the lithium anion of (S)-163 gave
chromanol 164, which after reaction with trimethylorthoformate/p-toluenesulfonic
acid (p-TsOH) gave the corresponding ketal. Treatment of ketal 165 with TiCl4 and
allyl trimethylsilane gave the sulfoxide 166 in 73% yield and > 99% e.e. The proposed
mechanism is shown in scheme 39. Attack of upper face of the oxonium intermediate
by allyl trimethylsilane rationalises the observed stereochemistry. A cross-metathesis
reaction with 166 and 3,7,11-trimethyldodec-1-ene gave a compound with the full
carbon skeleton of α-tocopherol, and a further three steps (desulfinylation, double 
bond hydrogenation and TBS deprotection) yielded (2R,4’RS,8’RS)-α-tocopherol 168
in ten steps and 24% overall yield.
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Scheme 39. Sulfoxide-directed allylation.
1.10 Our Planned Synthesis of α-Tocopherol 
As a known precursor to α-tocopherol, aldehyde 35 should be accessible from the
carboxylic acid 169, which in turn should be the product of the intramolecular Jocic
reaction of phenol 170 (Scheme 40). It was hoped that this phenol could ultimately be
derived from the enantiomerically enriched β-lactone 171. Given the importance of
the key cyclisation step in setting the stereochemistry of chroman-4-one 169, a detailed
discussion of the Jocic reaction and the synthesis of trichlorocarbinols will follow.
Scheme 40. Preliminary retrosynthesis of α-tocopherol 1.
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1.11 The Jocic Reaction
The transformation of trichlorocarbinols 172 into α-substituted carboxylic acids 173
under basic conditions is most commonly referred to in the literature as the Jocic
reaction (Scheme 41).221, 222
Scheme 41. The Jocic reaction.
The accepted mechanism is shown in scheme 42. After deprotonation by base, the
intramolecular displacement of chloride produces the gem-dichloroepoxide 174. The
regioselective, stereospecific SN2 ring-opening of this epoxide by a nucleophile,
followed by hydrolysis of the resulting acid chloride 175, yields α-substituted 
carboxylic acids 173.
Scheme 42. General mechanism for the Jocic reaction.
The alkyl or aryl groups R1 and R2 can be widely varied and the reaction works with
both organic and inorganic bases, in a variety of solvents. Many different nucleophiles
have been employed and these will be discussed later.
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1.12 The Bargellini Reaction
The Bargellini reaction is a variation on the Jocic reaction where the trichlorocarbinol
is not isolated but is generated in situ (Scheme 43).223
Scheme 43. General mechanism for the Bargellini reaction. R1, R2 = alkyl.
The mechanism goes through the same gem-dichloroepoxide 174 as the Jocic reaction,
with the main differences being that the trichlorocarbinol is not isolated, and that
neither R1 nor R2 are hydrogens. The reaction of aldehyde 177 with α-H fails to give 
carboxylic acid 178 under the same conditions due to competing aldol condensation
reactions (Scheme 44). The reaction of aldehyde 177 with no α-H yields mainly the 
alcohol and carboxylic acid products of the Cannizzaro224 reaction.
Scheme 44. Failure of aldehydes as substrates in the Bargellini reaction. R1 = alkyl.
Similarly to the Jocic reaction, a variety of bases and nucleophiles have been explored
and the reaction has found considerable use by researchers in the pharmaceutical
industry. Examples of the Jocic and Bargellini reactions will be discussed later.
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1.13 Synthesis of Racemic Trichlorocarbinols
The synthesis of racemic trichlorocarbinols can largely be separated into two groups;
the addition of a trichloromethyl anion to a carbonyl compound, or the addition of
nucleophiles to chloral (Cl3CCHO) or related ketones. Examples of each are discussed
in the following sections.
1.13.1 Trichloromethyl Anion Addition
One of the earliest examples of trichlorocarbinol synthesis via trichloromethide
addition was from Willgerodt, who synthesised 1,1,1-trichloro-2-methylpropan-2-ol
180 in 1881 by the reaction of acetone with chloroform and sodium hydroxide
(Scheme 45).225, 226 Saljoughian et al. later reported that the optimal molar ratio of
acetone:chloroform was 10:1, and that carrying out the reaction at -5 °C gave a yield
of 71%.227 The use KOH over NaOH gave higher yields.
Scheme 45. Early synthesis of 1,1,1-trichloro-2-methylpropan-2-ol. Yield not reported.
Jocic was the first to use this reaction with aldehydes under the same conditions to
give trichlorocarbinols (Scheme 46).221 In addition to benzaldehyde 181 he also
studied the reaction using isobutyraldehyde 183. However, it was found that
significant aldol condensation took place and he was unable to isolate the
trichlorocarbinol 184 cleanly.
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Scheme 46. Synthesis of 2,2,2-trichloro-1-phenylethan-1-ol by Jocic.
This chloroform/hydroxide methodology was later extended to furfural 186 and o-
chlorobenzaldehyde 187 by Howard (Scheme 47).228, 229 He also tested the reaction
using aliphatic aldehydes (190, Scheme 48), but found that aldol condensation was
prevalent as Jocic had reported previously. Howard also reported that bromoform
could be used in place of chloroform to yield the tribromo compound.230
Scheme 47. Synthesis of 2,2,2-trichloro-1-(furan-2-yl)ethan-1-ol.
Scheme 48. Attempted synthesis of aliphatic trichlorocarbinols. R = CH3CH2, CH3CH2CH2,
(CH3)2CHCH2.
Both Howard and Jocic used less than equimolar quantities of hydroxide in their
experiments since they assumed that it served as a catalyst for the reaction, which
accounts partly for the low yields they obtained. Bergmann et al. used a series of
substituted benzaldehydes with equimolar potassium hydroxide in order to obtain
improved yields of the addition product (Scheme 49).231
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Scheme 49. Improved synthesis of aryl trichlorocarbinols. R = o-CH3, m-CH3, p-CH3, o-OCH3, m-
OCH3, p-OCH3, o-Cl, m-Cl, p-Cl.
Viehe and Valange used sodium amide as the base for the addition of trichloromethide
to several carbonyl compounds (Table 7).232
carbonyl product yield (%) carbonyl product yield (%)
86a 74c
93b 32d
Table 7. Synthesis of trichlorocarbinols using sodium amide base. Reagents and conditions: a CHCl3
(1.0 equiv.), NaNH2 (1.0 equiv.); b CHCl3 (4.0 equiv.), NaNH2 (1.2 equiv.); c CHCl3 (3.0 equiv.),
NaNH2 (1.0 equiv.); d CHCl3 (1.0 equiv.), NaNH2 (1.0 equiv.). All reactions were carried out in liquid
ammonia solvent at -80 °C.
These reaction conditions gave good yields for the ketones studied. When
benzaldehyde was used a lower yield was obtained due to the competing addition of
amide and the Cannizzaro side reaction.
Merz and Tomahogh used a phase transfer-catalysed reaction to synthesise
trichlorocarbinols from both aldehydes and ketones (Table 8).233
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entry R1 R2 time (min) 195 yield (%)
a Phenyl H 90 80
b p-CH3OC6H4 H 120 62
c i-Propyl H 30 34
d Methyl CH3 15 69
e Ethyl CH3 15 13
f Cyclopentanone 15 33
g Cyclohexanone 20 23
Table 8. Synthesis of trichlorocarbinols using a phase transfer catalyst.
Cannizzaro and aldol reactions are the major side reactions when strongly basic
conditions are used in the presence of aldehydes.224, 234 The use of biphasic conditions
reduces the contact that the organic compounds have with the basic aqueous layer and
this suppresses these side reactions. Even under these conditions the yield of aliphatic
compound 195c was still low. Merz and Tomahogh put the unreactivity of 194e down
to steric hindrance since the yields with cyclic analogues were higher. Additionally, it
was found that a low temperature was necessary to obtain reasonable yields since at
higher temperatures the Cannizzaro reaction predominated over addition of
trichloromethide.
Wyvratt et al. developed a high yielding method for the synthesis of both secondary
and tertiary trichlorocarbinols, with no evidence of competing Cannizzaro reactions
(Scheme 50).235
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Scheme 50. Wyvratt synthesis of 2,2,2-trichloro-1-(3-nitrophenyl)ethan-1-ol 197.
The base was used in a methanolic solution in order to obtain a homogenous mixture,
since lower yields were obtained with solid base in DMF alone. In addition to 3-
nitrobenzaldehyde 197, benzaldehyde (99%), p-anisaldehyde (97%),
isobutyraldehyde (70%) and cyclohexanone (68%) were also used as substrates in the
reaction. The lower yields obtained for the enolisable carbonyl compounds is due to
the competing aldol condensation. Wyvratt attributed the success of the procedure to
the enhanced nucleophicity of the trichloromethyl anion in DMF solvent.
Aggarwal and Mereu developed an amidine-promoted protocol for the addition of
chloroform to benzaldehyde (Scheme 51).236
Scheme 51. 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU)-promoted addition of chloroform to
benzaldehyde.
Both amidines and guanidines were found to promote the reaction; the use of these
non-nucleophilic organic bases completely suppressed any Cannizzaro side reactions.
Table 9 shows a selection of results obtained by Aggarwal. Noteworthy is the
observation that enolisable aldehydes and ketones (entries e-g) gave better yields than
had previously been reported. This is due to competing side reactions being suppressed
by the mild conditions. The yield for mesitaldehyde (entry d) is lower due to steric
hindrance.
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entry carbonyl compound time (h) trichlorocarbinol yield (%)
a Benzaldehyde 3 98
b o-Chlorobenzaldehyde 4 94
c p-Anisaldehyde 6 95
d Mesitaldehyde 1 25
e Propanal 2 80
f Acetone 24 75
g Cyclohexanone 24 84
Table 9. Selection of results from Aggarwal et al. Reactions were performed in absence of solvent at
room temperature using a carbonyl compound:CHCl3:DBU ratio of 1:2:1.
Snowden et al. developed a one-pot synthesis of trichlorocarbinols from primary
alcohols (Table 10).237 By sequential addition of Dess-Martin periodinane (DMP) and
1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) to the alcohol in CHCl3, trichlorocarbinols
200 were synthesised in reasonable to good yield. 1,1,3,3-Tetramethylguanidine
(TMG) and DBU gave inferior results when used as the base. By removing the need
to isolate the aldehyde 199 the authors were able to trichloromethylate more sensitive
compounds, such as 2-thienylmethanol 198f, which formed a sensitive aldehyde that
proved difficult to isolate and trichloromethylate by other methods. Propargylic
alcohol 198g was an unsuitable substrate since several byproducts were formed upon
addition of base to the intermediate ynal.
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entry R time (h) 200 yield (%)
a p-OCH3Ph 24 83
b Ph 8 87
c p-NO2Ph 6 85
d PhCH2CH2 30 71
e CH3(CH2)8 30 60
f Thiophen-2-yl 48 61
g PhCCH 10 34
Table 10. One-pot oxidation/trichloromethylation of primary alcohols. Reactions were conducted on
a 1 mmol scale.
Li et al. used an organotitanium reagent to prepare trichlorocarbinols from enolisable
ketones (Table 11).238 Enolisation and steric hindrance remain problems in the
preparation of trichlorocarbinols from carbonyl compounds with α-protons. In 
searching for a solution to this issue, Li et al. noted that organotitanium reagents had
been shown to be superior to traditional Grignard reagents for additions to sterically
hindered and/or enolisable ketones.239, 240 Thus, when TiCl(Oi-Pr)3 was used as an
additive in the base-promoted addition of chloroform, a range of ketones were found
to be suitable substrates. Notably, the highly enolisable ketone 201c gave
trichlorocarbinol 202c in moderate yield.
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carbonyl product yield (%) carbonyl product yield (%)
95 84
93 96
45
Table 11. Reagents and conditions: CHCl3 (5.0 equiv.), n-BuLi (5.0 equiv.), TiCl(Oi-Pr)3 (2.0
equiv.), THF, -60 °C, 4 h.
Organometallic reagents of the type LiH2X, LiHX2 and LiX3 are known to add to
electrophiles; however they are highly thermolabile and their reactions require low
temperatures.241-245 α-Halo organosilanes were investigated by Hiyama and Fujita as 
an alternative method for generating halo-carbanions for use in organic synthesis
(Table 12).246 Treatment of the organosilane 203 with tris(dimethylamino)sulfonium
difluorotrimethylsilicate (TASF) generated the corresponding carbanion, which
readily added to aldehydes. When 2-phenylpropanal was used as the aldehyde (Table
12, entry c) the major product was the (2S,3R)-diastereomer. The use of more bulky
organosilanes (e.g R = PhMe2 or t-BuMe2) did not significantly alter this ratio,
indicating that the selectivity arises from the “naked” trichlorocarbanion.
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entry R R’ 205 yield (%)a
a CH3 Ph 77b
b CH3 n-C10H21 79c
c CH3 PhCH(CH3) 75d
Table 12. a Isolated after desilylation (1M HCl/MeOH, rt, 0.25-0.5 h). Reagents and conditions: b
TASF (0.1 equiv.), THF, rt, 8 h; c TASF (0.1 equiv.), THF, 0 °C, 12 h; d TASF (0.25 equiv.), THF, 0
°C, 4 h. In all entries 1.2 equiv. of silane was used. TASF = tris(dimethylamino)sulfonium
difluorotrimethylsilicate.
Scheme 52. Explanation for the observed selectivity using a Felkin-Anh model.
Although the TMS-CCl3 reagent had been shown above to add to aldehydes in useful
yields, and later extended to ketones by Fujita et al.,247 syntheses of the reagent itself
were generally low yielding;248-250 although more recently yields of 65-70% have been
reported.251 The reaction of TMS-CCl3 with electrophiles has also been catalysed by
sodium formate252 and by flash pyrolysis.253 Trimethylsilyl trichloroacetate has also
been used as a transfer agent.254, 255
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During scale-up studies Henegar and Lira developed a protocol for in situ generation
of TMS-CCl3 and addition to carbonyl compounds, thus avoiding the need to isolate
and handle the reagent (Table 13).256
entry carbonyl
compound
207 yield (%) entry carbonyl
compound
207 yield (%)
a 85 f 96
b 96 g 36
c 42 h 98
d 96a i 95
e
-b
Table 13. a Isolated as a > 20:1 mixture of diastereoisomers. b Not isolated, the deprotected carbinol
was obtained in a yield of 65% over two steps and as a > 20:1 mixture of diastereoisomers.
The reaction was successful with a range of carbonyl compounds. Notably, high
diastereoselectivity was obtained for entries d and e, where for 207d the addition of
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TMS-CCl3 was established to occur trans to the substituent on the ring. Compounds
which readily enolised (entries c and g) gave lower yields.
Whilst studying the thermal decarboxylation of trichloroacetate salts to generate
dichlorocarbenes, Wagner et al. found that when acetone or butanone were used as the
solvent addition of CCl3 anion occurred, according to Scheme 53.257, 258
Scheme 53. Addition of trichloromethyl anion to acetone via decarboxylation of trichloroacetate salts.
Winston et al. noted this observation and used the same conditions to prepare the
trichlorocarbinol 210 in reasonable yield (Scheme 54).259, 260 This appears to be the
first reported attempt to use the thermal decarboxylation of trichloroacetate as a
deliberate method for introducing the trichloromethyl group into organic structures.
Scheme 54. Synthesis of trichloromethylhydroxy lactone 210.
Corey and Link further developed a general synthesis of trichlorocarbinols from
aldehydes (Table 14).261 By avoiding the use of a strong base, neither Cannizzaro nor
aldol reaction side products were observed, as shown by the high yields obtained from
aldehydes containing α-protons (entries a, c, e and f). Mild conditions and simplicity
have allowed this procedure to find wide use for the synthesis of trichlorocarbinols, as
will be seen later in the chapter.
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entry aldehyde
TCA/NaTCA
(equiv.)
time (h) 212 yield (%)
a Hydrocinnamaldehyde 1.5 0.5 97
b Cinnamaldehyde 1.5 0.75 95
c Cyclohexanecarboxaldehyde 1.5 1 84
d Pivaldehyde 9.0 9 76
e Diphenylacetaldehyde 13.5 36 59
f 3,4,5-trimethoxyphenylacetaldehyde 10.0 12 74
Table 14. Reactions were run at 23 °C (entries a-d) or 4 °C (entries e and f). TCA = trichloroacetic
acid; NaTCA = sodium trichloroacetate.
1.13.2 Nucleophilic Addition to Chloral
The addition of nucleophiles to chloral to yield trichlorocarbinols considerably
predates trichloromethide addition to carbonyl compounds; as early as 1858 ammonia
had been used to yield the amino alcohol by Staedeler.262 The first example of a
carbon-based nucleophile being used in this way is from Garzarolli, who reported the
reaction of diethyl zinc with chloral to yield 1,1,1-trichlorobutan-2-ol 214 (Scheme
55).263
Scheme 55. Reaction of chloral with diethyl zinc.
Jocic first used the reaction of phenylmagnesium bromide with chloral to give 2,2,2-
trichloro-1-phenylethan-1-ol 215 (Scheme 56).222 A yield of 61% was obtained by
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Riemschneider for the same reaction.264 Kharasch et al. obtained a yield of 60% for
the reaction of methylmagnesium bromide with chloral.265
Scheme 56. Grignard reagent addition to chloral. R = Ph, Me.
A range of different Grignard reagents were studied by Howard (Table 15).266, 267
entry R yield (%)
214 Ethyl 32
a Propyl 24
b Butyl 41
c i-Propyl 41
d Benzyl 19
Table 15. Reaction of chloral with Grignard reagents.
Yields for the reaction of chloral with Grignard reagents that contain β-hydrogens are 
typically lower due to oxidation of the reagent, yielding significant quantities of
reduced chloral (trichloroethanol).268 An expanded range of Grignard reagents have
since been explored by other authors and were found to give reasonable yields.269-271
When aryl trichlorocarbinols are required, Friedel-Crafts procedures are useful. The
earliest reports, dating back to 1887, detail the reaction of benzene and chloral in the
presence of AlCl3, to yield 2,2,2-trichloro-1-phenylethan-1-ol.272, 273 Dinesmann
demonstrated the generality of the reaction by using toluene, p-xylene and anisole as
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the aromatic starting materials.274 AlCl3 is generally used as the Lewis acid catalyst
but BF3 has also been shown to be effective.275 When sulfuric acid is used as the
catalyst the products are exclusively diaryltrichloroethanes.276
Reeve et al. studied a variety of aromatic compounds in the Friedel-Crafts reaction
with chloral (Table 16).277
entry 216
ratio
216:chloral
AlCl3
(equiv.)
solvent
217 yield
(%)
a Benzene Excessa 0.22 Benzene 80
b Napthalene 0.5 0.15 Nitrobenzene 61
c Anisole Excessa 0.20 Anisole 39
d 2,4-Dichloroanisole 1.0 2.0 CS2 0
e 2,4-Dichlorophenol 0.9 2.1 CS2 60
f 2,5-Dichlorobenzene Excessa 0.9 2,5-Dichlorobenzene 76
g Fluorobenzene 1.0 1.0 CS2 62
h Chlorobenzene Excessa 0.2 Chlorobenzene 50
i Bromobenzene Excessa 0.2 Bromobenzene 55
j Iodobenzene 1.0 1.0 CS2 30
Table 16. Friedel-Crafts reaction of aromatic compounds with chloral. a Excess indicates that 7-10
equivalents were employed.
In general, the aromatic compound was used as both reactant and solvent. When CS2
was used as the solvent a complex of aryltrichlorocarbinol/AlCl3 precipitated out of
solution, so a stoichiometric quantity of AlCl3 was required for these reactions. The
molar equivalents of AlCl3 required varies with the reactivity of the aromatic substrate.
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Rezende et al. established that the optimum equivalent of AlCl3 was 0.2 for substrates
less reactive than benzene and 0.4 for substrates more reactive than benzene.278
Much like the Friedel-Crafts acylation reaction has found use in the synthesis of aryl
trichlorocarbinols, the aldol reaction can be used to synthesise alkyl trichlorocarbinols.
An early example of this from Koenigs in 1892 is shown in scheme 57.279
Scheme 57. Aldol condensation of acetone and acetophenone with chloral.
Note that the reaction stops after the addition of one chloral molecule. Similar results
were reported when the reactions were carried out in the absence of solvent.280
Reeve studied the condensation of a further four methyl ketones with chloral (Table
17).281 This study was undertaken partly to resolve discrepancies in the literature as to
the regiochemistry of the aldol adduct from 221b. Breusche and Keskin282, 283 stated
that condensation occurred at the methyl group, while Caujolle et al. believed that
condensation occurred at the methylene group.284 Reeve et al. confirmed that addition
occurred at the methyl group of 221b, indicating that the enol formation was
kinetically controlled. Steric hindrance is also a factor since butanone undergoes
reaction at both methylene and methyl sites.285
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entry R1 R2CO2Na (equiv.) temperature (°C) time (h) 222 yield (%)
a CH3 0.25 94 88 50
b (CH3)2CHCH2 0.25 100 108 59
c (CH3)2CCH 0.25 73 91 41
d PhCHCH 0.30 80 24 22
Table 17. Ketones were used in slight excess (1.25 equiv.) with respect to chloral. R2 = C2H5 (entries
b and c); R2 = CH3 (entries a and d).
Banno et al. used TiCl4 to mediate the aldol reaction between silyl enol ether 223 and
chloral (Scheme 58).286, 287 The reaction was rapid and high yielding even at -78 °C,
and no byproducts from poly- or self-condensation were detected.
Scheme 58. Crossed-aldol reaction using a silyl enol ether
Jiang et al. used ZnCl2/NEt3 to promote the alkynation of both chloral and bromal
(Scheme 59).288
Scheme 59. Reagents and conditions: alkyne 225 (1.1 equiv.), Cl3CCHO (1.0 equiv.), ZnCl2 (1.5
equiv.), NEt3 (1.5 equiv.).
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1.14 Synthesis of Enantiomerically Enriched Trichlorocarbinols
Considerable effort has gone into the asymmetric syntheses of trichlorocarbinols due
to the stereospecific nature of their reaction with nucleophiles under basic conditions
(see earlier, Scheme 41). An early example from Casiraghi et al. is shown in table
18.289, 290
entry phenol 230 yield (%) e.e. (%) configuration
a Phenol 96 34 R
b p-Methylphenol 97 48 R
c o-Methylphenol 65 76 R
d o-Isopropylphenol 78 54 R
e 2,5-Dimethylphenol 55 80 -a
Table 18. R2 = (-)-menthyl. Alkoxide 229 was prepared in situ from phenol (1.0 equiv.), (-)-menthol
(1.0 equiv.) and Et2AlCl (1.0 equiv.). a Not determined.
The authors used a chiral alkoxyaluminium chloride promoter in the o-alkylation of
phenols 228a-e. Presumably coordination of chloral to the phenoxy-aluminium
complex 229 in the reaction transition state provides the asymmetric induction,
although the e.e. values obtained were variable. Stoichiometric quantities of
aluminium reagent were also required.
Yamamoto et al. disclosed the first asymmetric ene-reaction catalysed by the chiral
Lewis acid (R)-232 (Table 19).291 The enantiomeric excesses obtained were fairly low,
and stoichiometric quantities of Lewis acid catalyst were required to maximise the e.e.
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values. A chiral poisoning strategy has also been used to yield a catalyst for the
asymmetric ene reaction with chloral, albeit with lower e.e. than those in the examples
above.292
entry R 233 yield (%) e.e. (%)
a CH3 79a 78
b (CH2)5CH3 99b 64
c Ph 40c 76
d SPh 69c 57
Table 19. Reagents and conditions: a (R)-232 (0.2 equiv.), 4 Å molecular sieves, CH2Cl2, -78 °C, 1.5
h; b (R)-232 (1.1 equiv.), CH2Cl2, -20 °C, 1 h; c (R)-232 (1.1 equiv.), -78 °C, 1-2 h. All reactions were
carried out with the alkene in slight excess (1.2 equiv.).
Jiang et al. reported the catalytic, asymmetric alkynation of chloral to yield
propargylic alcohols 236 (Table 20).293 Carreira and co-workers had previously
reported the first catalytic, asymmetric addition of terminal acetylenes to aldehydes
using Zn(OTf)2, (+)- or (-)-N-methylephedrine and NEt3.294-297 Jiang et al. expanded
on this work and studied the reaction of a variety of acetylenes 234 with chloral.
Ligand (S,S)-235 was found to provide greater selectivity than N-methylephedrine
used by Carreira. In addition, the ligand could be recovered unchanged in 96% yield
and recycled without loss of enantioselectivity.
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Table 20. Reagents and conditions: alkyne (1.1 equiv.), Zn(OTf)2 (0.50 equiv.), NEt3 (0.75 equiv.),
(S,S)-235 (0.55 equiv.). All reactions were carried out in toluene at room temperature.
1.14.1 Asymmetric Reduction
Corey and co-workers reported the highly enantioselective borane reduction of
ketones, catalysed by chiral oxazaborolidines.298-301 They applied this method to
trichloroketones 237 (Table 21),302 which were readily synthesised in two steps from
the corresponding aldehydes.261, 303 Excellent enantioselectivities were achieved for
all the ketone substrates screened, although low temperatures were necessary to
maximise the e.e. values (entries f and g).
entry R 236 yield (%) e.e. (%)
a Ph 96 94
b 2-Phenylethyl 76 98
c Cyclopropyl 90 96
d t-Butyl 60 93
e n-Butyl 79 98
f Trimethylsilyl 70 92
g CH2OTBDMS 71 98
h Cyclopentylmethyl 95 95
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entry R solvent temp, °C (time, h) e.e. (%)
a n-C5H11 Toluene -60 (12) 95
b C6H5(CH2)2 Toluene -78 (12) 95
c p-C6H5C6H4CH2 CH2Cl2 -44 (10) 96
d 2-Naphthylmethyl CH2Cl2 -23 (1.7) 93
e Cyclohexyl CH2Cl2 -28 (48) 92
f t-Butyl Toluene -20 (56) 98
g t-Butyl Toluene +23 (12) 95
Table 21. All reactions were initiated at -78 °C and brought to the indicated temperature after one
hour.
Enantioselective reductions of this type have also been carried out using
stoichiometric pinene-derived boranes in place of the oxazaborolidine 239, although
the reactions with trichloroketones were extremely slow (22 days to reach
completion).304, 305
Noyori first introduced the ruthenium catalyst (R,R)-241 for the asymmetric transfer
hydrogenation of acetophenones162, 306, 307 and Wills later improved the catalytic
activity of the reaction by developing the tethered analogue (R,R)-242.308, 309 Perryman
et al. reported the reduction of trichloroketones 243 using both of these catalysts
(Scheme 58).310 High enantioselectivities were obtained for a variety of alkyl
trichloroketones, however when R = aryl the selectivity was reduced due to
competition between Ar and CCl3 for coordination to the arene ligand. This is
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exemplified by the fact that the 2,2,2-trichloroacetophenone was reduced with the
opposite sense of asymmetric induction compared to acetophenone itself, albeit with
lower e.e. The difference in e.e. values obtained from using tethered catalyst (R,R)-
242 was typically small.
Scheme 60. Yields and enantiomeric excesses of trichloroketone reductions. Typical conditions:
ketone (1.0 mmol), HCO2H/NEt3 (5:2, 0.5 mL), under N2, 28 °C, 5-17 h. All results shown were
obtained using catalyst (R,R)-241.
1.14.2 Organocatalysis
Although not catalytic, Funabiki et al. used chiral imines in a stereoselective aldol
reaction with chloral to yield enantiomerically enriched β-trichloro-β-hydroxy ketones 
(Table 22).311 Yields were moderate in comparison to other methods although the e.e.
values were good. The reaction was also successful when chloral hydrate was used in
place of chloral, with slightly worse enantioselectivity.
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entry R 246 yield (%) e.e. (%)
a Ph 77 92
b p-ClC6H4 76 90
c p-CH3OC6H4 51 85
d 2-Thienyl 45 81
e Cyclohexyl 56 88
f t-Butyl 40 81
Table 22. Reagents and conditions: chloral (1.0 equiv.), toluene, -78 °C to rt, overnight.
Yamamoto et al. reported an asymmetric, direct aldol reaction promoted by a proline-
derived tetrazole catalyst (Table 23).312 List and co-workers were the first to report
proline as an effective asymmetric organic catalyst, which they used in several classes
of reaction.313-316 Yamamoto et al. used the proline-derived catalyst 248 to catalyse
the aldol reaction of ketones 247a-g with either chloral or chloral hydrate, and a high
enantioselectivity was observed. This was the first example of an organocatalysed
aldol reaction with a water-sensitive aldehyde component, and catalyst 248 was
generally found to be more effective than proline alone.
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entry R temp, °C (time, h) 249 yield (%) e.e. (%)a
a (CH3)2CH 40 (24) 79a 97
b (CH3)2C=CH(CH2) 30 (24) 93a 82
c CH3(CH2)3 30 (36) 91b 82
d CO2Et 30 (24) 55 86
e Ph 40 (48) 75 92 (R)
f p-BrC6H4 40 (96) 76 91
g 2-Naphthyl 40 (96) 83 91
Table 23. Reagents and conditions: ketone (2.0 equiv.), 248 (5 mol%), CH3CN. a The absolute
configurations were not determined except for entry e. b Chloral was used in place of its monohydrate.
Gong et al. reported the first example of the cross-aldol reaction of chloral with
aliphatic aldehydes (Table 24).317 When L-proline was used as the catalyst,
considerable self-condensation of aldehyde 250 was observed. The diastereo- and
enantioselectivities were generally poor and a limited number of aliphatic aldehyde
substrates were screened. In addition, a high catalyst loading of 30 mol% was required.
The authors screened L-proline in their reaction conditions but not catalyst 248, despite
it having been shown to be highly effective.
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entry R 251 yield (%) anti:syn e.e.- anti (%) e.e.- syn (%)
a Methyl 92 45:55 88 78
b Ethyl 95 85:15 75 65
c i-Propyl 35 80:20 70 65
d n-Pentyl 81 69:31 69 31
Table 24. Reagents and conditions: Cl3CCHO (1.0 equiv.), L-prolinamide (0.30 equiv.), CH2Cl2, rt,
24 h.
β-Lactones are masked aldol units, after ring opening by a suitable nucleophile. 
Wynberg et al. reported the first synthesis of enantiomerically enriched lactones 254,
via a cinchona alkaloid-catalysed aldol lactonisation (Table 25).318-320 These lactones
had previously only been synthesised in racemic form.321, 322 The general catalytic
cycle of the reaction is shown in scheme 61. Zwitterions such as 257 have been shown
to have a relatively long lifetime,323 providing the stereoselectivity when chiral tertiary
amines (such as quinidine and quinine) are used.
In general, much better enantioselectivities were obtained when using quinidine (255)
as the catalyst. The reason for the difference in selectivity between quinine and
quinidine is unclear, although it must be based on the relative position of the vinyl
group in the transition states. Sufficient polarisation of the carbonyl is necessary for
the reaction to take place. For example, no reaction was observed with
monochlorinated aldehydes or with trichloroacetophenone (entry g). However, with
para- electron withdrawing groups on the aromatic ring (entries h and i) the β-lactone 
was successfully isolated.
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entry R1 R2
e.e. (%) using catalyst
quinidine quinine
yield using quinidine
catalyst (%)b
a CCl3 H 98 a 76 89
b CCl2H H 45 - 67
c CCl2CH3 H 91 76 95
d CCl2C2H5 H 89 70 87
e CCl2C6H5 H 90 68 89
f CCl3 C2H5 - - Trace
g CCl3 C6H5 - - -
h CCl3 p-ClC6H4 90 65 68
i CCl3 p-NO2C6H4 89 65 95
171 CCl3 CH3 94 85 72
Table 25. Catalytic, asymmetric synthesis of 2-oxetanones. a Identified as the (R)-enantiomer by
conversion to malic acid. b The yield using quinine as the catalyst was not reported.
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Scheme 61. Catalytic cycle for the tertiary amine-catalysed aldol lactonisation of ketene 252 with
chloral.
Despite good e.e. values and high isolated yields, the need to use a ketene generator
remained a limitation in Wynberg’s protocol. Romo et al. used in situ-generated
ketene to synthesise a number of chlorinated β-lactones (Scheme 62).324
Scheme 62. The absolute configuration of 259b and 171 were confirmed as (R) by comparison of
optical rotations to literature data.319, 320 The remaining lactones were assumed to be of the same
configuration.
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Treatment of acetyl chloride with Hunig’s base (i-Pr2NEt) generated the required
ketene 252 by in situ dehydrochlorination, which then took part in the reaction with
the aldehydes 258. The tertiary amine used as a base has the potential to act as the
nucleophilic catalyst, thus leading to racemisation; however the high e.e. values
obtained, combined with the greater nucleophicity of the quinuclidine N-atom over
Hunig’s base,323, 325 suggest that this does not take place.
1.15 Jocic Reactions with Racemic Trichlorocarbinols
1.15.1 Reactions with Oxygen-based Nucleophiles
Much of the early work on Jocic reactions involved the reaction of trichlorocarbinols
260, with base in alcoholic solution to yield the α-alkoxy carboxylic acids 263
(Scheme 63). The reaction mechanism depicted is believed to be general regardless of
the nature of the nucleophile, and support for the gem-dichloroepoxide intermediate
comes both from the high stereospecificity of the reaction (discussed later) and from
the isolation of pentachloro-propylene oxide 261 (where R1 = CCl3, R2 = H).326 More
recently, the dichloroepoxide 264 was isolated and characterised by X-ray
crystallography.327
Scheme 63. General Jocic reaction mechanism, depicted with an alkoxide nucleophile.
Table 26 lists some α-alkoxy carboxylic acids synthesised by Bergmann et al.328 The
use of more bulky substrates and nucleophiles gave lower yields as would be expected.
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Bergmann et al. later found that aryl trichlorocarbinols (R1 = Ar, R2 = H) underwent
the same reaction under these conditions.231
entry R1 R2 R3 263 yield (%)
a CH3 CH3 Ethyl 68
b CH3 CH3 Butyl 78
c CH3 CH3 i-Propyl 44
d CH3 CH3 i-Butyl 75
e CH3 Ethyl i-Butyl 62
f - (CH2)5 - i-Butyl 61
Table 26. Synthesis of α-alkoxy carboxylic acids. Reagents and conditions: KOH (4.0 equiv.), R3OH,
rt to reflux, 3 h.
Reeve et al. later reported an improved synthesis of α-methoxyaryl acetic acids 266
using in situ trihalocarbinols (Scheme 64).329-331 By removing the need to isolate the
trihalocarbinols, the overall yields were improved and the reaction was successful for
a variety of aryl aldehydes with either chloroform or bromoform.
Scheme 64. Synthesis of α-methoxyaryl acetic acids. 
Scheme 65. Synthesis of α-methoxyaliphatic acetic acids. R = alkyl. 
Under the conditions shown in scheme 64, aliphatic aldehydes undergo considerable
aldol self-condensation. Using an inverse addition technique, Compere et al. were able
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to suppress aldol side reactions and synthesise a range of α-methoxyaliphatic acetic 
acids (Scheme 65).332 The acids 268 were isolated in yields of 24-63% after
purification.
The first example of a Jocic reaction using a phenoxide nucleophile with an isolated
trichlorocarbinol appears to be from Korger in 1963 (Scheme 66).333
Scheme 66. R1 = CH3, C2H5; R2 = H, OBn; X = H, Cl, Br.
The reaction was part of a synthesis towards analogues of Griseofulvin 272.334 Corey
used the reaction of 273 and 274 with “chloretone” 180, to yield α-phenoxy acids 275
and 276 (Scheme 67).335
Scheme 67. Reagents and conditions: phenol (2.0 equiv.), NaOH (8.0 equiv.), acetone, rt, 16 h.
Fechtel et al. studied a wider range of phenols in the reaction with trichlorocarbinol
277 (Table 27).336
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entry R1 R2 R3 yield (%) entry R1 R2 R3 yield (%)
a H H H 41 d CH3 H H 28
b H H CH3 45 e Cl H H 19
c H CH3 H 27 f Cl H Cl 9
Table 27. Phenoxide 278 was generated in situ by the addition of substituted phenol (1.02 equiv.) to
sodium in dry methanol.
The authors found that electron-donating groups on the phenol provided higher yields,
whilst the opposite was true for electron-withdrawing groups. This is due to the
increased or decreased electron density of the phenoxide ion, respectively. It would be
expected that methoxide (from the solvent) might compete with phenoxide as a
nucleophile. However, an excess of phenol compared to base diminishes the
concentration of methoxide ions in solution. In addition to the procedure shown above,
Fechtel et al. also carried out the reaction in a MeOH/H2O solvent system to yield the
corresponding acids in comparable yields.
Snowden et al. developed an approach to α- or γ-substituted enoic acids (Scheme 
68).337 The authors employed several oxygen-based nucelophiles in the Jocic reaction
of alkenyl trichlorocarbinols 280, and a selection of their results are shown in table 28.
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Scheme 68. Reaction of alkenyl trichlorocarbinols with various nucleophiles.
entry R solvent X 281:282 major regioisomer yield (%)
a n-C5H11 DME/MeOH OMe 5:1 81
b n-C5H11 DME/H2O OH 1:2 64
c n-C5H11 Allyl alcohol OAllyl > 20:1 93
d Ph DME/MeOH OMe 2.5:1 47
e Ph Allyl alcohol OAllyl -a -
Table 28. Reagents and conditions: NaOH (6.0 equiv.), 55 °C, 12 h. a Not determined.
As expected, methoxide showed preference for the SN2 pathway (entries a and d), with
reasonable regioselectivity. Allyl alkoxide showed high regioselectivity when R = n-
C5H11 (entry c). Methoxide reacted less selectively when R = Ph (entry d), possibly
due to conjugation between the aryl and alkene π systems. Unusually, hydroxide 
showed preference for the SN2’ pathway (entry d).
1.15.2 Reactions with Nitrogen-based Nucleophiles
Reeve et al. reported the first use of a nitrogen nucleophile in the Jocic reaction
(Scheme 69).338 The product amino acids 284 were obtained only after hydrolysis of
the crude mixture. Intermediate α-amino amides and peptides were postulated as 
intermediates, though these were not positively identified.
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Scheme 69. Reagents and conditions: KNH2 (4.6 equiv.), NH3 (l), -33 °C, 12 h. R = Et, i-Pr, Ph.
When cyanamide (NCNH2) was used as the nucleophile, an unexpected cyclisation
reaction occurred to yield cyclic compounds 289 (Scheme 70).339 Initial ring opening
of the gem-dichloroepoxide 286, followed by trapping of the resultant acyl chloride
with an additional cyanamide anion, yielded the amino amide 288. Subsequent
cyclisation and formation of a carboximidate (with alcohol from the solvent) led to the
cyclic compounds 289 in yields of 22-61%. A significant side reaction is the attack of
an alkoxide ion on the dichloroepoxide 286, leading to the formation of an α-
alkoxyaryl acetic acid.
Scheme 70. Reagents and conditions: NCNH2 (2.4 equiv.), KOH (5.9 equiv.), ROH, rt, overnight. R =
CH3, C2H5, n-Pr, n-Bu; X = H, p-Cl, p-OMe.
1.15.3 Reactions with Sulfur-based Nucleophiles
Reeve studied thiourea as an example of the Jocic reaction with a sulfur nucleophile
(Scheme 71).340 Although thiourea is potentially an ambidentate ligand, no evidence
was observed for attack by nitrogen on the gem-dichloroepoxide. Additionally, no α-
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methoxyaryl acetic acids were observed, indicating that the sulfur nucleophile
outcompetes any methoxide from the solvent.
Scheme 71. Jocic reaction of thiourea with aryltrichlorocarbinols. R = H, 3,4-dichloro, p-OMe.
The use of thiosemicarbazones or thioamide gave the heterocyclic compounds 293-
296 and 297 (Scheme 72) respectively, by an analogous mechanism.341 Further
bifunctional reagents containing a nucleophilic sulfur atom were studied by Reeve and
Coley III.342 Blanchett and Zhu later improved the yield of the reaction with
substituted thioureas by using DME/H2O as the solvent.343
Scheme 72. Additional reactions with sulfur nucleophiles.
1.15.4 Reactions with Halide Nucleophiles
The first example of a reaction of this type was in the original publication from Jocic
(Scheme 73), where he postulated chloride to be the nucleophile in the ring opening
of epoxide 298.221, 222 Reeve has suggested that this reaction may go via different
intermediates from the generally accepted gem-dichloroepoxide.344, 345 However, this
is not consistent with the stereospecificity of the reaction (see later) or with X-ray
crystallography data.327 At temperatures above 0 °C considerable hydrolysis of the α-
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chlorocarboxylic acid 300 occurs, to yield the α-hydroxy-substituted acid. When 
tertiary trichlorocarbinols are used, the elimination of CHCl3 from the
trichlorocarbinol 182 becomes a significant reaction pathway.
Scheme 73. The original Jocic reaction.
Oliver et al. prepared α-fluoro carboxylic acids by treatment of trichlorocarbinols with 
tetrabutylammonium fluoride (TBAF) and cesium fluoride (Table 29).346 Good yields
were obtained, although only four substrates were examined and all four were
structurally very similar. The reaction failed when methanol was used as the solvent
due to the formation of the α-methoxy acid. Oliver et al. later used enantiomerically
enriched trichlorocarbinols to obtain α-fluoro carboxylic acids in > 92% e.e. but with
α-chloro carboxylic acid side products.347
entry R 302 yield (%) entry R 302 yield (%)
a C9H19 100 c C8H17CC(CH2)8 81
b C16H31 81 d C2H5CC(CH2)8 76
Table 29. Reagents and conditions: TBAF (12 equiv.), CsF (14 equiv.), NEt3 (7.2 equiv.), THF,
reflux, 2 h.
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1.15.5 Reactions with Hydride Nucelophiles
Snowden et al. developed several one-carbon homologation reactions, starting from
trichlorocarbinols 304, employing hydride or selenide as the nucleophile (Scheme
74).348-350 Subtle differences in the reaction conditions provided either the
homologated carboxylic acid 305, or the alcohol 306. The acid product is a result of
hydrolysis of the intermediate acid chloride, whilst the alcohol results from faster
reduction of the acid chloride by LiBH4. A proposed mechanism for the selenium
reaction is shown in scheme 75. When amines are added to the reaction mixture they
trap the intermediate acid chloride (310) to yield amides 308.
Scheme 74. Various homologation procedures developed by Snowden et al. R1 = alkyl, alkenyl, aryl;
NH(R2)2 = NH2, benzylamine, morpholine.
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Scheme 75. Proposed conversion of dichloroepoxide 309 to carboxylate 307 using sodium
phenylseleno(triethyl)borate complex.
1.16 Jocic Reactions with Enantiomerically Enriched
Trichlorocarbinols
1.16.1 Reactions with Oxygen-Based Nucleophiles
The highly stereospecific nature of the Jocic reaction has made it an attractive
synthetic tool, if the starting trichlorocarbinols are obtainable in high stereochemical
purity and racemisation is minimised. Wynberg et al. synthesised (R)- and (S)-
citramalic acid via the ring opening and intramolecular Jocic reaction of lactone (R)-
171 (Scheme 76).351 (S)-Citramalic acid was obtained without racemisation and in
96% yield. The (R)-enantiomer was obtained using the same procedure but starting
from (S)-lactone.
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Scheme 76. Stereospecific synthesis of (S)-citramalic acid.
Corey and Link employed a p-methoxyphenol nucleophile in the Jocic reaction with
enantiomerically enriched trichlorocarbinols 312 (Scheme 77).352 The
trichlorocarbinols were synthesised in 92-98% e.e. by the previously reported CBS
reduction.298, 301 Only for R = C6H5(CH2)2 was experimental data provided, with the
authors claiming “optical purity” for the α-hydroxy methyl ester 314 without
providing additional evidence.
Scheme 77. Stereoselective synthesis of α-hydroxy esters. R = n-pentyl, C6H5(CH2)2, cyclohexyl, t-
butyl.
It has been shown previously that an appropriately placed hydroxyl group will act as
a nucleophile in an intramolecular Jocic reaction.336 Oliver and Schmidt used this
strategy in the synthesis of an enantiomerically enriched epoxyacid (318, Scheme
78).353
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Scheme 78. Synthesis of an epoxycarboxylic acid via an intramolecular Jocic reaction. TBAOH =
tetrabutylammonium hydroxide.
Alcohol 316 was obtained as a 63:27 ratio of diastereoisomers, of which the (2R,3R)-
isomer was obtained directly by recrystallisation. The Jocic reaction of diol 317 to
epoxide 318 proceeded stereospecifically with inversion, and none of the (2R,3R)
diastereoisomer was detected. The biphasic conditions employed in this step helped to
prevent racemisation of the C-2 centre.
1.16.2 Reactions with Nitrogen-Based Nucleophiles
Corey and Link reported the convenient, enantioselective synthesis of α-amino acids 
(Table 30).302 The amino acids 321 were obtained in high enantiomeric excess after
reduction. The success of the reaction (and absence of racemisation) under these
homogeneous conditions probably lies in the strong nucleophicity of azide.
110
entry R 320 yield (%) 321 yield (%)
a n-Pentyl 89 94
b C6H5(CH2)2 91 92
c p-C6H5C6H4CH2 82 98
d 2-Naphthylmethyl 84 88
e Cyclohexyl 89 92
f t-Butyl 80 94
Table 30. Reagents and conditions: NaOH (4.0 equiv.), NaN3 (2.0 equiv.), DME/H2O, rt, 12 h; 10%
Pd/C (25 wt%), H2, EtOAc, rt, 12 h.
Romo et al. used Corey’s conditions as part of the synthesis of an α-azido γ-lactone 
(Scheme 79).354-356 Ring opening of the enantiomerically pure lactone 254a by the
procedure of Fujisawa yielded diol 322 with no loss of stereochemistry.357, 358
Treatment with NaOH/NaN3 then gave the lactone 323, after gentle heating in
methanol to promote cyclisation.
Scheme 79. Stereospecific synthesis of an α-azido γ-lactone. Reagents and conditions: DIBAL (1.0 
equiv.), CH2Cl2, rt, 10 h; NaOH (4.0 equiv.), NaN3 (2.0 equiv.), DME/H2O, rt, 12 h.
As part of a synthesis towards Schulzeines B and C, Romo and Liu attempted to use
similar methodology to generate intermediate 327 (Scheme 80).359 Unexpectedly,
ring-opening of dichloroepoxide 325 by azide (path a) was not observed. Instead,
intramolecular attack by the piperidine nitrogen atom (path b) occurred and
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pyrrolidine 328 was formed as a 6:1 mixture of diastereoisomers. Boc protection of
the piperidine N atom prior to the Jocic reaction yielded the desired azido compound
327.
Scheme 80. Attempted synthesis of δ-lactam 327.
Shibasaki et al. described the diastereoselective synthesis of substituted azetidine-2-
carboxylic acids (Scheme 81).360 The trichlorocarbinol 329 was obtained in high d.e.
by reduction of the trichloroketone precursor. No epimerisation of the C-2 chiral centre
during the Jocic reaction was observed.
Scheme 81. Synthesis of a 3,4-syn-disubstituted azetidine-2-carboxylic acid.
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Perryman et al. have used both symmetrical and unsymmetrical diamines in Jocic-type
reactions with enantiomerically enriched trichlorocarbinols 332 (Scheme 82).361, 362
Generally, as the size of R2 on the secondary amine increases, the formation of 1-
substituted piperazin-2-ones (333) was favoured. This may be due to preferential
attack of the less sterically hindered amine when opening the dichloroepoxide. For all
the substrates examined high e.e. values were obtained; however, under homogenous
reaction conditions (aq. NaOH, MeOH) the e.e. of the products was lowered. Racemic
reactions of this type had been previously reported by Lai, although with lower
regioselectivity.363, 364
Scheme 82. Synthesis of piperazin-2-ones. R1 = (CH2)2Ph, R2 = alkyl, aryl.
Dominguez et al. reported so-called “modified Corey-Link” conditions in the
synthesis of (+)-LY354740, a potent agonist for the group 2 metabotropic gluatamate
receptors (mGluRs)365 (Scheme 83).366, 367 (+)-LY354740 showed efficacy in clinical
studies for the treatment of generalised anxiety disorder (GAD).368 Alcohol 336 was
obtained in enantiomerically pure form due to attack of the trichloromethyl anion on
the less sterically hindered face. When Corey’s conditions were applied the desired α-
azido acid 337 was contaminated with the diacid, which made purification difficult.
In order to avoid this partial ester hydrolysis, anhydrous conditions using the organic
base DBU were employed. Under these milder conditions the reaction proceeded
smoothly with complete inversion. Notably, the Strecker reaction gave rise to the
opposite stereochemistry at this quaternary centre.369 This “modified Corey-Link”
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methodology has found considerable application, particularly in sugar chemistry.370-
372
Scheme 83. Synthesis of (+)-LY354740.
Aitken et al. applied similar modified conditions in the synthesis of α-aryl glycines 
(Scheme 84).373 The use of Corey and Link’s original procedure resulted in complete
racemisation of 339. However, by using DBU as the base, the (S)-aryl glycines 340
were prepared in overall yields of 40-62% and > 97% e.e. in all examples.
Scheme 84. Reagents and conditions: DBU (1.0 equiv.), NaN3 (2.0 equiv.), DME/H2O, rt, 24 h.
Schafmeister et al. employed both modified and original Corey-Link conditions
during the separate syntheses of 342 and 344, precusors to bis-amino acid monomers
(Scheme 85).374, 375
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Scheme 85. Synthesis of two bis-amino acid monomer precursors.
Lee et al. synthesised α-azido acid 347 using modified Corey-Link conditions
(Scheme 86),376 as part of efforts to identify a novel series of β-site amyloid precursor 
protein cleaving enzyme (BACE-1) inhibitors.377, 378 During scale-up studies it was
found that a Jocic reaction with 3-fluoroaniline provided a better alternative to using
azides (Scheme 87).379, 380
Scheme 86. Discovery synthesis of lead compound 348.
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Scheme 87. Optimised synthesis for large-scale production.
1.16.3 Reactions with Other Nucleophiles
Stick et al. used a number of nucleophiles in the Jocic reaction with a sugar-derived
trichlorocarbinol (Scheme 88).327, 381
Scheme 88. Conditions: a) DBU, MeOH, 83%; b) CsF, DBU, MeOH, 85%; c) NaOMe, MeOH, 54%;
d) NaCN, DBU, MeOH, 80%; e) KOCN, DBU, MeOH, 50%.
1.17 Bargellini Reactions
Like the Jocic reaction, what has become known as the Bargellini reaction was
discovered in the early 1900s and involves a gem-dichloroepoxide as a key
intermediate. The difference between the two lies in the isolation of a
trichlorocarbinol; in the Jocic reaction these are typically synthesised or purchased
initially and then reacted further with nucleophiles, whilst in a Bargellini reaction they
are generated in situ (Scheme 43). The one-pot, operationally simple nature of these
reactions have made them attractive to researchers in the pharmaceutical industry.
Examples of such target molecules are shown in figure 5.382-389
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Figure 5. A selection of target compounds which use a Bargellini reaction to install the α-
disubstituted carboxylic acid motif.
Lai reported an interesting variation on the usual Bargellini reaction, using a hindered
phenol as the nucleophile (Scheme 89).390 Due to the hindered nature of the phenol,
the dichloroepoxide intermediate is attacked by the para carbon of the phenol. The
acid chloride was trapped by a range of secondary amines to yield amides 354.
Scheme 89. Reagents and conditions: ketone (8.0 equiv.), CHCl3 (1.3 equiv.), NaOH (4.5 equiv.),
10 °C, 20 h. R1/R2 = alkyl, cycloalkyl; R3 = alkyl.
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Classically, a phenol is used as the nucleophile in the Bargellini reaction. Butcher and
Hurst demonstrated that anilines work well in place of phenol (Table 31). Better yields
were obtained with the more electron-rich anilines (entries a and e), which mirrors the
reactivity of phenols as expected. In addition to the nucleophiles shown in table 31,
Butcher and Hurst also used thiophenol (71% yield), 2-aminopyridine (72% yield) and
1H-pyrazole (56% yield). KF on alumina was reported as an alternative base by
Myrboh and Rohman.391 Saidi and Aryanasab employed a wider range of thiol
nucleophiles, including the first reported use of dithiocarbamic acid as a
nucleophile.392
entry R 357 yield (%)
a H 70
b p-Br 56
c m-Br 67
d p-CO2Me 56
e m-OMe 99
Table 31. Reagents and conditions: ketone (3.0 equiv.), CHCl3 (5.0 equiv.), NaOH (5.0 equiv.), THF,
rt, 18 h.
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Chapter 2: The Total Synthesis of Vitamin E
The preliminary disconnections for the synthesis proposal are shown in scheme 90.
The disconnection of vitamin E to the chromane aldehyde 35 and (R,R)-
hexahydrofarnesol 32 is well documented in the literature.166, 167, 169-173, 196, 393, 394 We
imagined that we could ultimately synthesise the key aldehyde via the intramolecular
Jocic reaction of phenol 170. Using this strategy, all four tocopherol analogues should
be accessible.
Scheme 90. Disconnections for the synthesis of vitamin E. R1, R2, R3 = CH3 or H.
2.1 Synthesis of Model Compounds
We initially anticipated that the β-keto trichlorocarbinol 170 should be accessible from
the ring-opening of Wynberg lactone (R)-171. The Friedel-Crafts ring opening of a
related lactone (R)-254a was reported to take place with no change in the enantiomer
composition (Scheme 91).395
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Scheme 91. Friedel-Crafts acylation of anisole with trichlorolactone (R)-254a.
The ring opening of lactone 171 by this method has not been reported in the literature.
In contrast to the 4-monosubstituted derivative 254a, reports on the use of lactone 171
in synthesis are scarce. Of only two reports in the literature, both involve the basic
hydrolysis of (R)- or (S)-171 to yield (R)- or (S)-citramalic acid respectively (Scheme
92).351
Scheme 92. Synthesis of (S)-citramalic acid by Wynberg and Staring.
Gill et al. used lactone 171 as a source of citramalic acid for their synthesis of (1S,3S)-
Austrocortilutein (Scheme 93).396 Using (S)-171 allowed the synthesis of the other
(1R,2R) enantiomer.
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Scheme 93. Synthesis of (1S,3S)-austrocortilutein.
We anticipated that lactone 171 could be ring opened by a suitable 1,4-
dimethoxybenzene compound, to ultimately yield phenol 170 (Scheme 94).
Scheme 94. Proposed Friedel-Crafts acylation of protected hydroquinones.
Protecting groups were needed both to prevent O-acylation and to stabilise the
hydroquinone against oxidation during the reaction. Methyl ethers were expected to
survive the strongly acidic conditions, although they can require strong reagents for
deprotection. Accordingly, 2,3,5-trimethyldimethoxy benzene 364 and 2,3-
dimethyldimethoxy benzene 365 were synthesised using a literature procedure397
(Scheme 95) and subjected to the Friedel-Crafts conditions reported by Fujisawa et al.
(Scheme 96).395
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Scheme 95. Methylation of hydroquinones.
Scheme 96. Attempted ring opening of lactone 171 under Friedel-Crafts conditions.
Unfortunately, neither trichlorocarbinol 366 nor 367 were observed under these
conditions even at increased reaction temperatures and times. Seeking an alternative
procedure, we attempted to synthesise lithiated derivatives of 364 and 365 in situ, and
treat these with lactone 171 (Scheme 97).
Scheme 97. Attempted ring opening of lactone 171 by lithiation of arenes 364 and 365. TMEDA =
tetramethyl ethylenediamine.
This reaction yielded unchanged starting materials, although quenching the reaction
with D2O showed complete deuterium incorporation, suggesting that it was the ring-
opening step which was failing. The use of brominated arenes 370 or 371 in a lithium
exchange reaction also failed (Scheme 98).
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Scheme 98. Attempted ring opening of lactone 171 by the lithium exchange of bromobenzenes. NBS
= N-bromosuccinimide.
Since the reactions were probably failing on steric grounds, commercially available
1,4-dimethoxybenzene 372 was used as a less challenging model substrate. Thus,
treatment of 372 with AlCl3 and 171 in CH2Cl2 provided the trichlorocarbinol 373 in
good yield and with ≥ 98% e.e. (Scheme 99). The enantiomeric excess of
trichlorocarbinol 373 was measured by comparison with a racemic substrate (see
later).
Scheme 99. Successful ring opening of lactone 171.
Our proposal for an intramolecular Jocic reaction required that the 2’-methoxy group
be deprotected, and a report in the literature from Du et al. suggested that this could
be carried out selectively due to the ortho-acyl substitution.398 However, given that Du
et al. used AlCl3 to accomplish this transformation, and that no demethylated products
were observed in the reaction of 372 to 373, it seemed unlikely that this reaction would
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be successful. Nevertheless, it was attempted (1.5 equiv. AlCl3, CH2Cl2, rt) and found
that the starting materials remained unchanged. Using toluene as the solvent to
increase the reaction temperature resulted in decomposition of the substrate at
temperatures above 60 °C (Scheme 100).
Scheme 100. Failed ortho-selective demethylation reaction.
Using NaI or LiI in DMF under microwave irradiation399 also failed to yield any
phenol products (Scheme 101).
Scheme 101. Unsuccessful demethylation using NaI or LiI.
More promisingly, a TMS-Cl/NaI system developed by Olah et al.400 yielded a mixture
of both partially and completely demethylated compounds (Scheme 102). The ratio of
[374:375:376] was approximately 1:0.6:0.6 as determined from the 1H NMR spectrum
of the crude mixture. Even though this reaction displayed poor selectivity for the ortho
methoxy group, we decided to optimise the reaction conditions for the synthesis of the
hydroquinone 376 since separation of all three compounds by column chromatography
was difficult.
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Scheme 102. Unoptimised demethylation of methyl ether 373.
Unfortunately, the highest yield obtained for this reaction was 33% (Scheme 103).
This may be partly because hydroquinone 376 is readily oxidised – the compound was
also unstable towards column chromatography.
Scheme 103. Optimised demethylation protocol.
Despite the low yields obtained from the demethylation step, sufficient material could
be brought through to test the key step; the intramolecular Jocic reaction. Thus,
treatment of hydroquinone 376 with four equivalents of 2M NaOH (aq.) yielded the
4-oxochromane-2-carboxylic acid 379 (Scheme 104). The reaction was carried out
under nitrogen and in a sparged solution to minimise oxidation of the hydroquinone.
Initially, the work up consisted of pH adjustment to 2-3 followed by extraction with
EtOAc. Cleaner product could be obtained by first washing the alkaline solution with
organic solvent to remove organic soluble byproducts, before lowering the pH to
release the compound.
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Scheme 104. Intramolecular Jocic reaction mechanism.
The accepted mechanism for the conversion of 376 into 379 is shown in scheme 104.
Contrary to Reeve’s claim that tertiary trichlorocarbinols cannot take part in the Jocic
reaction,345 reasonable yields of the α-disubstituted carboxylic acid 379 could be
obtained. No evidence of ring opening of the intermediate epoxide 377 by either
chloride or another molecule of 376 was observed.
We first attempted to measure the enantiomeric excess of the C-2 centre by coupling
carboxylic acid 379 to (S)- and (R)-α-methylbenzylamine (Scheme 105). 
Unfortunately, the CH3CH doublets in (S,S)- and (S,R)-380 were not different enough
in chemical shift to be useful as a measure of the diastereomeric ratio. The CH3 singlet
also did not show enough of a difference in chemical shift in either diastereoisomer.
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Scheme 105. Synthesis of diastereomeric amides 380.
A racemic synthesis of 379 was planned (Scheme 106), which would also allow for
an e.e. measurement of compound 373.
Scheme 106. Synthesis of 4-oxo-chromane (±)-382.
The aldol condensation of acetophenone 381 with 1,1,1-trichloroacetone proceeded
with moderate yields, and no elimination product was observed. An attempted acid
catalysed aldol reaction failed (Scheme 107).
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Scheme 107. Failed acid-catalysed aldol condensation.
The demethylation of trichlorocarbinol (±)-373 proceeded with slightly greater yield
than for the enantiomerically enriched compound, and subsequent treatment with 2M
NaOH (aq.) in acetone yielded the carboxylic acid (±)-379. Chiral HPLC analysis was
performed on the ester (±)-382.
Chiral HPLC analysis showed no loss of stereochemistry during the ring-opening
reaction of lactone 171, as hoped (Figure 6). The intramolecular Jocic reaction also
proceeded without racemisation (Figure 7). This complete lack of racemisation is a
consequence of the intramolecular ring opening of the intermediate dichloroepoxide
377 taking place in strict SN2 fashion. Additionally, neither acid chloride 378 nor the
acetate product 379 are enolisable.
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Figure 6. Top: HPLC trace of (±)-373. Bottom: HPLC trace of (R)-373. Conditions: Daicel Chiralcel
AD-H column, 2-propanol : hexane = 90 : 10, 1 mL/min, 221 nm, (R) isomer 14.81 min, (S) isomer
16.33 min.
Figure 7. Top: HPLC trace of (±)-382. Bottom: HPLC trace of (S)-382. Conditions: Daicel Chiralcel
AD-H column, 2-propanol : hexane = 90 : 10, 1 mL/min, 220 nm, (R) isomer 14.35 min, (S) isomer
16.12 min.
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2.2 Synthesis of Aldehyde 35
Having proved that we could synthesise chromane compounds in high enantiomeric
excess using our Jocic reaction strategy, we turned our attention back to the synthesis
of aldehyde 35. Inspired by a report in the literature,216 we hoped that the Fries
rearrangement of 385 would give phenol 386 (Scheme 108). Unfortunately, the
reaction of ester 385 failed to give any trace of phenol 386 even after heating at reflux
temperature for three days. Thankfully, we found that using TiCl4 in place of AlCl3 in
the ring-opening of lactone 171 gave the acylated compound 366 in good yield after
optimisation of the reaction conditions (Scheme 109).
Scheme 108. Attempted synthesis of monoprotected phenol 386.
Scheme 109. Successful ring opening reaction of lactone 171.
The reaction failed or was very low yielding when fewer than 10 equivalents of the
arene 364 were used, although a large proportion (~ 80%) could be recovered and
reused. It was notable that the reaction was also low yielding when TiCl4 was used as
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a 1M solution in CH2Cl2, or when the neat TiCl4 was more than a month old. Despite
the large excess of 364, the reaction is easily monitored using 1H NMR spectroscopy
by the change in chemical shift of the alkyl methyl group (highlighted, Figure 8).
Compound 366 was then subjected to the same sequence of reactions previously
developed, to yield 4-oxochromane ester 387 (Scheme 110). The racemate of ester 387
was prepared in the same way for HPLC analysis (Scheme 111). Figures 9 and 10
show that a high enantiomeric excess was maintained throughout the synthesis.
Figure 8. Top 1H NMR spectrum: (R)-lactone 171. Bottom 1H NMR spectrum: compound 366.
2.0556
1.8076
131
Scheme 110. Synthesis of ester 387.
Scheme 111. Synthesis of racemate (±)-387.
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Figure 9. Top: HPLC trace of (±)-366. Bottom: HPLC trace of (R)-366 Conditions: Daicel Chiralcel
AD-H column, 2-propanol : hexane = 95 : 5, 1 mL/min, 214 nm, (R) isomer 7.67 min, (S) isomer 8.65
min.
Figure 10. Top: HPLC trace of (±)-387. Bottom: HPLC trace of (S)-387. Conditions: Daicel Chiralcel
AD-H column, 2-propanol : hexane = 95 : 5, 1 mL/min, 221 nm, (S) isomer 29.05 min, (R) isomer
31.92 min.
3
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Despite the low yielding demethylation of the trichlorocarbinol 366, multigram
quantities of ester 387 could still be obtained through this route so we decided to
continue the synthesis of aldehyde 35. The synthesis of primary alcohol 390 had been
reported from ester 388,140 and the oxidation of alcohol 390 was a known reaction201,
394, 401(Schemes 112 and 113).
Scheme 112. Planned synthesis of aldehyde 35.
Therefore, all we had to do to get to known chemistry from our intermediate 387 was
reduce the carbonyl group; this was achieved in 51% yield by using a Clemmensen
reduction.402 The remainder of the synthesis proceeded smoothly. The oxidising
reagent 2-iodoxybenzoic acid (IBX)403 was chosen over other common oxidation
protocols (Swern, Parikh-Doering) as it was higher yielding. Additionally, the crude
product was clean enough to be used in the next step without further purification.
Scheme 113. Synthesis of aldehyde 35.
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 2.3 Completion of the α-Tocopherol Synthesis 
With aldehyde 35 in hand, the final steps in the synthesis consisted of the Wittig
coupling of aldehyde 35 with the phosphonium salt 392, followed by concurrent
hydrogenation of the double bond and removal of the benzyl protecting group (Scheme
114). (R,R)-Hexahydrofarnesol 32 was provided by DSM Nutritional Products and it
can be synthesised by the asymmetric hydrogenation of farnesol (Scheme 115).
O
BnO
O
35
R
R = OH: I2, PPh3, imidazole
CH2Cl2, 83%
PPh3, CH3CN, 78%
392, n-BuLi, THF
O
BnO
393
R = I:
R = PPh3I
O
R
H2, Pd/C, EtOAc
73%
96%
Ac2O, pyridine
90%
R = OH -tocopherol 1
R = OAc -tocopheryl acetate 394
392
391
32
Scheme 114. Completion of the synthesis of α-tocopherol 1.
Scheme 115. Synthesis of (R,R)-hexahydrofarnesol. The supplied hexahydrofarnesol 32 was of the
following stereochemical composition: (3R,7R) 93%, (3S,7S) 0%, (3R,7S) 5.8%, (3S, 7R) 0.75%. This
corresponds to an e.e. (C-3) = 99% and e.e. (C-7) = 88%.
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Both the 1H and 13C NMR spectra of our synthesised α-tocopherol 1 showed good
correlation with an authentic sample (Figures 11 and 12). The phenol was protected
as its acetate 394 to prevent ready oxidation of the compound.
Figure 11. Top 1H NMR spectrum: synthesised α-tocopherol 1. Bottom 1H NMR spectrum: authentic
sample purchased from TCI (UK).
Figure 12. Top 13C spectrum: Synthesised α-tocopherol 1. Bottom 13C spectrum: authentic sample
purchased from TCI (UK).
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2.4 Trolox
Trolox, 395, is a water-soluble vitamin E analogue which is known to prevent cell
death by apoptosis.404-407 This compound is commonly synthesised in racemic form
via hydrolysis of the ester (±)-388, which in turn can be synthesised using a hetero-
Diels-Alder reaction (Scheme 116).408, 409 This carboxylic acid (±)-395 can then be
resolved using an amine base such as (1R,2S)-cis-2-
(benzylamino)cyclohexylmethanol 396.
We synthesised (S)-Trolox 395 by the hydrolysis of the previously synthesised ester
(S)-388 (Scheme 117).
Scheme 116. Industrial synthesis of (S)-Trolox 395.
Scheme 117. Synthesis of (S)-Trolox 395 by the hydrolysis of methyl ester (S)-388.
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2.5 Revised Preparation of Methyl Ester 387
Having completed the synthesis of α-tocopherol 1, we felt that the demethylation step
in particular left a lot to be desired in terms of yield and ease of purification.
Alternative protecting groups which would potentially be easier to remove (benzyl,
benzoyl and acetyl) failed to survive the strongly acidic conditions of the Friedel-
Crafts ring opening (Scheme 118).
Scheme 118. Attempted use of alternative phenol protecting groups.
Any methyl ether deprotection methods that required alkaline conditions, for example
sodium thioethoxide in DMF,410-412 were not considered due to the base-sensitive
nature of the trichlorocarbinol group. In addition, due to the observed instability of the
hydroquinone 170, we sought a procedure where we could carry out the key Jocic
reaction without isolation of this unstable intermediate.
In our original synthesis proposal we focused on milder demethylation methods
because we were concerned about the stability of the trichlorocarbinol moiety;
however, since the group survived the reaction with TiCl4, it was shown to be more
stable to Lewis acids than we imagined. BBr3 is an extremely Lewis acidic reagent
commonly used to remove methyl ethers,413, 414 but one which was initially rejected
by us due to its highly reactive nature. However, in light of the results obtained, we
decided to test this reagent in the demethylation reaction of 366 (Scheme 119).
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Scheme 119. Demethylation of aryl methyl ethers using BBr3.
Pleasingly, treatment of 366 with BBr3 gave complete conversion into 170. In order
to minimise exposure of hydroquinone 170 to air, the reaction was quenched under
nitrogen and the CH2Cl2 solvent was removed under a flow of nitrogen. Redissolving
this crude mixture in THF and adjusting the pH to 13-14 triggered the desired Jocic
reaction. The carboxylic acid 169 was then directly esterified as a crude mixture to
yield the methyl ester 387, in a yield of 34% from 366. This improved procedure
provided the ester 387 in an approximately two-fold better yield than the previous
synthesis, with the total reaction time reduced from five days to three days.
2.6 Synthesis of γ-Tocopherol 
2.6.1 Previous Literature Syntheses
There are considerably fewer reports on the synthesis of γ-tocopherol compared to α-
tocopherol, probably due to the higher biological activity of the α-form. The first 
asymmetric synthesis of γ-tocopherol was reported by Minnaard et al. (Scheme
120).415
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Scheme 120. Total synthesis of γ-tocopherol. 
The key step was the asymmetric 1,2-addition of the Grignard reagent 401 to
acetophenone 400, using a chiral ferrocenyl ligand.416, 417 Of the nine different ligands
screened, the highest d.e. attained for the 1,2-addition was 73%. The Grignard reagent
401 was derived from natural phytol. Attempted hydrogenation of the allylic alcohol
402 using conventional metal catalysts (Pd/C, Pt/C, PtO2) resulted in hydrogenolysis
of the alcohol, hence the use of flavin catalysis.418, 419 The remainder of the synthesis
from compound 403 was carried out according to the synthesis of α-tocopherol by 
Cohen et al.171
In a synthesis by Reuping et al., a gold-catalysed allylic substitution was used to
produce vinyl chromane 405 with 86% e.e. (Scheme 121).420 A cross-metathesis
reaction with alkene 406, obtained from the asymmetric hydrogenation of phytol by
the method of Pfaltz,164 yielded γ-tocopherol 3 after hydrogenation.
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Scheme 121. Synthesis of γ-tocopherol by Reuping et al.
γ-Tocopherol is arguably most easily synthesised from commercially available α-
tocopherol. Salvadori et al. synthesised γ-tocopherol by the aryl demethylation of α-
tocopherol (Scheme 122).421 This builds on previous work reported by Rosenau and
Habicher,422 who accomplished the decarboxylation of carboxylic acid 409 by photo-
irradiation.
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Scheme 122. Synthesis of γ-tocopherol by the demethylation of α-tocopherol. 
2.6.2 Our Total Synthesis
Examples in the literature seemed scarce, and previous attempts at the asymmetric
synthesis of γ-tocopherol had resulted in unsatisfactory enantiomeric excess at the C-
2 centre. Therefore, we decided to synthesise γ-tocopherol 3 using our protocol
(Scheme 123).
The synthesis started from 2,3-dimethyl-1,4-dimethoxybenzene 365, which was
synthesised using the same literature procedure as for 364 (see scheme 95). The rest
of the synthesis proceeded using identical conditions to those used in the synthesis of
α-tocopherol, with the exception that our demethylation/Jocic reaction procedure was 
used to give the ester 411 in comparable yield.
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Scheme 123. Synthesis of γ-tocopherol. 
The enantiomeric excess of ester 411 was measured to be ≥ 98% by chiral HPLC 
(Figures 13 and 14). This synthesis represents an improvement on previous reports in
the literature where enantiomeric purity at the C-2 centre was unattainable. In addition,
this work represents the first synthesis of γ-tocopherol by the popular Wittig coupling 
route on which the majority of asymmetric vitamin E syntheses are based.
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Figure 13. Top: HPLC trace of (±)-367. Bottom: HPLC trace of (R)-367. Conditions: Daicel
Chiralcel AD-H column, 2-propanol : hexane = 4 : 96, 1 mL/min, 227 nm, (S) isomer 18.55 min, (R)
isomer 19.88 min.
Figure 14. Top: HPLC trace of (±)-411. Bottom: HPLC trace of (S)-411. Conditions: Daicel Chiralcel
AD-H column, 2-propanol : hexane = 6 : 94, 1 mL/min, 231 nm, (S) isomer 19.64 min, (R) isomer
22.59 min.
2
(S)-411
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144
2.7 Other Tertiary Trichlorocarbinol Substrates
2.7.1 Reactions with Carbon Nucleophiles
Given the success of the previous work, we were interested in potentially expanding
the methodology to include nitrogen and sulfur-based nucleophiles, as well as altering
the position of the intramolecular nucleophile in order to generate either 5- or 6-
membered rings.
We anticipated that the lactone 171 would be susceptible to ring-opening by a variety
of nucleophiles, and in addition it is a source of tertiary trichlorocarbinols which are
hard to synthesise in high enantiomeric excess by other means. Using carbon-based
nucleophiles as the starting point, it has been shown that using N-methoxy-N-methyl
amide or morpholine amide derivatives prevents over-addition if lactones such as 254a
are directly reacted with organometallic reagents (Scheme 124).355
Scheme 124. Preparation of β-hydroxy(trichloromethyl) ketones. R = alkyl, aryl, allyl, vinyl. 
N-Methoxy-N-methyl amides (Weinreb amides) are well known to afford a variety of
ketones cleanly and in good yield on reaction with organolithium and Grignard
reagents (Scheme 125).423
Scheme 125. Synthesis of ketones using Weinreb amides.
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Little or no double addition is observed even with excess organometallic reagent. This
is possibly due to metal chelation to the methoxy group which ensures that collapse of
the tetrahedral intermediate 420 only occurs on work up, with simultaneous quenching
of the excess organometallic species. Morpholine amides work by a similar
mechanism (Scheme 126).424
Scheme 126. Acylation of organometallic compounds using morpholine amide.
Ring opening of lactone 171 with N,O-dimethylhydroxylamine 425 was expected to
give the amide 426 (Scheme 127), which could then undergo coupling with
organometallic reagents. Our initial plan was that the organometallic species would
contain a protected nucleophilic group, which would be unmasked to take part in an
intramolecular Jocic reaction. The desired ketone product could also potentially
undergo a reductive amination,425, 426 followed by an intramolecular Jocic reaction, to
yield substituted azetidines (433) in diastereoselective fashion (Scheme 128).
Scheme 127. Synthesis of morpholine amide 428. DIPEA = diisopropylethylamine, DMAP = p-
dimethylaminopyridine.
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Unfortunately, attempts to synthesise the Weinreb amide 426 failed, either by a
reported direct ring opening of the lactone 171 or by coupling with carboxylic acid
427 using an acid activating reagent. However, the lactone underwent ring opening
readily with morpholine to give the amide 428. Microwave conditions were chosen
since the required reaction time was greatly reduced compared to conventional
heating.
Scheme 128. Proposed synthesis of cyclic structures using an intramolecular Jocic reaction.
With the morpholine amide 428 in hand, we first sought to test the reaction using
EtMgCl as a simple Grignard reagent. Unfortunately, the expected ketone was not
observed under any of the conditions tested. Using two equivalents of EtMgCl in THF
at room temperature overnight yielded largely unreacted starting material, with a small
amount of an unknown side product (Scheme 129). This was eventually identified by
1H and 13C NMR spectroscopy as compound 434 (Figure 15) and two mechanisms for
its formation are proposed (Schemes 130 and 131). In addition, the crude 1H NMR
spectrum showed the presence of unsaturated compounds, although these could not be
identified.
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Scheme 129. Unexpected formation of compound 434.
The alkyl migration proposed in scheme 130 bears similarity to other well-known
rearrangements which involve migration to electron deficient nitrogen, in particular
the Lossen,427 Curtius,428 Schmidt,429 Beckmann430 and Tiffenau-Demjanov431
rearrangements. Migrations of this type have not been reported for trichlorocarbinol
compounds. The second mechanism (Scheme 131) requires the formation of a
dichlorocyclopropane.432, 433
Scheme 130. Mechanism for the formation of compound 434 involving an alkyl migration.
Scheme 131. Mechanism for the formation of compound 434 via a cyclopropane rearrangement.
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The EtMgCl is acting as both a base and a nucleophile in both mechanisms. Compound
434 was isolated as a single diastereoisomer, with the other diastereoisomer being
inseparable from the unreacted starting material. The crude mixture showed an
approximate 2.5:1 ratio of these diastereoisomers, with the major isomer being the one
isolated (Figure 15).
Figure 15. Top 1H NMR spectrum: isolated single diastereoisomer of compound 434. Bottom 1H
NMR spectrum: crude reaction mixture. Inset: CHCl doublets.
In an attempt to increase the yield of 434 the reaction was carried out under elevated
temperatures, from 40 °C to reflux (Scheme 132). At reflux temperature, lactone 435
(Figure 16) was formed in addition to amide 434. Its formation can be rationalised by
either of the mechanisms shown in schemes 133 and 134.
PPM 4.64 4.60 4.56 4.52 4.48
PPM 6.8 6.4 6.0 5.6 5.2 4.8 4.4 4.0 3.6 3.2 2.8 2.4 2.0 1.6 1.2 0.8
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Scheme 132. Unexpected formation of lactone 435.
Figure 16. 1H NMR spectrum of isolated lactone 435.
2
428
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Scheme 133. Potential mechanism for the formation of lactone 435.
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Scheme 134. Potential mechanism for the formation of lactone 435.
The two mechanisms proposed for the formation of lactone 435 involve either an alkyl
migration or a cyclopropane rearrangement. The γ-keto amide 434 cannot be an
intermediate in the reaction mechanism as this would yield the lactones 436 or 437.
(Scheme 135).
Scheme 135. Potential mechanisms for the formation of lactones which were not observed in the
reaction mixture.
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The reaction with PhMgCl yielded largely unreacted starting material with some
unidentifiable side products (Scheme 136). None of the desired addition to the
morpholine amide was observed.
Scheme 136. Unsuccessful reaction with phenylmagnesium chloride.
Grignard reagents had appeared to be unsuitable, so organolithium reagents were
explored instead. The reaction with n-butyllithium appeared to give none of the desired
addition product (Scheme 137).
Scheme 137. Reaction of morpholine amide 428 with n-BuLi.
At 0 °C the crude reaction mixture was largely unreacted starting material. However,
when the reaction was stirred at 23 °C for 16 hours more of the starting material was
consumed. Unfortunately, it was not converted into the ketone 438 but mainly into a
compound 439 which we were unable to identify (Scheme 138 and Figure 17).
Scheme 138. Reaction of morpholine amide 428 at elevated reaction temperature and time.
This compound was not a result of addition of the organolithium to the amide, since
the broad peak between 3.95-3.32 ppm can be assigned to the protons on the
morpholine ring. Peaks corresponding to vinyl protons were also present (5.13, 5.04
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and 4.90 ppm), as well as incorporation of two butyl groups (triplet at 0.91 integrates
to six protons).
Figure 17. 1H NMR of isolated side product 439.
Even with the use of HSQC and HMBC correlation experiments we were not able to
positively identify this compound.
When KOt-Bu was used as a strong, non-nucleophilic base, the sole product obtained
was 1-morpholinobutane-1,3-dione 440, by elimination of CHCl3 (Scheme 139).
These results indicate that the EtMgCl potentially has some function as a Lewis acid
assisting the chloride leaving in all of the mechanisms previously discussed.
Scheme 139. Elimination of CHCl3 from amide 428.
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2.7.2 Reactions with Nitrogen Nucleophiles
Using organometallic reagents in the presence of the trichlorocarbinol functional
group had proved troublesome. However, amides of the type 441 are readily
synthesised in high yields. Ongoing work in the group had shown that amides such as
441 will ring close when treated with four equivalents of NaOH, to produce β-lactams 
with complete stereocontrol (Scheme 140).
Scheme 140. Intramolecular Jocic reaction to produce β-lactams. 
Hydrazine compounds offer a potentially interesting extension to this type of reaction,
as there should now be two competing nucleophiles in the Jocic reaction. Benzyl
hydrazinecarboxylate was the first compound studied and the corresponding amide,
444, has the potential to form either a 4-membered ring (β-lactam) or a 5-membered 
ring (pyrazolidin-3-one). Amide 444 was prepared by the ring opening of lactone 171
with hydrazine 443, and was subsequently subjected to the standard Jocic conditions
to yield either β-lactam 445 or pyrazolidin-3-one 446 (Scheme 141). Given that the
product was not crystalline and that it was not possible to determine which structure
was formed based on NMR data alone, we planned to couple β-lactam 445 or
pyrazolidin-3-one 446 with a benzylamine compound in the hope that the amide would
be crystalline for X-ray crystallography analysis (Scheme 142).
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Scheme 141. Proposed synthesis of cyclic structures using an intramolecular Jocic reaction.
Scheme 142. Amide synthesis.
Unfortunately, of the amide derivatives synthesised, suitable crystals could not be
grown. Attempts to remove the Cbz group to give a potentially more crystalline
compound resulted in degradation of the material. However, by comparing the infrared
data to the literature we were able to make a tentative assignment (Figure 18).434
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Figure 18. Comparison of IR data to the literature.
The higher frequency absorption in the known compounds 450 and 451 can be
assigned to the β- and γ-lactam C=O stretches, respectively. Compound 448 or 449
showed a highest C=O stretch of 1787 cm-1. β-Lactam 448 is therefore the most likely
structure based on the data available to us, although this is not conclusive evidence.
2.7.3 Reactions with Oxygen Nucleophiles
Treatment of amide 428 with NaOH and p-methoxyphenol was anticipated to yield
the phenoxy-substituted acid 452 (Scheme 143), since there was precedent in the
literature for phenoxide to act as a nucleophile in the Jocic reaction.336, 435
Unfortunately, the reaction failed to give any identifiable products. Since the
Bargellini reaction is almost exclusively the reaction of phenoxide nucleophiles with
tertiary trichlorocarbinols (generated in situ), it is unclear as to why the reaction in
scheme 143 should fail completely. The reason cannot be slower formation of the
intermediate gem-dichloroepoxide since the rate of this step will be enhanced for
tertiary trichlorocarbinols due to the Thorpe-Ingold effect.436, 437
Scheme 143. Attempted Jocic reaction with 4-methoxyphenol.
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The amide 453 was also synthesised as a substrate for the same reaction, by ring
opening of lactone 171 with dibenzylamine (Scheme 144).
Scheme 144. Attempted Jocic reaction using an alternative amide.
Dibenzyl amide 453 should be more stable to alkaline hydrolysis than the potentially
labile morpholine amides. Unfortunately, the Jocic reaction with this amide also failed
to yield any identifiable products.
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2.8 Conclusions and Future Work
The asymmetric syntheses of both natural products α-tocopherol and γ-tocopherol 
were completed. The asymmetric synthesis of γ-tocopherol had previously only been 
achieved by a gold-catalysed allylic substitution or by an enantioselective 1,2-
addition. Neither of these syntheses managed to achieve a high enantiomeric excess at
the tertiary C-2 centre. In this sense, our work represents an improvement on the
previously reported work since we were able to achieve ≥ 98% e.e. at the C-2 centre.
The key step in the synthesis was an intramolecular Jocic reaction which proceeded
with complete inversion and retained the ≥ 98% enantiomeric excess of the 
trichlorolactone starting material. Difficulties during the synthesis included the
Friedel-Crafts ring opening of a β-lactone with a sterically hindered 
dimethoxybenzene, and the demethylation of aryl methyl ethers. The Friedel-Crafts
reaction was found to be mediated by TiCl4 in high yield, whilst BBr3 was eventually
used to remove the methyl ethers. Despite the strongly Lewis acidic nature of both
reagents, no degradation of our substrate was observed. Trichlorocarbinols are
particularly stable to acidic conditions due to the electron withdrawing CCl3 moiety.
The later steps in the synthesis were known in the literature and proceeded smoothly.
The water-soluble vitamin E analogue (S)-Trolox could also be obtained by hydrolysis
of one of the intermediate ester compounds. β-Tocopherol is also theoretically 
obtainable using the synthesis we developed, if 2,5-dimethyl-1,4-dimethoxybenzene
is used as the arene starting material.
The reaction is a potentially useful general synthesis of tertiary chromanes which have
been shown to be difficult to access in high enantiomeric excess by other methods.
Aniline or thiphenol analogues should in theory yield 2-substituted
tetrahydroquinolines and thiochromanes, respectively. Trichlorolactones with
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different substitution patterns are known, and these would offer different substitution
at the 2-position of the chromane ring.
In addition, attempts were made to expand the methodology to include inter- rather
than intramolecular nucleophiles. The attempted addition of organometallic reagents
to a morpholine amide containing the trichlorocarbinol group failed to give the
expected ketone product, with the reaction instead yielding several unexpected
compounds. Attempts to use p-methoxyphenol as a nucleophile in the Jocic reaction
with this amide also failed to yield the expected α-disubstituted carboxylic acid, 
whereas the intramolecular version gave reasonable yields of cyclised product during
the synthesis of the tocopherols 1 and 3. Despite this lack of success, we felt that
further studies using lactone 171 as a masked source of an enantiomerically enriched
trichlorocarbinol were warranted as there were very few examples of this in the
literature.
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2.9 Experimental Section
All the reagents and solvents used were purchased from Sigma-Aldrich, Alfa-Aesar,
TCI, Fluorochem or Acros Organics and were used as received unless stated
otherwise. Solvents were dried over 3 Å or 4 Å molecular sieves where necessary.
1H and 13C NMR spectra were recorded on a Bruker AVII-700 MHz, AVIII HD-500
MHz, AVIII HD-400 MHz, AVIII HD-300 MHz or AV-300 MHz Fourier transform
spectrometer, at room temperature unless stated otherwise. Chemical shifts are quoted
in parts per million (ppm) downfield from tetramethylsilane. Solvents were used as an
internal standard when assigning NMR spectra (δH: CDCl3 7.26 ppm, CD3OD 3.31
ppm, (CD3)2SO 2.50 ppm, D2O 4.79 ppm; δC: CDCl3 77.1 ppm, CD3OD 49.0 ppm,
(CD3)2SO 39.5 ppm). Coupling constants (J) are quoted in Hertz (Hz) and rounded to
the nearest 0.5 Hz. Abbreviations used in the descriptions of spectra are as follows; s
= singlet, d = doublet, t = triplet, q = quartet, quin. = quintet, m = multiplet, br = broad.
13C NMR spectra were recorded with proton decoupling and the spectra were assigned
on the basis of COSY, PENDANT, HSQC and HMBC experiments.
Infrared spectra were recorded on a Bruker ALPHA platinum ATR spectrometer using
OPUS software and are quoted in wavenumbers (cm-1).
Optical rotations were recorded on an Optical Activity Ltd. AA-1000 millidegree auto-
ranging polarimeter (using the sodium D line, 589 nm) and [α]D values are given in
units of 10-1deg cm2 g-1. The samples were prepared using spectroscopic grade CHCl3
or MeOH.
HPLC data were obtained on a Varian Prostar 335LC detector using a Chiralcel Daicel
AD-H column (4.6 mm x 250 mm), with a solvent system of n-hexane:2-propanol.
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Melting points for solid crystalline products were determined using a Stuart Scientific
SMP10 Digital Melting Point Apparatus, with a range given in °C and rounded to the
nearest degree. The melting points are uncorrected.
Thin Layer Chromatography (TLC) was carried out using silica coated (0.25 mm)
alumina plates, and the plates were visualised using UV light or staining by KMnO4.
Tocopherol-derived compounds are numbered according the following IUPAC
system:
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1,4-Dimethoxy-2,3,5-trimethylbenzene 364
The compound was prepared according to a method adapted from the literature.397 To
a solution of trimethylhydroquinone (10.0g, 64.7 mmol) in acetone (100 mL) was
added K2CO3 (36.3g, 263 mmol) and MeI (16.4 mL, 263 mmol) under nitrogen, and
the mixture was stirred for 48 hours at reflux temperature. The solvent was removed
in vacuo, water was added and the compound was extracted with Et2O. The combined
organic layers were washed with water and dried over Na2SO4, the solvent was
removed in vacuo and the residue was purified by column chromatography (95:5
petroleum ether/Et2O) to give the product as a white solid (9.70 g, 82%). ν (cm-1);
2936 (C-H stretch), 1120 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 6.56 (1H, s, 
Ph-H), 3.80 (3H, s, OCH3), 3.68 (3H, s, OCH3), 2.31 (1H, s, Ar-CH3), 2.23 (1H, s, Ar-
CH3), 2.15 (1H, s, Ar-CH3); 13C NMR (CDCl3, 125 MHz) δ 153.6 (COCH3), 150.7
(COCH3), 130.7 (Ph-C), 127.9 (Ph-C), 123.6 (Ph-C), 110.4 (Ph-CH), 60.2 (OCH3),
55.8 (OCH3), 16.3 (CH3), 12.7 (CH3), 11.9 (CH3); LRMS (ESI) m/z: calcd. for
C11H16NaO2 [M+Na]+ 203.1, found 203.2; m.p = 35-36 °C. Data are consistent with
that previously reported.397
1,4-Dimethoxy-2,3-dimethylbenzene 365
The compound was prepared according to a method adapted from the literature.397 To
a solution of 1,4-dihydroxy-2,3-dimethylbenzene (6.03 g, 36.3 mmol) in acetone (60
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mL) was added K2CO3 (20.0 g, 145 mmol) and MeI (9.00 mL, 145 mmol) under
nitrogen, and the mixture was stirred for 48 hours at reflux temperature. The solvent
was removed in vacuo, water was added and the compound was extracted with Et2O.
The combined organic layers were washed with water and dried over Na2SO4, the
solvent was removed in vacuo and the residue was purified by column
chromatography (95:5 petroleum ether/Et2O) to yield product as a white solid (5.42 g,
79%). ν (cm-1); 2952 (C-H stretch), 1094 (C-O stretch); 1H NMR (CDCl3, 500 MHz)
δ 6.76 (2H, s, H5 and H6), 3.89 (6H, s, OCH3), 2.32 (6H, s, Ph-CH3); 13C NMR (CDCl3,
125 MHz) δ 151.4 (C1 and C4), 126.1 (C2 and C3), 107.2 (C5 and C6), 55.3 (OCH3),
11.52 (CH3); LRMS (ESI) m/z: calcd. for C10H14NaO2 [M+Na]+ 189.1, found 189.2;
m.p = 78-79 °C. Spectroscopic data are consistent with that previously reported.438
1-Bromo-2,5-dimethoxy-3,4,6-trimethylbenzene 370
The compound was prepared according to a literature procedure.415 To a solution of
1,4-dimethoxy-2,3,5-trimethylbenzene 364 (0.36 g, 2.0 mmol) in CH3CN (10 mL) was
added N-bromosuccinimide (0.53 g, 3.0 mmol) and the mixture was stirred at room
temperature for 2.5 hours. The solvent was removed in vacuo and the residue was
extracted with Et2O, washed with water and brine and dried over Na2SO4 to yield
product as an off-white solid which was used without further purification (0.50 g,
97%). ν (cm-1); 2935 (alkyl C-H stretch), 1222 (C-O stretch), 753 (C-Br stretch); 1H
NMR (CDCl3, 500 MHz) δ 3.73 (3H, s, OCH3), 3.65 (3H, s, OCH3), 2.35 (3H, s, CH3),
2.23 (3H, s, CH3), 2.17 (3H, s, CH3); 13C NMR (CDCl3, 125 MHz) δ 152.6 (Ph-C), 
151.1 (Ph-C), 150.6 (Ph-C), 129.1 (Ph-C), 129.0 (Ph-C), 117.0 (Ph-C), 59.72 (OCH3),
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59.61 (OCH3), 15.93 (CH3), 13.19 (CH3), 12.50 (CH3); LRMS (ESI) m/z: calcd. for
C11H1579BrNaO2 [M+Na]+ 281.0, found 281.0; m.p = 70-71 °C. Spectroscopic data
are consistent with that previously reported.415, 439
1-Bromo-2,5-dimethoxy-3,4-dimethylbenzene 371
The compound was prepared according to a literature procedure.415 To a solution of
1,4-dimethoxy-2,3-dimethylbenzene 365 (0.20 g, 1.2 mmol) in CH3CN (5 mL) was
added N-bromosuccinimide (NBS) (0.32 g, 1.8 mmol) and the mixture was stirred at
room temperature for 45 minutes. The solvent was removed in vacuo and the residue
was extracted with Et2O, washed with water and brine and dried over Na2SO4 to yield
product to yield product as a pale yellow oil (292 mg, 91%) after column
chromatography (95:5 petroleum ether/Et2O). ν (cm-1); 3018 (C-H stretch), 1214 (C-
O stretch), 751 (C-H bend); 1H NMR (CDCl3, 500 MHz) δ 6.86 (1H, s, Ph-H), 3.76 
(3H, s, OCH3), 3.72 (3H, s, OCH3), 3.23 (3H, s, CH3), 2.08 (3H, s, CH3); 13C NMR
(CDCl3, 125 MHz) δ 153.5 (Ph-C), 148.7 (Ph-C), 131.7 (Ph-C), 125.2 (Ph-C), 112.8 
(Ph-C), 111.7 (Ph-CH), 59.9 (OCH3), 55.3 (OCH3), 12.7 (CH3), 11.5 (CH3); LRMS
(ESI) m/z: calcd. for C10H1379BrNaO2 [M+Na]+ 267.0, found 267.1. Spectroscopic data
are consistent with that previously reported.438
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(R)-4,4,4-Trichloro-1-(2’,5’-dimethoxyphenyl)-3-hydroxy-3-methylbutan-1-one
373
The compound was prepared according to a procedure adapted from the literature.395
To a solution of AlCl3 (0.632g, 4.75 mmol) and 1,4-dimethoxybenzene 372 (1.38g, 10
mmol) in CH2Cl2 (10 mL) was added a solution of (R)-(+)-4-methyl-4-
(trichloromethyl)-2-oxetanone 171 (0.203g, 1.00 mmol) in CH2Cl2 (2 mL), at 0 °C.
The mixture was warmed to room temperature and stirred overnight. The resulting
solution was then cooled to 0 °C, quenched with saturated NH4Cl (aq.) and extracted
with CH2Cl2. The organic fractions were washed with brine, dried over Na2SO4 and
the solvent was removed in vacuo. The residue was purified by column
chromatography (95:5 petroleum ether/EtOAc to 1:1) to yield product as a yellow
solid (0.292 g, 85%, ≥ 98% e.e.).  ν (cm-1); 3444 (br, O-H stretch), 1647 (C=O stretch),
1278 and 1030 (C-O stretch), 794.9 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 7.29 
(1H, d, J 3, H6’), 7.10 (1H, dd, J 9.5, 3, H4’), 6.95 (1H, d, J 9, H3’), 5.49 (1H, s, OH),
3.92 (3H, s, OCH3), 3.83 (1H, d, J 16, CHHCO), 3.81 (3H, s, OCH3), 3.64 (1H, d, J
16.5, CHHCO), 1.72 (3H, s, CH3); 13C NMR (CDCl3, 125 MHz) δ 201.7 (CO), 153.7 
(C5’), 153.3 (C2’), 127.9 (C1’), 121.6 (C4’), 114.0 (C6’), 113.4 (C3’), 108.0 (CCl3), 82.7
(C(OH)), 56.2 (OCH3), 55.9 (OCH3), 46.7 (CH2), 23.4 (C(CH3)); HRMS (ESI) m/z:
calcd. for C13H1535Cl3NaO4 [M+Na]+ 362.9928, found 362.9931; m.p = 89-91 °C; [α]D
30 +7.7 (c 1, CHCl3). Enantiomeric excess was determined by chiral HPLC (Daicel
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Chiralcel AD-H column, 2-propanol : hexane = 10 : 90, 1 mL/min, 227 nm, (R) isomer
14.81 min, (S) isomer 16.33 min).
4,4,4-Trichloro-1-(2’,5’-dimethoxyphenyl)-3-hydroxy-3-methylbutan-1-one (±)-
373
A solution of diisopropylamine (1.40 mL, 10.0 mmol) in dry Et2O (20 mL) was cooled
to -78 °C and n-BuLi (3.60 mL, 9.16 mmol) was added dropwise. After stirring for 30
minutes at this temperature, 1-(2’,5’-dimethoxyphenyl)ethan-1-one 381 (1.35 mL,
8.54 mmol) was added dropwise over 20 minutes. After stirring for one hour 1,1,1-
trichloroacetone (1.41 mL, 12.5 mmol) was added slowly over 20 minutes and the
mixture was stirred at -78 °C for a further three hours, before warming to room
temperature and stirring overnight. The reaction was quenched with saturated NH4Cl
(aq.) (20 mL), extracted with Et2O and the organic fractions were washed with water
and brine. The solvent was removed in vacuo and the residue was purified by column
chromatography (95:5 petroleum ether/EtOAc) to yield product as an off-white solid
(1.63 g, 56%). ν (cm-1); 3407 (br, O-H stretch), 1643 (C=O stretch), 1261 and 1091
(C-O stretch), 787 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 7.28 (1H, d, J 3, H6’),
7.09 (1H, dd, J 9, 3, H4’), 6.95 (1H, d, J 9, H3’), 5.98 (1H, s, OH), 3.91 (3H, s, OCH3),
3.84 (1H, d, J 17, CHHCO), 3.80 (3H, s, OCH3) 3.63 (1H, d, J 16.5, CHHCO), 1.71
(3H, s, C3-CH3); 13C NMR (CDCl3, 125 MHz) δ 201.7 (CO), 153.7 (C5’), 153.2 (C2’),
127.9 (C1’), 121.6 (C4’), 114.0 (C6’), 113.4 (C3’), 108.0 (CCl3), 82.7 (C(OH)), 56.2
(C2’-OCH3), 55.9 (C5’-OCH3), 46.7 (CH2), 23.4 (C(CH3)); HRMS (ESI) m/z: calcd.
for C13H1535Cl3NaO4 [M+Na]+ 362.9928, found 362.9925; m.p = 105-106 °C.
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(R)-4,4,4-Trichloro-1-(2’,5’-dihydroxyphenyl)-3-hydroxy-3-methylbutan-1-one
376
The compound was prepared according to a procedure adapted from the literature.400
To a solution of (R)-4,4,4-trichloro-1-(2’,5’-dimethoxyphenyl)-3-hydroxy-3-
methylbutan-1-one 373 (0.751g, 2.20 mmol) and sodium iodide (1.98g, 13.2 mmol)
in dry CH3CN (10 mL) was added chlorotrimethylsilane (1.44g, 13.2 mmol), slowly
with continuous stirring under nitrogen. The reaction mixture was heated to 70 °C for
60 hours, before being quenched with water and extracted with Et2O. The organic
layer was washed with 5% sodium thiosulfate (aq.), brine and dried over Na2SO4. The
residue was purified by column chromatography (95:5 petroleum ether/EtOAc) to
yield product as a yellow crystalline solid (0.225 g, 33%). ν (cm-1); 3360 (br, O-H
stretch), 1644 (C=O stretch), 1186 (C-O stretch), 775 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 11.6 (1H, s, C2’-OH), 7.25 (1H, d, J 3, H6’), 7.10 (1H, dd, J 9, 3, H4’),
6.94 (1H, d, J 9, H3’), 4.84 (1H, s, C5’-OH), 4.97 (1H, s, C3-OH), 3.77 (1H, d, J 15.5,
CHHCO), 3.44 (1H, d, J 15.5, CHHCO), 1.77 (3H, s, C(CH3)); 13C NMR (CDCl3, 125
MHz) δ 204.6 (CO), 157.4 (C2’), 147.6 (C5’), 126.6 (C4’), 119.9 (C3’), 119.8 (C1’),
114.9 (C6’), 107.6 (CCl3), 82.4 (C(CH3)), 41.8 (CH2), 25.3 (CH3); HRMS (ESI) m/z:
calcd. for C11H1135Cl3NaO4 [M+Na]+ 334.9615, found 334.9620; m.p = 135-136 °C;
[α]D 30 +17.8 (c 0.64, CHCl3).
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4,4,4-Trichloro-1-(2’,5’-dihydroxyphenyl)-3-hydroxy-3-methylbutan-1-one (±)-
376
The compound was prepared according to a procedure adapted from the literature.400
To a solution of 4,4,4-trichloro-1-(2’,5’-dimethoxyphenyl)-3-hydroxy-3-
methylbutan-1-one (±)-373 (0.120 g, 0.351 mmol) and sodium iodide (0.317 g, 2.11
mmol) in dry CH3CN (5 mL) was added chlorotrimethylsilane (0.269 g, 2.11 mmol),
slowly with continuous stirring under nitrogen. The reaction mixture was heated to 70
°C for 60 hours, before being quenched with water and extracted with Et2O. The
organic layer was washed with 5% sodium thiosulfate (aq.), brine and dried over
Na2SO4. The residue was purified by column chromatography (95:5 petroleum
ether/EtOAc) to yield product as a yellow crystalline solid (61 mg, 55%). ν (cm-1);
3363 (br, O-H stretch), 1640 (C=O stretch), 1181 (C-O stretch), 780 (C-Cl stretch);
1H NMR (CDCl3, 500 MHz) δ 11.55 (1H, s, C2’-OH), 7.25 (1H, d, J 3, H6’), 7.10 (1H,
dd, J 9, 3, H4’), 6.93 (1H, d, J 9, H3’), 4.97 (1H, s, C5’-OH), 4.49 (1H, s, C3-OH), 3.77
(1H, d, J 15.5, CHHCO), 3.44 (1H, d, J 15.5, CHHCO), 1.77 (3H, s, C(CH3)); 13C
NMR (CDCl3, 125 MHz) δ 204.7 (CO), 157.4 (C2’), 147.7 (C5’), 126.3 (C4’), 119.8
(C3’), 119.5 (C1’), 115.1 (C6’), 107.6 (CCl3), 82.4 (C(CH3)), 41.8 (CH2), 23.5 (CH3);
HRMS (ESI) m/z: calcd. for C11H1135Cl3NaO4 [M+Na]+ 334.9615, found 334.9615;
m.p = 127-128 °C.
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Methyl (S)-6-hydroxy-2-methyl-4-oxochromane-2-carboxylate 379
To a deoxygenated solution of (R)-4,4,4-trichloro-1-(2’,5’-dihydroxyphenyl)-3-
hydroxy-3-methylbutan-1-one 376 (0.340 g, 1.08 mmol) in acetone (10 mL) was
added deoxygenated 2M NaOH (aq.) (2.17 mL, 4.33 mmol) and the mixture was
stirred under nitrogen at room temperature overnight. The resulting alkaline solution
was washed three times with Et2O, acidified to pH 2 with 1M HCl (aq.) and extracted
with EtOAc. The combined organic fractions were washed with pH 2 buffer and dried
over Na2SO4. The solvent was removed in vacuo to yield crude product as a brown
crystalline solid which was used without further purification (0.140 g, 58%). A sample
was purified by column chromatography (8:2:0.1 EtOAc/MeOH/AcOH) for analysis.
ν (cm-1): 3217 (br, O-H stretch), 1675 (C=O stretch), 1213 (C-O stretch); 1H NMR
((CD3)2SO, 500 MHz) δ 7.02-6.96 (2H, m, Ar-H), 6.89 (1H, d, J 8.5, H8), 2.98 (1H, d,
J 16.5, CHHCO), 2.89 (1H, d, J 17, CHHCO), 1.56 (3H, s, C(CH3)); 13C NMR (
(CD3)2SO, 125 MHz) δ 191.3 (CO), 173.9 (CO2), 154.1 (C6), 151.8 (C8a), 124.9 (C8),
120.8 (C4a), 119.54 (C7), 110.0 (C5), 81.7 (C(CH3)), 45.9 (CH2), 25.2 (C(CH3));
HRMS (ESI) m/z: calcd. for C11H9O5 [M-H]- 221.0455, found 221.0456; m.p = 141-
142 °C; [α]D 30 +45 (c 0.80, CHCl3).
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Methyl (S)-6-hydroxy-2-methyl-4-oxochromane-2-carboxylate 382
A solution of (S)-6-hydroxy-2-methyl-4-oxochromane-2-carboxylic acid 379 (20 mg,
0.1 mmol) in 2M methanolic HCl (5 mL) was stirred at room temperature for 16 hours.
After this time the mixture was concentrated in vacuo and the residue was taken up
with EtOAc, washed with saturated NaHCO3 (aq.), water, and dried over Na2SO4. The
solvent was removed in vacuo and the resulting residue was purified by column
chromatography (1:1 petroleum ether/EtOAc) to yield product as a white solid (21 mg,
90%, ≥ 98% e.e.). ν (cm-1); 3413 (br, O-H stretch), 1737 (ester C=O stretch), 1683
(ketone C=O stretch), 1199 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 7.30 (1H, d, 
J 3, H5), 7.08 (1H, dd, J 9, 3, H7), 6.98 (1H, d, J 9, H8), 5.63 (1H, s, OH), 3.68 (3H, s,
OCH3), 3.19 (1H, d, J 16.5, CHHCO), 2.85 (1H, d, J 17, CHHCO), 1.71 (3H, s,
C(CH3)); 13C NMR (CDCl3, 125 MHz) δ 190.6 (CO), 172.3 (CO2), 154.0 (C6), 150.5
(C8a), 125.2 (C7), 120.4 (C4a), 119.5 (C8), 111.0 (C5), 81.4 (C(CH3)), 53.1 (OCH3),
45.5 (CH2), 24.9 (C(CH3)); HRMS (ESI) m/z: calcd. for C12H12NaO5 [M+Na]+
259.0577, found 259.0579; m.p = 150-151 °C; [α]D 25 +49.6 (c 0.50, CHCl3).
Enantiomeric excess was determined by chiral HPLC (Daicel Chiralcel AD-H column,
2-propanol : hexane = 10 : 90, 1 mL/min, 227 nm, (R) isomer 14.35 min, (S) isomer
16.12 min).
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Methyl 6-hydroxy-2-methyl-4-oxochromane-2-carboxylate (±)-382
To a deoxygenated solution of 4,4,4-trichloro-1-(2’,5’-dihydroxyphenyl)-3-hydroxy-
3-methylbutan-1-one (±)-376 (60.0 mg, 0.192 mmol) in acetone (2.5 mL) was added
deoxygenated 2M NaOH (aq.) (0.382 mL, 0.764 mmol) and the mixture was stirred
under nitrogen at room temperature overnight. The resulting alkaline solution was
washed three times with Et2O, acidified to pH 2 with 1M HCl (aq.) and extracted with
EtOAc. The combined organic fractions were washed with pH 2 buffer and dried over
Na2SO4. The solvent was removed in vacuo to yield (±)-379 as a brown crystalline
solid, which was used straight away in the next step without further purification. A
sample was purified by column chromatography (8:2:0.1 EtOAc/MeOH/AcOH) for
analysis. ν (cm-1); 3272 (br, O-H stretch), 1674 (C=O stretch), 1212 (C-O stretch); 1H
NMR ((CD3)2SO, 500 MHz) δ 6.96 (1H, d, J 3, H5), 6.91 (1H, dd, J 9, 3, H7), 6.80
(1H, d, J 9, H8), 3.00 (1H, d, J 16, CHHCO), 2.62 (1H, d, J 16, CHHCO), 1.45 (3H,
s, CH3); 13C NMR ((CD3)2SO, 125 MHz) δ 192.5 (CO), 174.3 (CO2), 155.2 (C6), 151.0
(C8a), 124.2 (C8), 121.2 (C4a), 119.4 (C7), 109.9 (C5), 82.8 (C(CH3)), 47.0 (CH2), 25.9
(C(CH3)); HRMS (ESI) m/z: calcd. for C11H9O5 [M-H]- 221.0455, found 221.0460;
m.p = 163-164 °C.
To a solution of crude 6-hydroxy-2-methyl-4-oxochromane-2-carboxylic acid (±)-379
(20 mg, 0.10 mmol) in MeOH (5 mL) was added p-toluenesulfonic acid (PTSA) (20
mg, 0.10 mmol), and the solution was stirred at reflux temperature for six hours. After
cooling to room temperature the solvent was removed in vacuo and the residue was
taken up with EtOAc. The organic fraction was washed with saturated NaHCO3 (aq.)
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and water and dried over Na2SO4. The residue was purified by column
chromatography (1:1 petroleum ether/EtOAc) to yield product as an off-white white
solid (21 mg, 39% from (±)-376). ν (cm-1); 3389 (br, O-H stretch), 1744 (ester C=O
stretch), 1680 (ketone C=O stretch), 1196 (C-O stretch); 1H NMR (CDCl3, 500 MHz)
δ 7.32 (1H, d, J 3, H5), 7.08 (1H, dd, J 9, 3, H7), 6.97 (1H, d, J 9, H8), 6.15 (1H, s,
OH), 3.68 (3H, s, OCH3), 3.20 (1H, d, J 17, CHHCO), 3.86 (1H, d, J 17, CHHCO),
1.71 (3H, s, C(CH3)); 13C NMR (CDCl3, 125 MHz) δ 191.0 (CO), 172.4 (CO2), 154.5
(C6), 150.7 (C8a), 125.4 (C7), 120.3 (C4a), 119.5 (C8), 111.0 (C5), 81.39 (C(CH3)),
53.10 (OCH3), 45.50 (CH2), 24.89 (C(CH3)); HRMS (ESI) m/z: calcd. for C12H12NaO5
[M+Na]+ 259.0577, found 259.0582; m.p = 180-181 °C.
(S,R)-6-Hydroxy-2-methyl-4-oxo-N-[1-phenylethyl]chromane-2-carboxamide
380
To a solution of (S)-6-hydroxy-2-methyl-4-oxochromane-2-carboxylic acid 379 (30.0
mg, 0.135 mmol) in EtOH (5 mL) was added (R)-α-methylbenzylamine (24.0 mg, 
0.203 mmol), HOBt (18.0 mg, 0.135 mmol), EDCI.HCl (53.0 mg, 0.338 mmol) and
NMM (50.0 µL, 0.473 mmol) and the mixture was stirred overnight at room
temperature. The resulting mixture was partitioned between pH 2 buffer and EtOAc,
the combined organic fractions were washed with water and brine and dried over
Na2SO4. The solvent was removed in vacuo and the residue was purified by column
chromatography (8:2 petroleum ether/EtOAc to 1:1) to yield product as a white solid
(20 mg, 30%). ν (cm-1); 3337 (br, N-H stretch), 1683 (ketone C=O stretch), 1643
(amide C=O stretch), 1205 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 7.28 (1H, d, 
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J 3, H5), 7.23-7.16 (3H, m, Ph-H), 7.04 (1H, dd, J 9, 3, H7), 6.98-6.93 (2H, m, Ph-H),
6.90 (1H, d, J 9.0, H8), 6.62 (1H, d, J 8.0, NH), 5.26 (1H, s, OH), 5.05 (1H, dq, J 8,
7, NHCH), 3.20 (1H, d, J 17, CHHCO), 2.81 (1H, d, J 17, CHHCO), 1.65 (3H, s,
C(CH3)), 1.50 (3H, d, J 7, CHCH3); 13C NMR (CDCl3, 125 MHz) δ 190.2 (CO), 171.0 
(CONH), 153.0 (C6), 150.7 (C8a), 142.4 (Ph-C), 129.0 (Ph-C), 127.3 (Ph-C), 125.7
(Ph-C), 124.6 (C7), 121.1 (C4a), 119.1 (C8), 111.5 (C5), 82.42 (C(CH3)), 48.46
(NHCH), 44.77 (CH2), 24.05 (C(CH3)), 21.52 (CHCH3); HRMS (ESI) m/z: calcd. for
C19H20NO4 [M+H]+ = 326.1387, found 326.1389; m.p = 190-191 °C.
(S,S)-6-Hydroxy-2-methyl-4-oxo-N-[1-phenylethyl]chromane-2-carboxamide
380
To a solution of (S)-6-hydroxy-2-methyl-4-oxochromane-2-carboxylic acid 379 (60.0
mg, 0.270 mmol) in EtOH (5 mL) was added (S)-α-methylbenzylamine (65.0 mg, 
0.540 mmol), HOBt (36.0 mg, 0.270 mmol), EDCI.HCl (105 mg, 0.675 mmol) and
NMM (0.104 mL, 0.945 mmol) and the mixture was stirred overnight at room
temperature. The resulting mixture was partitioned between pH 2 buffer and EtOAc,
the combined organic fractions were washed with water and brine and dried over
Na2SO4. The solvent was removed in vacuo and the residue was purified by column
chromatography (8:2 petroleum ether/EtOAc to 1:1) to yield product as a colourless
oil (20 mg, 23%). ν (cm-1); 3330 (br, N-H stretch), 1679 (ketone C=O stretch), 1650
(amide C=O stretch), 1215 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 7.40-7.32 
(3H, m, Ar-H), 7.31-7.27 (3H, m, Ar-H), 7.10 (1H, dd, J 9, 3, H7), 6.94 (1H, d, J 9,
H8), 6.68 (1H, d, J 8, NH), 5.74 (1H, s, OH), 5.04 (1H, dq, J 8, 7, NHCH), 3.22 (1H,
173
d, J 17, CHHCO), 2.86 (1H, d, J 17, CHHCO), 1.59 (3H, s, C(CH3)), 1.33 (3H, d, J 7,
CHCH3); 13C NMR (CDCl3, 125 MHz) δ 190.5 (CO), 171.1 (CONH), 152.8 (C6),
150.9 (C8a), 142.6 (Ph-C), 128.3 (Ph-C), 127.6 (Ph-C), 126.0 (Ph-C), 124.8 (C7), 121.0
(C4a), 119.0 (C8), 111.6 (C5), 82.3 (C2), 48.7 (NHCH), 44.8 (CH2), 23.7 (C(CH3)), 21.6
(CHCH3); HRMS (ESI) m/z: calcd. for C19H20NNaO4 [M+H]+ 348.1206, found
348.1205; m.p = 60-61 °C.
4-Hydroxy-2,3,5-trimethylphenyl pivalate 383
The compound was prepared according to a literature procedure.216 To a suspension
of trimethylhydroquinone (5.00 g, 32.9 mmol) in CH2Cl2 (40 mL) was added pyridine
(8.33 mL, 105 mmol) and the mixture was cooled to 0 °C. Pivaloyl chloride (4.25 mL,
34.5 mmol) in CH2Cl2 (20 mL) was then added dropwise over 45 minutes and the
solution was stirred at room temperature for an additional 18 hours, after which time
it was washed with 2M HCl (aq.), 5% NaHCO3 (aq.) and brine. The organic fractions
were dried over Na2SO4 and the solvent was removed in vacuo to yield crude product
as an orange solid (7.04 g). This solid was recrystallised in petroleum ether to give
product as a white crystalline solid (4.81 g, 62%). ν (cm-1); 3490 (br, O-H stretch),
1730 (C=O stretch), 1135 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 6.56 (1H, s, 
Ph-H), 5.00 (1H, s, OH), 2.12 (3H, s, CH3), 2.09 (3H, s, CH3), 2.01 (3H, s, CH3), 1.39
(9H, s, C(CH3)3); 13C NMR (CDCl3, 125 MHz) δ 177.3 (CO2), 149.2 (Ar-C), 141.7
(Ar-C), 126.5 (Ar-C), 123.2 (Ar-C), 120.5 (Ar-C), 120.0 (Ar-C), 38.6 (C(CH3)3), 26.7
(C(CH3)3), 15.3 (Ar-CH3), 12.0 (Ar-CH3), 11.6 (Ar-CH3); LRMS (ESI) m/z: calcd. for
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C14H20NaO3 [M+Na]+ 259.1, found 259.1; m.p = 123-124 °C. Spectroscopic data are
consistent with that previously reported.216
4-Methoxy-2,3,5-trimethylphenol 384
The compound was prepared according to a literature procedure.216 To a solution of
4-hydroxy-2,3,5-trimethylphenyl 2,2-dimethylpropanoate 383 (14.2 g, 60.3 mmol) in
acetone (150 mL) was added K2CO3 (16.7 g, 121 mmol) and MeI (11.3 mL, 181 mmol)
under nitrogen, and the mixture was stirred at reflux temperature for 48 hours. After
cooling to room temperature, the solids were filtered off and washed with acetone, the
filtrate was removed in vacuo and the residue was taken up in Et2O. The organic layer
was washed with saturated Na2CO3 (aq.), water and dried over Na2SO4. The solvent
was removed in vacuo to yield the methyl ether as an orange oil (12.7 g, 84%), which
was used directly in the next step without further purification. ν (cm-1); 2973 (C-H
stretch), 1746 (C=O stretch), 1117 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 6.65
(1H, s, Ph-H), 3.68 (3H, s, OCH3), 2.25 (3H, s, CH3), 2.21 (3H, s, CH3), 2.02 (3H, s,
CH3), 1.38 (9H, s, C(CH3)3); 13C NMR (CDCl3, 125 MHz) δ 177.2 (CO2), 154.4 (Ar-
C), 145.1 (Ar-C), 130.9 (Ar-C), 128.8 (Ar-C), 127.4 (Ar-C), 121.0 (Ar-C), 60.0
(OCH3), 39.1 (C(CH3)3), 27.4 (C(CH3)3), 16.0 (Ar-CH3), 12.7 (Ar-CH3), 12.6 (Ar-
CH3); LRMS (ESI) m/z: calcd. for C15H22NaO3 [M+Na]+ 273.1, found 272.8.
Spectroscopic data are consistent with that previously reported.216
To a solution of 4-methoxy-2,3,5-trimethylphenyl pivalate (5.0 g, 20 mmol) in MeOH
(30 mL) was added a solution of KOH (1.8 g, 32 mmol) in water (10 mL) and the
mixture was stirred at reflux temperature for six hours, then at room temperature
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overnight. The solvent was then removed in vacuo and the residue was diluted with
water and acidified with 2M HCl (aq.). The aqueous layer was extracted with Et2O
and the organic fractions were washed with saturated Na2CO3 (aq.), brine and dried
over Na2SO4 to give crude product as a dark brown oil. Further purification by column
chromatography (8:2 petroleum ether/EtOAc) yielded product as a yellow solid after
drying under high vacuum (3.14 g, 95%). ν (cm-1); 3404 (br, O-H stretch), 1224 (C-O
stretch); 1H NMR (CDCl3, 500 MHz) δ 6.43 (1H, s, Ph-H), 5.44 (1H, s, OH), 3.69 
(3H, s, OCH3), 2.23 (3H, s, CH3), 2.22 (3H, s, CH3), 2.15 (3H, s, CH3); 13C NMR
(CDCl3, 125 MHz) δ 150.3 (Ar-C), 149.7 (Ar-C), 130.7 (Ar-C), 128.3 (Ar-C), 121.4 
(Ar-C), 114.6 (Ar-C), 60.8 (OCH3), 16.0 (Ar-CH3), 12.7 (Ar-CH3), 11.9 (Ar-CH3);
LRMS (ESI) m/z: calcd. for C10H14NaO2 [M+Na]+ 189.1, found 189.0; m.p = 50-51
°C. Spectroscopic data are consistent with that previously reported.216
(R)-4,4,4-Trichloro-1-(2’,5’-dimethoxy-3’,4’,6’-trimethylphenyl)-3-hydroxy-3-
methylbutan-1-one 366
A solution of 1,4-dimethoxy-2,3,5-trimethylbenzene (14.0 g, 77.8 mmol) 364 in
CH2Cl2 (30 mL) was cooled to 0 °C and TiCl4 (3.11 mL, 28.3 mmol) was added
dropwise under nitrogen. After stirring for five minutes, (R)-(+)-4-methyl-4-
(trichloromethyl)-2-oxetanone 171 (1.58 g, 7.78 mmol) dissolved in minimum CH2Cl2
was added dropwise and the mixture was stirred at room temperature overnight. The
reaction was quenched with saturated NH4Cl (aq.) and extracted with CH2Cl2, the
combined organic fractions were washed with water and brine and dried over Na2SO4.
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The solvent was removed in vacuo and the resulting residue was purified by column
chromatography (95:5 petroleum ether/EtOAc to 8:2) to yield product as a yellow oil
(2.40 g, 80 %). ν (cm-1); 3437 (br, O-H stretch), 1688 (C=O stretch), 1259 and 1082
(C-O stretch), 791 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 4.93 (1H, s, OH), 
3.67 (3H, s, OCH3), 3.66 (3H, s, OCH3), 3.56-3.50 (2H, m, CH2), 2.22 (3H, s, Ar-
CH3), 2.17 (6H, s, Ar-CH3), 1.81 (3H, s, C3-CH3); 13C NMR (CDCl3, 125 MHz) δ 
207.9 (CO), 153.4 (C5’), 150.8 (C2’), 133.6 (C4’), 129.8 (C6’), 129.1 (C3’), 125.2 (C1’),
107.3 (CCl3), 81.8 (C(OH)), 62.5 (C2’-OCH3), 60.2 (C5’-OCH3), 49.0 (CH2), 23.3 (C3-
CH3), 13.04 (Ar-CH3), 12.39 (2 x Ar-CH3); HRMS (ESI) m/z: calcd. for
C16H2135Cl3NaO4 [M+Na]+ 405.0398, found 405.0397; [α]D 25 -0.6 (c 12.56, CHCl3).
1-(2’,5’-Dimethoxy-3’,4’,6’-trimethylphenyl)ethan-1-one 388
A solution of 1,4-dimethoxy-2,3,5-trimethyl benzene 364 (11.6 g, 64.4 mmol) in
CH2Cl2 (100 mL) was cooled to 0 °C and TiCl4 (2.12 mL, 19.3 mmol) was added under
nitrogen. After stirring for 10 minutes, acetyl chloride (0.460 mL, 6.44 mmol) was
added dropwise and the solution was stirred overnight at room temperature. The
reaction was quenched with saturated NH4Cl (aq.) and extracted with CH2Cl2. The
combined organic fractions were washed with water and brine, dried over Na2SO4 and
the solvent was removed in vacuo. The residue was purified by column
chromatography (97.5:2.5 petroleum ether/EtOAc to 8:2) to yield the product as a
yellow oil (0.910 g, 64%). ν (cm-1); 1697 (C=O stretch), 1269 and 1084 (C-O stretch);
1H NMR (CDCl3, 500 MHz) δ 3.65 (3H, s, C5’-OCH3), 3.63 (3H, s, C2’-OCH3), 2.50
(3H, s, COCH3), 2.20 (3H, s, C4’-CH3), 2.16 (3H, s, C3’-CH3), 2.14 (3H, s, C6’-CH3);
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13C NMR (CDCl3, 125 MHz) δ 205.8 (CO), 153.2 (C5’), 150.2 (C2’), 134.8 (C1’),
132.1, 128.7 (C3’and C4’), 124.5 (C6’), 62.2 (C2’-OCH3), 60.1 (C5’-OCH3), 32.4
(COCH3), 12.9 (Ar-CH3), 12.3 (2 x Ar-CH3); HRMS (ESI) m/z: calcd. for C13H18NaO3
[M+Na]+ 245.1148, found 245.1151.
4,4,4-Trichloro-1-(2’,5’-dimethoxy-3’,4’,6’-trimethylphenyl)-3-hydroxy-3-
methylbutan-1-one (±)-366
A solution of diisopropylamine (0.680 mL, 4.86 mmol) in dry Et2O (20 mL) was
cooled to -78 °C and n-BuLi (2.5 M, 1.78 mL, 4.46 mmol) was added dropwise. After
stirring for 30 minutes at this temperature, 1-(2’,5’-dimethoxy-3’,4’,6’-
trimethylphenyl)ethan-1-one 368 (0.900 g, 4.05 mmol) was added dropwise over 20
minutes. After stirring for one hour 1,1,1-trichloroacetone (0.685 mL, 6.08 mmol) was
added slowly over 20 minutes and the mixture was stirred at -78 °C for a further three
hours, before warming to room temperature and stirring overnight. The reaction was
quenched with saturated NH4Cl (aq.) (20 mL), extracted with Et2O and the organic
fractions were washed with water and brine. The solvent was removed in vacuo and
the residue was purified by column chromatography (95:5 petroleum ether/EtOAc) to
yield product as an orange solid (0.630 g, 41%) after column chromatography (85:15
petroleum ether/Et2O). ν (cm-1); 3485 (br, O-H stretch), 1687 (C=O stretch), 1180 and
1075 (C-O stretch), 777 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 4.98 (1H, s, 
OH), 3.66 (3H, s, C5’-OCH3), 3.65 (3H, s, C2’-OCH3), 3.55-3.52 (2H, m, CH2), 2.22
(3H, s, Ar-CH3), 2.18-2.15 (6H, m, Ar-CH3), 1.80 (3H, s, C3-CH3); 13C NMR (CDCl3,
125 MHz) δ 207.7 (CO), 153.4 (C5’), 150.8 (C2’), 133.5 (C4’), 129.4, 129.2 (C6’ and
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C3’), 125.2 (C1’), 107.2 (CCl3), 83.8 (C(OH)), 62.5 (C2’-OCH3), 60.2 (C5’-OCH3),
48.9 (CH2), 23.3 (C3-CH3), 13.1 (Ar-CH3), 12.4 (2 x Ar-CH3); HRMS (ESI) m/z: calcd.
for C16H2235Cl3O4 [M+H]+ 383.0578, found 383.0575; m.p = 87-88 °C.
Methyl (S)-6-hydroxy-2,5,7,8-tetramethyl-4-oxochromane-2-carboxylate 387
To a solution of (R)-4,4,4-trichloro-1-(2’,5’-dimethoxy-3’,4’,6’-trimethylphenyl)-3-
hydroxy-3-methylbutan-1-one 366 (0.910 g, 2.37 mmol) in dry CH2Cl2 (20 mL) was
added BBr3 (0.900 mL, 9.48 mmol) at -78 °C under nitrogen, and the mixture was
warmed to room temperature and stirred overnight. After this time the reaction was
quenched with water and the solvent was removed under a flow of nitrogen. To obtain
the best yields the crude mixture of hydroquinone 170 was reacted immediately in the
next step. A sample could be prepared for analysis by column chromatography (8:2
petroleum ether/EtOAc). ν (cm-1); 3447 (br, O-H stretch), 1648 (C=O stretch), 1295
(C-O stretch), 795 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 9.88 (1H, s, C2’-OH),
5.19 (1H, s, C3-OH), 4.36 (1H, s, C5’-OH), 3.61 (1H, d, J 15.5, CHHCO,), 3.52 (1H,
d, J 16, CHHCO,), 2.39 (3H, s, C6’-CH3), 2.24 (3H, s, C4’-CH3), 2.19 (3H, s, C3’-
CH3), 1.67 (3H, s, C3-CH3); 13C NMR (CDCl3, 125 MHz) δ 208.0 (CO), 151.8 (C2’),
145.5 (C5’), 132.0 (C4’), 124.0 (C3’), 122.1 (C1’), 118.6 (C6’), 107.2 (CCl3), 83.0 (C3),
47.1 (CH2), 23.5 (C3-CH3), 15.8 (C6’-CH3), 13.3 (C4’-CH3), 11.9 (C3’-CH3); HRMS
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(ESI) m/z: calcd. for C14H15Cl3NaO4 [M+Na]+ 374.9928, found 374.9933;  [α]D25 -7.1
(c 0.28, MeOH).
To a deoxygenated solution of crude (R)-4,4,4-trichloro-1-(2’,5’-dihydroxy-3’,4’,6’-
trimethylphenyl)-3-hydroxy-3-methylbutan-1-one 170 in THF (15 mL) was added
deoxygenated 2M NaOH (aq.) until the solution reached a pH of ≥ 12 (17 mL, 34.0 
mmol), and the mixture was stirred under nitrogen at room temperature overnight. The
resulting alkaline solution was washed three times with Et2O, acidified to pH 2 with
1M HCl (aq.) and extracted with EtOAc. The combined organic fractions were washed
with pH 2 buffer and dried over Na2SO4. The solvent was removed in vacuo to yield
product as a brown crystalline solid which was used in the next step without further
purification. A sample was purified by column chromatography (8:2:0.1
EtOAc/MeOH/AcOH) for analysis. ν (cm-1); 3389 (br, O-H stretch), 1707 (carboxylic
acid C=O stretch), 1628 (ketone C=O stretch), 1207 and 1084 (C-O stretch); 1H NMR
((CD3)2SO, 500 MHz) δ 7.96 (1H, s, C6-OH), 2.95 (1H, d, J 16.5, CHHCO), 2.89 (1H,
d, J 16.5, CHHCO), 2.40 (3H, s, C5-CH3), 2.17 (3H, s, C7-CH3), 2.13 (3H, s, C8-CH3),
1.60 (C2-CH3); 13C NMR ((CD3)2SO, 125 MHz) δ 193.0 (CO), 174.0 (CO2), 153.4
(C8a), 147.5 (C6), 134.3 (C8), 125.5 (C5 and C7), 117.1 (C4a), 80.5 (C2), 47.4 (CH2),
25.2 (C2-CH3), 14.27 (C5-CH3 and C7-CH3), 12.52 (C8-CH3); HRMS (ESI) m/z: calcd.
for C14H15O5 [M-H]- 263.0925, found 263.0911; m.p = 194-195 °C; [α]D25 +22.5 (c
0.2, MeOH).
Crude (S)-6-hydroxy-2,5,7,8-tetramethyl-4-oxochromane-2-carboxylic acid 169 was
dissolved in 2M methanolic HCl (10 mL) and stirred at room temperature overnight.
The solvent was removed in vacuo and the residue was extracted with Et2O, the
combined organic fractions were washed with water and brine and dried over Na2SO4.
The crude product was purified using column chromatography (8:2 petroleum
ether/EtOAc) to yield product as a pale yellow crystalline solid (0.260 g, 42% from
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366, ≥ 98% e.e.). ν (cm-1); 3532 (br, O-H stretch), 1727 (ester C=O stretch), 1668
(ketone C=O stretch), 1200 and 1086 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 
4.89 (1H, s, C6-OH), 3.65 (3H, s, CO2CH3), 3.16 (1H, d, J 16.5, CHHCO), 2.83 (1H,
d, J 16.5, CHHCO), 2.50 (3H, s, C5-CH3), 2.23 (6H, s, C7-CH3 and C8-CH3), 1.68 (3H,
s, C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 192.7 (CO), 172.9 (CO2), 153.5 (C8a),
146.8 (C6), 132.8 (C7), 124.2 (C8), 121.2 (C5), 116.9 (C4a), 80.4 (C2), 52.8 (CO2CH3),
47.3 (CH2), 25.08 (C2-CH3), 13.43 (C7-CH3 or C8-CH3), 12.94 (C5-CH3), 12.04 (C7-
CH3 or C8-CH3); HRMS (ESI) m/z: calcd. for C15H18NaO5 [M+Na]+ 301.1046, found
301.1048; m.p = 112-113 °C; [α]D25 +16.3 (c 0.04, CHCl3). Enantiomeric excess was
determined by HPLC analysis (Daicel Chiralcel AD-H column, 2-propanol : hexane =
5 : 95, 1 mL/min, 219 nm, (R) isomer 29.05 min, (S) isomer 31.92 min).
6-Hydroxy-2,5,7,8-tetramethyl-4-oxochromane-2-carboxylic acid (±)-169
Hydroquinone (±)-170 was prepared according to a procedure adapted from the
literature.400 To a solution of 4,4,4-trichloro-1-(2’,5’-dimethoxy-3’,4’,6’-
trimethylphenyl)-3-hydroxy-3-methylbutan-1-one (±)-366 (0.751g, 2.20 mmol) and
sodium iodide (1.98 g, 13.2 mmol) in dry CH3CN (10 mL) was added
chlorotrimethylsilane (1.44 g, 13.2 mmol), slowly with continuous stirring under
nitrogen. The reaction mixture was heated to 70 °C for 60 hours, before being
quenched with water and extracted with Et2O. The organic layer was washed with 5%
sodium thiosulfate (aq.), brine and dried over Na2SO4. The crude hydroquinone (±)-
170 was not isolated and was used in the next step without further purification. To a
deoxygenated solution of crude 4,4,4-trichloro-1-(2’,5’-dihydroxy-3’,4’,6’-
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trimethylphenyl)-3-hydroxy-3-methylbutan-1-one (±)-170 in THF (15 mL) was added
deoxygenated 2M NaOH (aq.) until the solution reached a pH of ≥ 12 (17 mL, 34.0 
mmol), and the mixture was stirred under nitrogen at room temperature overnight. The
resulting alkaline solution was washed three times with Et2O, acidified to pH 2 with
1M HCl (aq.) and extracted with EtOAc. The combined organic fractions were washed
with pH 2 buffer and dried over Na2SO4. The solvent was removed in vacuo to yield
product as a brown crystalline solid (0.220 g, 37% from (±)-366) after column
chromatography (100% EtOAc to 8:2:0.1 EtOAC/MeOH/AcOH). ν (cm-1); 3429 (br,
O-H stretch), 1714 (acid C=O stretch), 1658 (ketone C=O stretch), 1200 and 1083 (C-
O stretch); 1H NMR ((CD3)2SO, 500 MHz) δ 2.94 (1H, d, J 16.5, CHHCO), 2.86 (1H,
d, J 16.5, CHHCO), 2.40 (3H, s, C5-CH3), 2.16 (3H, s, C7-CH3), 2.12 (3H, s, C8-CH3),
1.58 (3H, s, C2-CH3); 13C NMR ((CD3)2SO, 125 MHz) δ 193.2 (CO), 174.1 (CO2),
153.5 (C8a), 147.5 (C6), 134.4 (C8), 123.5, 123.4 (C7 and C5), 117.1 (C4a), 80.5 (C2),
47.4 (CH2), 25.2 (C2-CH3), 14.3 (C7-CH3 and C5-CH3), 12.5 (C8-CH3); HRMS (ESI)
m/z: calcd. for C14H15O5 [M-H]- 263.0925, found 263.0924; m.p = 70-71 °C.
Methyl 6-hydroxy-2,5,7,8-tetramethyl-4-oxochromane-2-carboxylate (±)-387
Crude (S)-6-hydroxy-2,5,7,8-tetramethyl-4-oxochromane-2-carboxylic acid (±)-169
(79 mg, 0.30 mmol) was dissolved in 2M methanolic HCl (10 mL) and stirred at room
temperature overnight. The solvent was removed in vacuo and the residue was
extracted with Et2O, the combined organic fractions were washed with water and brine
and dried over Na2SO4. The residue was purified by column chromatography (8:2
petroleum ether/EtOAc) to yield product as an off-white solid (60 mg, 72%). ν (cm-1);
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3529 (br, O-H stretch), 1727 (ester C=O stretch), 1671 (ketone C=O stretch), 1197
and 1091 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 4.67 (1H, s, OH), 3.65 (3H, s, 
CO2CH3), 3.16 (1H, d, J 16.5, CHHCO), 2.82 (1H, d, J 16.5, CHHCO), 2.51 (3H, s,
C5-CH3), 2.23 (3H, s, C7-CH3 or C8-CH3), 2.22 (3H, s, C7-CH3 or C8-CH3), 1.68 (3H,
s, C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 192.6 (CO), 172.8 (CO2), 153.5 (C8a),
146.8 (C6), 132.6 (C7), 124.3 (C8), 121.0 (C5), 116.9 (C4a), 80.4 (C2), 52.8 (CO2CH3),
47.3 (CH2), 25.1 (C2-CH3), 13.4 (C7-CH3 or C8-CH3), 12.9 (C5-CH3), 12.0 (C7-CH3 or
C8-CH3); HRMS (ESI) m/z: calcd. for C15H18NaO5 [M+Na]+ 301.1046, found
301.1047; m.p = 148-149 °C.
Methyl (S)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylate 388
To a solution of methyl (S)-6-hydroxy-2,5,7,8-tetramethyl-4-oxochromane-2-
carboxylate 387 (0.550 g, 1.98 mmol) in MeOH (25 mL) was added fine zinc powder
(1.29 g, 19.8 mmol) and concentrated HCl (4.13 mL, 49.5 mmol) and the mixture was
stirred at room temperature for five hours. After filtering through celite, the filtrate
was concentrated in vacuo. The resulting residue was taken up with Et2O and washed
with brine. The organic fractions were dried over Na2SO4 and the solvent was removed
in vacuo. The crude material was purified by column chromatography (85:15
petroleum ether/EtOAc) to yield product as a white solid (0.264 g, 51%). ν (cm-1);
3531 (br, O-H stretch), 1718 (C=O stretch), 1197 and 1103 (C-O stretch); 1H NMR
(CDCl3, 500 MHz) δ 4.27 (1H, s, OH), 3.67 (3H, s, CO2CH3), 2.64 (1H, ddd, J 17, 6,
3.5, ArCHH), 2.50 (1H, ddd, J 17.5, 11.5, 6.5, ArCHH), 2.42 (1H, ddd, J 13.5, 6.5, 3,
ArCH2CHH), 2.18 (3H, s, Ar-CH3), 2.15 (3H, s, Ar-CH3), 2.05 (3H, s, Ar-CH3), 1.86
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(1H, ddd, J 13, 11, 6, ArCH2CHH), 1.60 (3H, s, C2-CH3); 13C NMR (CDCl3, 125
MHz) δ 174.5 (CO2), 145.5, 145.3 (C6 and C8a), 122.6, 121.3, 118.4, 116.9 (C4a and
C5 and C7 and C8), 77.1 (C2), 52.4 (CO2CH3), 30.6 (C3), 25.4 (C2-CH3), 21.0 (C4),
12.2, 11.8, 11.2 (Ar-CH3); HRMS (ESI) m/z: calcd. for C15H20NaO4 [M+Na]+
287.1254, found 287.1256; m.p = 134-135 °C; [α]D25 -61.7 (c 5, MeOH).
Methyl (S)-6-(benzyloxy)-2,5,7,8-tetramethylchromane-2-carboxylate 389
The compound was prepared according to a literature procedure.140 To a solution of
methyl (S)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylate 388 (0.150 g,
0.573 mmol) in DMF (2 mL) was added K2CO3 (0.119 g, 0.860 mmol) at 0 °C and
stirred for 20 minutes. Benzyl bromide (82.0 µL, 0.687 mmol) was then added
dropwise and the mixture was stirred at room temperature overnight. The reaction was
diluted with water and EtOAc and the aqueous layer was extracted with EtOAc. The
combined organic fractions were washed thoroughly with water and dried over
Na2SO4. The solvent was removed in vacuo and the crude residue was purified by
column chromatography (9:1 petroleum ether/EtOAc) to yield product as a white solid
(0.193 g, 95%). ν (cm-1); 1747 (C=O stretch), 1253 and 1105 (C-O stretch), 733 and
699 (monosubstituted benzene C-H bend); 1H NMR (CDCl3, 500 MHz) δ 7.55-7.32 
(5H, m, Ph-H), 4.70 (2H, s, OCH2), 3.70 (3H, s, CO2CH3), 2.65 (1H, ddd, J 17, 6.5,
3.5, ArCHH), 2.57-2.40 (2H, m, ArCHH and ArCH2CHH), 2.25 (3H, s, C7-CH3), 2.20
(3H, s, C8-CH3), 2.15 (3H, s, C5-CH3), 1.90 (1H, ddd, J 12.5, 10.5, 5.5, ArCH2CHH),
1.64 (3H, s, C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 174.4 (CO2), 148.9 (C6), 147.8
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(C8a), 137.8 (Ph-C), 128.5 (Ph-C), 128.3 (C7 or C8), 127.8, 127.7 (Ph-C), 126.0 (C5),
123.0 (C7 or C8), 117.2 (C4a), 76.8 (C2), 74.7 (OCH2), 52.4 (CO2CH3), 30.5 (C3), 25.5
(C2-CH3), 20.9 (C4), 12.9 (C7-CH3), 12.0 (C8-CH3), 11.9 (C5-CH3); HRMS (ESI) m/z:
calcd. for C22H26NaO4 [M+Na]+ 377.1723, found 277.1723; m.p = 100-101 °C; [α]D25
-43.9 (c 5, CHCl3). Spectroscopic data are consistent with that previously reported.140
(S)-(6-(Benzyloxy)-2,5,7,8-tetramethylchroman-2-yl)methanol 390
The compound was prepared according to a literature procedure.140 To a stirred
suspension of LiAlH4 (80.0 mg, 2.03 mmol) in dry THF (6 mL) was added dropwise
methyl (S)-6-(benzyloxy)-2,5,7,8-tetramethylchromane-2-carboxylate 389 (0.240 g,
0.678 mmol), under nitrogen and at 0 °C. The solution was stirred at 0 °C for one hour
then at room temperature for a further two hours. The reaction was cooled to 0 °C and
quenched with saturated NH4Cl (aq.), then filtered through celite. The filtrate was
concentrated in vacuo, the residue was taken up in EtOAc and washed with brine and
water. The organic fractions were dried over Na2SO4 and solvent was removed in
vacuo. The crude residue was purified by column chromatography (3:1 petroleum
ether/EtOAc) to yield product as a white solid (0.183 g, 83%). ν (cm-1); 3403 (br, O-
H stretch), 1254, 1085 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 7.53-7.30 (5H, 
m, Ph-H), 4.70 (2H, s, OCH2), 3.66 (1H, d, J 11.5, CHHOH), 3.60 (1H, d, J 11.5,
CHHOH), 2.72-2.58 (2H, m, ArCH2), 2.27 (3H, s, C7-CH3), 2.18 (3H, s, C5-CH3), 2.11
(3H, s, C8-CH3), 2.02 (1H, ddd, J 13.5, 10, 7, ArCH2CHH), 1.74 (1H, ddd, J 13.5, 6,
4.5, ArCH2CHH), 1.24 (3H, s, C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 148.7 (C6),
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147.3 (C8a), 137.9 (Ph-C), 128.5 (Ph-C), 128.3 (C7 or C8), 127.9, 127.8 (Ph-C), 126.3
(C5), 123.0 (C7 or C8) 117.6 (C4a), 75.4 (C2), 74.8 (PhCH2O), 69.4 (CH2OH), 27.7
(C3), 20.6 (C2-CH3), 20.2 (C4), 12.9 (C7-CH3), 12.1 (C5-CH3), 11.9 (C8-CH3); HRMS
(ESI) m/z: calcd. for C21H26NaO3 [M+Na]+ 349.1774, found 349.1780; m.p = 68-69
°C; [α]D25 -0.8 (c 0.6, CHCl3). Spectroscopic data are consistent with that previously
reported.140
(S)-6-(Benzyloxy)-2,5,7,8-tetramethylchromane-2-carbaldehyde 35
To a solution of IBX (90.0 mg, 0.323 mmol) in DMSO (4 mL) was added a solution
of (S)-(6-(benzyloxy)-2,5,7,8-tetramethylchroman-2-yl)methanol 390 (70.0 mg, 0.215
mmol) in dry CH2Cl2 (2 mL) and the solution was stirred at room temperature
overnight. The mixture was filtered through celite with EtOAc and the filtrate was
washed with water and brine, dried over Na2SO4 and the solvent was removed in
vacuo. The crude product was purified by column chromatography (95:5 petroleum
ether/EtOAc) to yield product as an off-white solid (50 mg, 72%). ν (cm-1); 1737 (C=O
stretch), 1253, 1088 (C-O stretch), 698 (Ar-H bend); 1H NMR (CDCl3, 500 MHz) δ 
9.65 (1H, d, J 1, CHO), 7.54-7.31 (5H, m, Ph-H), 4.70 (2H, s, OCH2), 2.62 (1H, dt, J
17, 6, ArCHH), 2.54 (1H, ddd, J 17, 9, 7, ArCHH), 2.29 (1H, ddd, J 13.5, 6.5, 5,
ArCH2CHH), 2.25 (3H, s, C7-CH3), 2.21 (3H, s, C8-CH3), 2.14 (3H, s, C5-CH3), 1.84
(1H, dddd, J 16, 13.5, 6.5, 1, ArCH2CHH), 1.42 (3H, s, C2-CH3); 13C NMR (CDCl3,
125 MHz) δ 204.6 (CHO), 149.3 (C6), 147.6 (C8a), 137.9 (Ph-C), 128.8 (C7 or C8),
128.6, 128.0, 127.0 (5 x Ph-C), 126.5 (C5), 123.3 (C7 or C8), 117.9 (C4a), 80.6 (C2),
186
74.9 (OCH2), 27.9 (C3), 21.7 (C2-CH3), 20.4 (C4), 13.0, 12.12, 12.07 (Ar-CH3); HRMS
(ESI) m/z: calcd. for C21H24NaO3 [M+Na]+ 347.1618, found 347.1615; m.p = 54-56
°C; [α]D25 +7.6 (c 0.36, CHCl3). Spectroscopic data are consistent with that previously
reported.171, 196
Triphenyl((3R,7R)-3,7,11-trimethyldodecyl)phosphonium iodide 392
To a solution of (3R,7R)-hexahydrofarnesol 32 (1.14 g, 5.00 mmol) in dry CH2Cl2 (25
mL) was added PPh3 (1.57 g, 6.00 mmol), imidazole (0.409 g, 6.00 mmol) and I2 (1.52
g, 6.00 mmol). The mixture was stirred at room temperature for one hour, then the
solvent was removed in vacuo. The residue was passed through a short plug of silica
eluting with pentane, to yield product as a colourless oil (1.40 g, 83%), which was
used immediately in the next step. Iodide 391 (1.40 g, 4.13 mmol) was dissolved in
CH3CN (15 mL), PPh3 (1.08 g, 4.13 mmol) was added and the solution was stirred at
80 °C for 48 hours. The solvent was removed in vacuo to yield the phosphonium salt
392 as a viscous oil (1.94 g, 78%) which solidified on standing. ν (cm-1); 2923 (C-H
stretch), 1436 (P-Ph stretch), 739 and 689 (Ar-H bend monosubsituted benzene); 1H
NMR (CDCl3, 500 MHz) δ 7.87-7.70 (15H, m, Ph-H), 3.71-3.60 (2H, m, CH2PPh3),
1.85-1.74 (1H, m, CHCH2CH2PPh3), 1.66-1.54 (1H, m, CHHCH2PPh3), 1.53-1.47
(1H, m, CHCH3), 1.46-1.37 (1H, m, CHHCH2PPh3), 1.34-0.95 (13H, m, CH2 and CH),
0.99 (3H, d, J 7.5, CH3CHCH2CH2PPh3), 0.85 (6H, d, J 6.5, CH3CH), 0.79 (3H, d, J
6.5, CH3CH); 13C NMR (CDCl3, 125 MHz) δ 135.2 (Ph-C), 133.9 (d, J 10, Ph-C),
130.7 (d, J 12.5, Ph-C), 130.5 (d, J 471.5, Ph-C), 39.5, 37.4, 37.3, 36.8 (CH2), 33.7 (d,
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J 13, CHCH2CH2PPh3), 32.9 (CH3CH), 29.5 (d, J 4, CH2CH2PPh3), 28.1 (CH3CH),
24.9, 24.3 (CH2), 22.8, 22.9 (CH3CH), 21.4 (d, J 50.5, CH2PPh3), 19.8 (CH3CH), 19.5,
(CH3CHCH2CH2PPh3); HRMS (ESI) m/z: calcd. for C33H46P [M]+ 473.3332, found
473.3334; m.p = 78-79 °C; [α]D25 -3.7 (c 0.27, CHCl3). This compound was previously
reported without spectroscopic data.440
(2S,4’R,8’R)-6-(Benzyloxy)-2,5,7,8-tetramethyl-2-(4’,8’,12’-trimethyltridec-1’-
en-1’-yl)chromane 393
To a solution of triphenyl((3R,7R)-3,7,11-trimethyldodecyl)phosphonium iodide 392
(0.430 g, 0.717 mmol) in dry THF (3.8 mL) was added n-BuLi (2.23 M, 0.290 mL,
0.652 mmol) at 0 °C under nitrogen. After stirring for one hour at this temperature a
solution of (S)-6-(benzyloxy)-2,5,7,8-tetramethylchromane-2-carbaldehyde 35 (0.106
g, 0.327 mmol) in THF (1.2 mL) was added dropwise and the solution was stirred at
room temperature for two hours. The reaction was quenched with saturated NH4Cl
(aq.) and extracted with Et2O, the combined organic fractions were washed with water
and brine, dried over Na2SO4 and the solvent was removed in vacuo. To remove
triphenylphosphine (present due to incomplete conversion in the synthesis of
phosphonium salt 392) the residue was dissolved in THF (2 mL) and MeI (0.100 mL,
1.60 mmol) was added. This mixture was stirred at room temperature until the
triphenylphosphine was consumed as monitored by TLC. The solids were filtered off
and the crude residue was purified by column chromatography (1:39 Et2O/petroleum
ether) to yield product as a colourless oil (0.142 g, 73%), as a mixture of cis/trans
isomers. ν (cm-1); 2925 (C-H stretch), 1253,1088 (C-O stretch), 732, 696 (Ar-H bend);
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1H NMR (CDCl3, 500 MHz) δ 7.54-7.30 (5H, m, Ph-H), 5.87 (1H, dd, J 13.5, 11,
trans-CH=CH), 5.47-5.29 (2H, m, cis-CH=CH), 5.03 (1H, dd, J 11, 1.5, trans-
CH=CH), 4.69 (2H, s, OCH2), 2.68-2.53 (2H, m, ArCH2), 2.26-2.06 (2H, m,
CH=CHCH2), 2.21 (3H, s, Ar-CH3), 2.15 (6H, s, Ar-CH3), 2.02 (1H, dt, J 13.5, 5.5,
ArCH2CHH), 1.77 (1H, ddd, J 16, 8.5, 7, ArCH2CHH), 1.54-1.46 (1H, m, H4’), 1.49
(3H, s, C2-CH3), 1.38-0.97 (14H, m, (CH2)3CH(CH2)3CH), 0.88-0.80 (12H, m,
CHCH3); 13C NMR (CDCl3, 125 MHz) δ 148.4, 148.2 (C6 and C8a), 138.2 (Ph-C),
134.0 (CH=CH), 131.7 (CH=CH), 128.6 (2 x Ph-C), 128.1 (C7 or C8), 127.81, 127.88
(Ph-C), 126.1 (C5), 122.9 (C7 or C8), 118.2 (C4a), 76.0 (C2), 74.8 (OCH2), 39.5, 37.5,
37.4, 37.3, (CH2), 35.2 (CH=CHCH2), 33.7 (CH), 33.4, (C3), 33.0 (CH), 28.1 (CH),
27.3 (C2-CH3), 25.0, 24.8 (CH2), 22.9, 22.8 (CHCH3), 21.2 (C4), 19.9, 19.8 (CHCH3),
13.0 (Ar-CH3), 12.3 (Ar-CH3), 12.2 (Ar-CH3); HRMS (ESI) m/z: calcd. for
C36H54NaO2 [M+Na]+ 541.4016, found 541.4019; [α]D20 -27.5 (c 0.04, CHCl3). This
compound was previously reported with incomplete 1H and 13C NMR data.394
α-Tocopherol 1 
To a solution of (2S,4’R,8’R)-6-(benzyloxy)-2,5,7,8-tetramethyl-2-(4’,8’,12’-
trimethyltridec-1’-en-1’-yl)chromane 393 (98.0 mg, 0.189 mmol) in EtOAc (5 mL)
was added 10% Pd/C (40.0 mg, 0.0378 mmol) and the mixture was stirred at room
temperature under an atmosphere of hydrogen for one hour. The mixture was filtered
through celite and the filtrate was concentrated in vacuo to give a crude product which
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was purified by column chromatography (95:5 petroleum ether/EtOAc), to yield α-
tocopherol 1 as a colourless oil (78 mg, 96%). ν (cm-1); 3407 (br, O-H stretch), 2926
(C-H stretch), 1212, 1086 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 4.16 (1H, s, 
OH), 2.60 (2H, t, J 7, ArCH2), 2.16 (3H, s, Ar-CH3), 2.11 (6H, s, Ar-CH3), 1.86-1.71
(2H, m, ArCH2CH2), 1.61-0.99 (21H, m, (CH2)3CH(CH2)3CH(CH2)3CH)), 1.23 (3H,
s, C2-CH3), 0.93-0.79 (12H, m, CHCH3); 13C NMR (CDCl3, 125 MHz) δ 145.7 (C4a),
144.7 (C8a), 122.8 (C7), 121.1 (C8), 118.6 (C6), 117.5 (C5), 74.7 (C2), 40.0 (C1’), 39.5
(C11’), 37.62 (C3’), 37.60 (C9’), 37.58 (C5’), 37.4 (C7’), 33.0 (C8’), 32.9 (C4’), 31.7
(C3), 28.1 (C12’), 25.0 (C10’), 24.6 (C6’), 24.0 (C2-CH3), 22.9, 22.8 (C12’-CH3), 21.2
(C2’), 20.9 (C4), 19.9 (C8’-CH3), 19.8 (C4’-CH3), 12.4 (C7-CH3), 11.9 (C8-CH3), 11.4
(C5-CH3); HRMS (ESI) m/z: calcd. for C29H49O2 [M-H]- 429.3738, found 429.3735;
[α]D20 +1.0 (c 0.2, CHCl3). Spectroscopic data are consistent with that previously
reported.171
α-Tocopheryl acetate 394 
α-Tocopherol 1 (78 mg, 0.18 mmol) was stirred in a solution of Ac2O (0.40 mL) and
pyridine (1 mL) at room temperature for 18 hours. After this time the volatiles were
removed under high vacuum and the residue was purified by column chromatography
(9:1 petroleum ether/Et2O), to yield product as a colourless oil (75 mg, 90%). ν (cm-
1); 2925 (C-H stretch), 1757 (C=O stretch), 1207 (C-O stretch); 1H NMR (CDCl3, 500
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MHz) δ 2.59 (2H, t, J 7, ArCH2), 2.33 (3H, s, OCOCH3), 2.09 (3H, s, C5-CH3), 2.02
(3H, s, C8-CH3), 1.98 (3H, s, C7-CH3), 1.85-1.70 (2H, m, ArCH2CH2), 1.60-1.00 (21H,
m, (CH2)3CH(CH2)3CH(CH2)3CH)), 1.23 (C2-CH3), 0.89-0.80 (12H, m, CHCH3); 13C
NMR (CDCl3, 125 MHz) δ 170.0 (OCOCH3), 149.6 (C4a), 140.6 (C8a), 126.8 (C7 or
C8), 125.0 (C6), 123.2 (C7 or C8), 117.5 (C5), 75.1 (C2), 39.5, 37.6, 37.8, 37.56, 37.54,
37.4 (CH2), 32.9, 32.8 (CH), 31.1 (C3), 28.1 (CH), 25.0, 24.6 (CH2), 24.4 (C2-CH3),
22.9, 22.8 (CHCH3), 21.2 (CH2), 20.74 (C4), 20.72 (OCOCH3), 19.9, 19.8 (CHCH3),
13.1, 12.2, 12.0 (Ar-CH3); HRMS (ESI) m/z: calcd. for C31H52NaO3 [M+Na]+
495.3809, found 495. 3811; [α]D25 +3.7 (c 0.25, CHCl3). Spectroscopic data are
consistent with that previously reported.171
(S)-Trolox 399
To a solution of methyl (S)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylate
388 (0.100 g, 0.400 mmol) in MeOH (3 mL) was added 2M NaOH (aq.) (2 mL, 4.00
mmol) and the solution was stirred at 80 °C for 16 hours. After cooling to room
temperature, the pH of the solution was adjusted to ≤ 2 using concentrated HCl (aq.). 
The product was extracted with EtOAc, the combined organic fractions were washed
with water, dried over Na2SO4 and the solvent was removed in vacuo to yield product
as a brown crystalline solid. ν (cm-1); 3442 (O-H stretch), 2930 (C-H stretch), 1715
(acid C=O stretch), 1648 (ketone C=O stretch), 1085 (C-O stretch); 1H NMR (CDCl3,
500 MHz) δ 2.68 (1H, dt, J 17, 6, ArCHH), 2.60 (1H, ddd, J 17, 9.5, 6.5, ArCHH),
2.37 (1H, dt, J 13.5, 6, ArCH2CHH), 2.17 (6H, s, Ar-CH3), 2.09 (3H, s, Ar-CH3), 1.98-
1.89 (1H, m, ArCH2CHH), 1.61 (3H, s, C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 177.2 
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(CO2), 146.0 (C6), 144.6 (C8a), 122.6, 121.6, 118.8, 117.3 (Ar-C), 77.2 (C2), 30.1 (C3),
24.5 (C2-CH3), 20.7 (C4), 12.3, 12.0, 11.4 (Ar-CH3); HRMS (ESI) m/z: calcd. for
C14H18NaO4 [M+Na]+ 273.1097, found 273.1097; m.p = 157-159 °C; [α]D25 -50 (c
1.02, MeOH). Spectroscopic data are consistent with that previously reported in the
literature.420
(R)-4,4,4-Trichloro-1-(2’,5’-dimethoxy-3’,4’-dimethylphenyl)-3-hydroxy-3-
methylbutan-1-one 367
A solution of 1,4-dimethoxy-2,3-dimethylbenzene (16.8 g, 101 mmol) 365 in CH2Cl2
(60 mL) was cooled to 0 °C and TiCl4 (3.33 mL, 30.3 mmol) was added dropwise
under nitrogen. After stirring for five minutes, (R)-(+)-4-methyl-4-(trichloromethyl)-
2-oxetanone 171 (2.05 g, 10.1 mmol) dissolved in minimum CH2Cl2 was added
dropwise and the mixture was stirred at room temperature overnight. The reaction was
quenched with saturated NH4Cl (aq.) and extracted with CH2Cl2. The combined
organic fractions were washed with water, brine and dried over Na2SO4. The solvent
was removed in vacuo and the residue was purified by column chromatography (95:5
petroleum ether/EtOAc to 8:2) to yield product as a yellow oil (3.14 g, 84%, ≥ 98% 
e.e.). ν (cm-1); 3442 (br, O-H stretch), 1655 (C=O stretch), 1232, 1101 (C-O stretch),
792 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 7.01 (1H, s, Ar-H), 5.53 (1H, s, 
OH), 3.84 (1H, d, J 16.5, CHHCO), 3.83 (3H, s, C2’-OCH3), 3.73 (1H, d, J 16.5,
CHHCO), 3.72 (3H, s, C5’-OCH3), 2.24 (3H, s, C3’-CH3), 2.19 (3H, s, C4’-CH3), 1.70
(3H, s, C3-CH3); 13C NMR (CDCl3, 125 MHz) δ 202.8 (CO), 154.0 (C5’), 152.2 (C2’),
192
133.7 (C4’), 132.3 (C3’), 129.4 (C1’), 107.8 (C6’ and CCl3), 92.5 (C3), 62.5 (C2’-
OCH3), 55.8 (C5’-OCH3), 46.1 (CH2), 23.5 (C3-CH3), 12.79 (2 x Ar-CH3); HRMS
(ESI) m/z: calcd. for C15H1935Cl3NaO4 [M+Na]+ 391.0241, found 391.0239; [α]D 25
+15.6 (c 1.8, CHCl3). Enantiomeric excess was determined by chiral HPLC (Daicel
Chiralcel AD-H column, 2-propanol : hexane = 4 : 96, 1 mL/min, 227 nm, (S) isomer
18.55 min, (R) isomer 19.88 min).
1-(2’,5’-Dimethoxy-3’,4’-dimethylphenyl)ethan-1-one
A solution of 1,4-dimethoxy-2,3-dimethyl benzene 365 (12.9 g, 77.7 mmol) in CH2Cl2
(100 mL) was cooled to 0 °C and TiCl4 (2.56 mL, 23.3 mmol) was added under
nitrogen. After stirring for 10 minutes, acetyl chloride (0.550 mL, 7.77 mmol) was
added dropwise and the solution was stirred overnight at room temperature. The
reaction was quenched with saturated NH4Cl (aq.) and extracted with CH2Cl2. The
combined organic fractions were washed with water and brine, dried over Na2SO4 and
the solvent was removed in vacuo. The residue was purified by column
chromatography (97.5:2.5 petroleum ether/EtOAc to 8:2) to yield product as a yellow
oil (2.15 g, 66%). ν (cm-1); 1654 (C=O stretch), 1100 (C-O stretch); 1H NMR (CDCl3,
500 MHz) δ 7.00 (1H, s, Ar-H), 3.82 (3H, s, C2’-OCH3), 3.69 (3H, s, C5’-OCH3), 2.66
(3H, s, COCH3), 2.24 (3H, s, C4’-CH3), 2.18 (3H, s, C3’-CH3); 13C NMR (CDCl3, 125
MHz) δ 200.6 (CO), 153.8 (C2’), 152.4 (C5’), 132.3 (C1’), 132.0 (C3’ or C4’), 130.1
(C3’ or C4’), 108.0 (C6’), 62.4 (C5’-OCH3), 55.9 (C2’-OCH3), 30.8 (COCH3), 12.8
(C3’-CH3 and C4’-CH3); LRMS (ESI) m/z: calcd. for C12H16NaO3 [M+Na]+ 231.1,
found 231.1. Spectroscopic data are consistent with that previously reported.441
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4,4,4-Trichloro-1-(2’,5’-dimethoxy-3’,4’-dimethylphenyl)-3-hydroxy-3-
methylbutan-1-one (±)-367
A solution of diisopropylamine (1.74 mL, 12.4 mmol) in dry Et2O (50 mL) was cooled
to -78 °C and n-BuLi (2.5 M, 4.52 mL, 11.3 mmol) was added dropwise. After stirring
for 30 minutes at this temperature, 1-(2’,5’-dimethoxy-3’,4’-dimethylphenyl)ethan-1-
one (2.15 g, 10.3 mmol) was added dropwise over 20 minutes. After stirring for one
hour 1,1,1-trichloroacetone (1.75 mL, 15.5 mmol) was added slowly over 20 minutes
and the mixture was stirred at -78 °C for a further three hours, before warming to room
temperature and stirring overnight. The reaction was quenched with saturated NH4Cl
(aq.) (20 mL), extracted with Et2O and the organic fractions were washed with water
and brine. The solvent was removed in vacuo and the residue was purified by column
chromatography yield product as a yellow oil (1.97 g, 52%) after column
chromatography (100% CH2Cl2) . ν (cm-1); 3442 (br, O-H stretch), 1654 (C=O
stretch), 1100 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 7.00 (1H, s, Ar-H), 5.53 
(1H, s, OH), 3.85 (1H, d, J 17, CHHCO), 3.83 (3H, s, C2’-OCH3), 3.73 (1H, d, J 16.5,
CHHCO), 3.72 (3H, s, C5’-OCH3), 2.24 (3H, s, C3’-CH3), 2.19 (3H, s, C4’-CH3), 1.70
(3H, s, C3-CH3); 13C NMR (CDCl3, 125 MHz) δ 202.9 (CO), 154.2 (C5’), 152.3 (C2’),
133.8 (C4’), 132.4 (C3’), 129.6 (C1’), 108.0 (CCl3), 107.9 (C6’), 82.6 (C3), 62.7 (C2’-
OCH3), 55.9 (C5’-OCH3), 46.3 (CH2), 23.7 (C3-CH3), 12.9 (2 x Ar-CH3); HRMS (ESI)
m/z: calcd. for C15H1935Cl3NaO4 [M+Na]+ 391.0241, found 391.0238.
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Methyl (S)-6-hydroxy-2,7,8-trimethyl-4-oxochromane-2-carboxylate 411
To a solution of (R)-4,4,4-trichloro-1-(2’,5’-dimethoxy-3’,4’-dimethylphenyl)-3-
hydroxy-3-methylbutan-1-one 367 (0.240 g, 0.649 mmol) in dry CH2Cl2 (5 mL) was
added BBr3 (0.250 mL, 2.60 mmol) at -78 °C under nitrogen, and the mixture was
warmed to room temperature and stirred overnight. After this time the reaction was
quenched with water and the solvent was removed under a flow of nitrogen. To obtain
the best yields, the crude mixture of hydroquinone 410 was reacted immediately in the
next step. To a deoxygenated solution of crude (R)-4,4,4-trichloro-1-(2’,5’-dihydroxy-
3’,4’-dimethylphenyl)-3-hydroxy-3-methylbutan-1-one 410 in THF (5 mL) was added
deoxygenated 2M NaOH (aq.) until the solution reached a pH of ≥ 12 (5 mL, 10.0 
mmol), and the mixture was stirred under nitrogen at room temperature overnight. The
resulting alkaline solution was washed three times with Et2O, acidified to pH 2 with
1M HCl (aq.) and extracted with EtOAc. The combined organic fractions were washed
with pH 2 buffer and dried over Na2SO4. The solvent was removed in vacuo to yield
product as a brown crystalline solid which was used in the next step without further
purification. A sample of the acid for analysis could be obtained by column
chromatography (8:2:0.1 EtOAc/MeOH/AcOH). ν (cm-1); 3392 (br, O-H stretch),
1735 (acid C=O stretch), 1602 (ketone C=O stretch), 1236 and 1085 (C-O stretch); 1H
NMR ((CD3)2SO, 500 MHz) δ 6.95 (1H, s, H5), 2.95 (1H, d, J 17, CHHCO), 2.88 (1H,
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d, J 17, CHHCO), 2.14 (3H, s, C8-CH3), 2.11 (3H, s, C7-CH3), 1.61 (3H, s, C2-CH3);
13C NMR: ((CD3)2SO, 125 MHz) δ 191.2 (CO), 174.1 (CO2), 151.6 (C6), 149.3 (C8a),
133.1 (C4a), 126.3 (C7 or C8), 117.6 (C7 or C8), 106.1 (C5), 80.9 (C2), 45.2 (CH2), 24.8
(C2-CH3), 13.2 (C7-CH3), 12.3 (C8-CH3); HRMS (ESI) m/z: calcd. for C13H13O5 [M-
H]- 249.0768, found 249.0771; m.p = 219-220 °C; [α]D 25 -83.3 (c 0.012, MeOH).
Crude (S)-6-hydroxy-2,7,8-trimethyl-4-oxochromane-2-carboxylic acid was
dissolved in 2M methanolic HCl (5 mL) and stirred at room temperature overnight.
The solvent was removed in vacuo and the residue was extracted with Et2O, the
combined organic fractions were washed with water and brine and dried over Na2SO4.
The crude product was purified using column chromatography (8:2 petroleum
ether/EtOAc) to yield the ester as a brown solid (50 mg, 30% from 367, ≥ 98% e.e.)
after column chromatography (8:2 petroleum ether/EtOAc). ν (cm-1); 3277 (br, O-H
stretch), 1735 (ester C=O stretch), 1680 (ketone C=O stretch), 1204 and 1083 (C-O
stretch); 1H NMR (CDCl3, 500 MHz) δ 7.18 (1H, s, H5), 5.80 (1H, s, C6-OH), 3.65
(3H, s, CO2CH3), 3.18 (1H, d, J 17, CHHCO), 2.83 (1H, d, J 17, CHHCO), 2.24 (3H,
s, C7-CH3), 2.23 (3H, s, C8-CH3), 1.72 (C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 191.4 
(CO), 172.8 (CO2), 153.1 (C6), 148.9 (C8a), 134.7 (C7), 127.6 (C8), 117.9 (C4a), 107.5
(C5), 81.4 (C2), 53.1 (CO2CH3), 45.7 (CH2), 25.4 (C2-CH3), 13.2 (C7-CH3), 12.1 (C8-
CH3); HRMS (ESI) m/z: calcd. for C14H16NaO5 [M+Na]+ 287.0890, found 287.0891;
m.p = 159-160 °C; [α]D 25 +45.6 (c 0.08, CHCl3). Enantiomeric excess was determined
by chiral HPLC analysis (Daicel Chiralcel AD-H column, 2-propanol : hexane = 6 :
94, 1 mL/min, 231 nm, (S) isomer 19.64 min, (R) isomer 22.59 min).
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Methyl 6-hydroxy-2,7,8-trimethyl-4-oxochromane-2-carboxylate (±)-411
4,4,4-Trichloro-1-(2’,5’-dihydroxy-3’,4’-dimethylphenyl)-3-hydroxy-3-methylbutan-
1-one (±)-410 was prepared according to a procedure adapted from the literature.400
To a solution of 4,4,4-trichloro-1-(2’,5’-dimethoxy-3’,4’-dimethylphenyl)-3-
hydroxy-3-methylbutan-1-one (±)-367 (0.770g, 2.08 mmol) and sodium iodide (2.19
g, 14.6 mmol) in dry CH3CN (25 mL) was added chlorotrimethylsilane (1.86 mL, 14.6
mmol), slowly with continuous stirring under nitrogen. The reaction mixture was
heated to 70 °C for 60 hours, before being quenched with water and extracted with
Et2O. The organic layer was washed with 5% sodium thiosulfate (aq.), brine and dried
over Na2SO4. The crude hydroquinone (±)-410 was not isolated and was used in the
next step without further purification. To a deoxygenated solution of crude 4,4,4-
trichloro-1-(2’,5’-dihydroxy-3’,4’-dimethylphenyl)-3-hydroxy-3-methylbutan-1-one
(±)-410 in THF (10 mL) was added deoxygenated 2M NaOH (aq.) until the solution
reached a pH of ≥ 12 (10 mL, 20.0 mmol), and the mixture was stirred under nitrogen 
at room temperature overnight. The resulting alkaline solution was washed three times
with Et2O, acidified to pH 2 with 1M HCl (aq.) and extracted with EtOAc. The
combined organic fractions were washed with pH 2 buffer and dried over Na2SO4. The
solvent was removed in vacuo to yield product as a brown crystalline solid which was
used in the next step without further purification. A pure sample of the acid for analysis
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could be obtained by column chromatography (100% EtOAc to 8:2:0.1
EtOAc/MeOH/AcOH). ν (cm-1); 3412 (br, O-H stretch), 1707 (acid C=O stretch),
1671 (ketone C=O stretch), 1204 and 1088 (C-O stretches); 1H NMR ((CD3)2SO, 500
MHz) δ 9.28 (1H, s, Ar-OH), 6.95 (1H, s, H5), 2.95 (1H, d, J 17, CHHCO), 2.91 (1H,
d, J 17, CHHCO), 2.14 (3H, s, C8-CH3), 2.11 (3H, s, C7-CH3), 1.62 (3H, s, C2-CH3);
13C NMR ((CD3)2SO, 125 MHz) δ 191.0 (CO), 174.0 (CO2), 152.0 (C6), 149.9 (C8a),
133.7 (C4a), 126.8 (C7 or C8), 118.1 (C7 or C8), 106.7 (C5), 81.3 (C2), 45.6 (CH2), 25.2
(C2-CH3), 13.3 (C7-CH3), 12.3 (C8-CH3); HRMS (ESI) m/z: calcd. for C13H14NaO5
[M+Na]+ 273.0733, found 273.0729; m.p = 263-264 °C.
Crude 6-hydroxy-2,7,8-trimethyl-4-oxochromane-2-carboxylic acid was dissolved in
2M methanolic HCl (5 mL) and stirred at room temperature overnight. The solvent
was removed in vacuo and the residue was extracted with Et2O, the combined organic
fractions were washed with water and brine and dried over Na2SO4. The crude product
was purified by column chromatography (8:2 petroleum ether/EtOAc) to yield product
as an off-white solid (116 mg, 23% from (±)-367). ν (cm-1); 3339 (br, O-H stretch),
1748 (ester C=O stretch), 1666 (ketone C=O stretch), 1198 and 1087 (C-O stretches);
1H NMR (CDCl3, 500 MHz) δ 7.05 (1H, s, H5), 4.73 (1H, s, OH), 3.65 (3H, s,
CO2CH3), 3.17 (1H, d, J 17, CHHCO), 2.82 (1H, d, J 17, CHHCO), 2.25 (3H, s, C7-
CH3), 2.22 (3H, s, C8-CH3), 1.72 (3H, s, C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 
190.6 (CO), 172.6 (CO2), 152.6 (C6), 148.3 (C8a), 134.0 (C7), 127.4 (C8), 117.9 (C4a),
107.3 (C5), 81.3 (C2), 52.9 (CO2CH3), 45.6 (CH2), 25.3 (C2-CH3), 13.0 (C7-CH3), 12.0
(C8-CH3); HRMS (ESI) m/z: calcd. for C14H16NaO5 [M+Na]+ 287.0890, found
287.0895; m.p = 185-186 °C.
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Methyl (S)-6-hydroxy-2,7,8-trimethylchromane-2-carboxylate 412
To a solution of methyl (S)-6-hydroxy-2,7,8-trimethyl-4-oxochromane-2-carboxylate
411 (0.550 g, 1.98 mmol) in MeOH (25 mL) was added fine zinc powder (1.36 g, 20.8
mmol) and concentrated HCl (4.30 mL, 52.0 mmol) and stirred at room temperature
for five hours. After filtering through celite, the filtrate was concentrated in vacuo.
The resulting residue was taken up with Et2O and washed with brine. The organic
fractions were dried over Na2SO4 and the solvent was removed in vacuo. The crude
material was purified by column chromatography (85:15 petroleum ether/EtOAc) to
yield product as a white solid (0.406 g, 78%). ν (cm-1); 3447 (br, O-H stretch), 1729
(C=O stretch), 1190 and 1107 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 6.31 (1H, 
s, H5), 4.34 (1H, s, OH), 3.68 (3H, s, CO2CH3), 2.66-2.58 (2H, m, ArCH2), 2.35 (1H,
ddd, J 13.5, 6, 4.5, ArCH2CHH), 2.18 (3H, s, Ar-CH3), 2.13 (3H, s, Ar-CH3), 1.85
(1H, ddd, J 17.5, 9.5, 8, ArCH2CHH), 1.60 (3H, s, C2-CH3); 13C NMR (CDCl3, 125
MHz) δ 174.6 (CO2), 147.1 (C8a), 145.7 (C6), 125.9 (C7 or C8), 122.1 (C4a), 118.0 (C7
or C8), 112.1 (C5), 77.9 (C2), 52.5 (CO2CH3), 30.7 (C3), 25.7 (C4), 22.8 (C2-CH3), 12.1
(C7-CH3 or C8-CH3), 12.0 (C7-CH3 or C8-CH3); HRMS (ESI) m/z: calcd. for
C14H18NaO4 [M+Na]+ 273.1097, found 273.1102; m.p = 104-105 °C; [α]D 25 -81.7 (c
0.06, CHCl3).
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Methyl (S)-6-(benzyloxy)-2,7,8-trimethylchromane-2-carboxylate 413
The compound was prepared according to a literature procedure.140 To a solution of
methyl (S)-6-hydroxy-2,7,8-trimethylchromane-2-carboxylate 412 (0.400 g, 0.573
mmol) in DMF (5 mL) was added K2CO3 (0.330 g, 2.40 mmol) at 0 °C and stirred for
20 minutes. Benzyl bromide (0.285 mL, 2.40 mmol) was then added dropwise and the
mixture was stirred at room temperature overnight. The reaction was diluted with
water and EtOAc and the aqueous layer was extracted with EtOAc. The combined
organic fractions were washed thoroughly with water and dried over Na2SO4. The
solvent was removed in vacuo and residue was purified by column chromatography
(95:5 petroleum ether/EtOAc) to yield product as a white solid (0.340 g, 63%). ν (cm-
1); 1727 (C=O stretch), 1206 and 1101 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 
7.46-7.41 (2H, m, Ph-H), 7.40-7.35 (2H, m, Ph-H), 7.34-7.29 (1H, m, Ph-H), 6.44
(1H, s, H5), 5.00 (2H, s, OCH2), 3.68 (3H, s, CO2CH3), 2.73-2.62 (2H, m, ArCH2),
2.38 (1H, ddd, J 13.5, 5.5, 4.5, ArCH2CHH), 2.20 (3H, s, C7-CH3), 2.19 (3H, s, C8-
CH3), 1.87 (1H, ddd, J 13.5, 10, 7.5, ArCH2CHH), 1.61 (3H, s, C2-CH3); 13C NMR
(CDCl3, 125 MHz) δ 174.5 (CO2), 150.6 (C8a), 145.9 (C6), 138.0 (Ph-C), 128.4 (Ph-
C), 127.6 (Ph-C), 127.2 (Ph-C), 125.9 (C8), 125.1 (C4a), 117.1 (C7), 109.9 (C5), 77.8
(C2), 70.8 (OCH2), 52.4 (CO2CH3), 30.6 (C3), 25.5 (C2-CH3), 23.0 (C4), 12.1 (C7-CH3
or C8-CH3), 12.0 (C7-CH3 or C8-CH3); HRMS (ESI) m/z: calcd. for C21H24NaO4
[M+Na]+ 363.1567, found 363.1570; m.p = 56-57 °C; [α]D 25 -31.1 (c 0.42, CHCl3).
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(S)-(6-(Benzyloxy)-2,7,8-trimethylchroman-2-yl)methanol 414
The compound was prepared according to a literature procedure.140 To a stirred
suspension of LiAlH4 (0.109 g, 2.87 mmol) in dry THF (8 mL) was added dropwise
methyl (S)-6-(benzyloxy)-2,7,8-trimethylchromane-2-carboxylate 413 (0.325 g, 0.956
mmol), under nitrogen and at 0 °C. The solution was stirred at 0 °C for one hour then
at room temperature for a further two hours. The reaction was cooled to 0 °C and
quenched with saturated NH4Cl (aq.), then filtered through celite. The filtrate was
concentrated in vacuo, the residue was taken up in EtOAc and washed with brine and
water. The organic fractions were dried over Na2SO4 and solvent was removed in
vacuo. The resulting white solid was used without further purification (0.250 g, 84%).
ν (cm-1); 3458 (br, O-H stretch), 1229 and 1098 (C-O stretch); 1H NMR (CDCl3, 500
MHz) δ 7.47-7.43 (2H, m, Ph-H), 7.41-7.36 (2H, m, Ph-H), 7.34 (1H, m, Ph-H), 6.52 
(1H, s, H5), 4.98 (2H, s, OCH2), 3.65 (1H, dd, J 11.5, 6.5, CHHOH), 3.60 (1H, dd, J
11.5, 7, CHHOH), 2.81 (1H, ddd, J 16.5, 10.5, 6, ArCHH), 2.71 (1H, dt, J 16.5, 5.5,
ArCHH), 2.19 (3H, s, C7-CH3), 2.13 (3H, s, C8-CH3), 2.00 (1H, ddd, J 13.5, 10.5, 6,
ArCH2CHH), 1.90 (1H, t, J 6.5, OH), 1.68 (1H, ddd, J 13.5, 6.5, 4.5, ArCH2CHH),
1.25 (3H, s, C2-CH3); 13C NMR (CDCl3, 125 MHz) δ 150.5 (C6), 145.5 (C8a), 138.1
(Ph-C), 128.6 (Ph-C), 127.8 (Ph-C), 127.4 (Ph-C), 126.1 (C4a), 125.3 (C7), 117.7 (C8),
110.4 (C5), 76.2 (C2), 71.1 (PhCH2O), 69.7 (CH2OH), 28.0 (C3), 22.4 (C4), 20.9 (C2-
CH3), 12.2 (C7-CH3 or C8-CH3), 12.1 (C7-CH3 or C8-CH3); HRMS (ESI) m/z: calcd.
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for C20H24NaO3 [M+Na]+ 335.1618, found 335.1620; m.p = 123-124 °C; [α]D 25 +22.5
(c 0.14, CHCl3). Spectroscopic data are consistent with that previously reported.442
(S)-6-(Benzyloxy)-2,7,8-trimethylchromane-2-carbaldehyde 415
To a solution of IBX (0.188 g, 0.673 mmol) in DMSO (4 mL) was added a solution of
(S)-(6-(benzyloxy)-2,7,8-trimethylchroman-2-yl)methanol 414 (0.140 g, 0.448 mmol)
in dry CH2Cl2 (2mL) and the solution was stirred at room temperature overnight. The
mixture was filtered through celite with EtOAc and the filtrate was washed with water
and brine, dried over Na2SO4 and the solvent was removed in vacuo. The residue was
purified by column chromatography (95:5 petroleum ether/EtOAc) to yield product as
an off-white solid (90 mg, 65%). ν (cm-1); 1739 (C=O stretch), 1102 (C-O stretch); 1H
NMR (CDCl3, 500 MHz) δ 9.65 (1H, s, CHO), 7.47-7.43 (2H, m, Ph-H), 7.42-7.37 
(2H, m, Ph-H), 7.35 (1H, m, Ph-H), 6.47 (1H, s, H5), 4.98 (2H, s, OCH2), 2.72-2.66
(2H, m, ArCH2), 2.27-2.19 (1H, m, ArCH2CHH), 2.23 (3H, s, Ar-CH3), 2.22 (3H, s,
Ar-CH3), 1.86-1.78 (1H, m, ArCH2CHH), 1.41 (3H, s, C2-CH3); 13C NMR (CDCl3,
125 MHz) δ 204.6 (CHO), 151.0 (C6), 145.6 (C8a), 137.9 (Ph-C), 128.6 (Ph-C), 127.8
(Ph-C), 127.3 (Ph-C), 126.3 (C4a), 125.5 (C7), 117.4 (C8), 110.1 (C5), 81.1 (C2), 70.9
(OCH2), 28.0 (C3), 22.4 (C4), 21.9 (C2-CH3), 12.2 (C7-CH3 and C8-CH3); HRMS (ESI)
m/z: calcd. for C20H22NaO3 [M+Na]+ 333.1461, found 333.1461; m.p = 95-96 °C;
[α]D 25 +15 (c 0.04, CHCl3).
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(2S,4’R,8’R)-6-(Benzyloxy)-2,7,8-trimethyl-2-(4’,8’,12’-trimethyltridec-1-en-1-
yl)chromane 416
To a solution of triphenyl((3R,7R)-3,7,11-trimethyldodecyl)phosphonium iodide 392
(0.612 g, 1.02 mmol) in dry THF (5 mL) was added n-BuLi (2.23 M, 0.460 mL, 0.957
mmol) at 0 °C under nitrogen. After stirring for one hour at this temperature a solution
of (S)-6-(benzyloxy)-2,7,8-trimethylchromane-2-carbaldehyde 415 (90.0 mg, 0.290
mmol) in THF (5 mL) was added dropwise and the solution was stirred at room
temperature for two hours. The reaction was quenched with saturated NH4Cl (aq.) and
extracted with Et2O, the combined organic fractions were washed with water and
brine, dried over Na2SO4 and the solvent was removed in vacuo. To remove
triphenylphosphine (present due to incomplete conversion in the synthesis of
phosphonium salt 392) the residue was dissolved in THF (2 mL) and MeI (50.0 µL,
0.800 mmol) was added. This mixture was stirred at room temperature until the
triphenylphosphine was consumed as monitored by TLC. The solids were filtered off
and the crude residue was purified by column chromatography (100% petroleum ether
to 97.5:2.5 petroleum ether/EtOAc) to yield product as a colourless oil (61 mg, 42%),
as a mixture of cis/trans isomers. ν (cm-1); 2924 (C-H stretch), 1231 and 1098 (C-O
stretch); 1H NMR (CDCl3, 500 MHz) δ 7.49-7.28 (5H, m, Ph-H), 6.49 (1H, s, H5),
5.85 (1H, dd, J 17.5, 11, trans CH=CH), 5.53-5.29 (2H, m, CH=CH), 4.96 (2H, s,
OCH2), 2.79 (1H, ddd, J 16.5, 10, 6, ArCHH), 2.63 (1H, dt, J 16, 5, ArCHH), 2.67-
2.14 (1H, m, CH=CHCHH), 2.18, (3H, s, Ar-CH3), 2.17 (3H, s, Ar-CH3), 2.01 (1H,
ddd, J 14.5, 5.5, 4, CH=CHCHH), 1.96 (1H, ddd, J 13.5, 5.5, 5, ArCH2CHH), 1.74
(1H, ddd, J 16, 10.5, 5.5, ArCH2CHH), 1.56-1.46 (1H, m, H4’), 1.49 (3H, s, C2-CH3),
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1.42-0.96 (14H, m, (CH2)3CH(CH2)3CH), 0.88-0.80 (12H, m, CHCH3); 13C NMR
(CDCl3, 125 MHz) δ 150.2 (C6), 146.2 (C8a), 138.2 (Ph-C), 134.1 (CH=CH), 131.7
(CH=CH), 128.5, 127.7, 127.4 (5 x Ph-C), 125.9 (C4a), 124.9 (C7), 118.0 (C8), 110.2
(C5), 76.6 (C2), 71.0 (OCH2), 39.5, 37.5, 37.41, 37.36, (CH2), 35.1 (CH=CHCH2), 33.7
(CH), 33.4 (C3), 32.9 (CH), 27.8 (CH), 27.4 (C2-CH3), 24.9, 24.7, (CH2), 23.1 (C4),
22.9, 22.8, 19.9, 19.8, (CHCH3) 12.3 (Ar-CH3), 12.2 (Ar-CH3); HRMS (ESI) m/z:
calcd. for C35H52NaO2 [M+Na]+ 527.3860, found 527.3853; [α]D 25 -14.1 (c 0.32,
CHCl3).
γ-Tocopherol 3 
To a solution of (2S,4’R,8’R)-6-(benzyloxy)-2,7,8-trimethyl-2-(4’,8’,12’-
trimethyltridec-1’-en-1’-yl)chromane 416 (20.0 mg, 0.0397 mmol) in EtOAc (3 mL)
was added 10% Pd/C (8.00 mg, 7.94 µmol) and the mixture was stirred at room
temperature under an atmosphere of hydrogen for one hour. The mixture was filtered
through celite and the filtrate was concentrated in vacuo to yield product as a brown
oil (15 mg, 91%). ν (cm-1); 3398 (br, O-H stretch), 2924 (C-H stretch), 1223, 1080 (C-
O stretch); 1H NMR (CDCl3, 500 MHz) δ 6.37 (1H, s, H5), 4.23 (1H, s, OH), 2.73-
2.61 (2H, m, ArCH2), 2.14 (3H, s, Ar-CH3), 2.11 (3H, s, Ar-CH3), 1.82-1.67 (2H, m,
ArCH2CH2), 1.63-1.00 (21H, m, (CH2)3CH(CH2)3CH(CH2)3CH), 1.24 (3H, s, C2-
CH3), 0.90-0.81 (12H, m, CHCH3); 13C NMR (CDCl3, 125 MHz) δ 146.3 (C6), 145.9
(C8a), 125.9 (C8), 121.7 (C7), 118.5 (C4a), 112.3 (C5), 75.6 (C2), 40.2 (C1’), 39.5 (C11’),
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37.61 (C3’), 37.60 (C9’), 37.56 (C5’), 37.4 (C7’), 32.9 (C8’), 32.8 (C4’), 31.5 (C3), 28.1
(C12’), 25.0 (C10’), 24.6 (C6’), 24.2 (C2-CH3), 22.8, 22.9 (C12’-CH3), 22.5 (C4), 21.2
(C2’), 19.9 (C4’-CH3), 19.8 (C8’-CH3), 12.1 (Ar-CH3), 12.0 (Ar-CH3); HRMS (ESI)
m/z: calcd. for C28H48NaO2 [M+Na]+ 439.3547, found 439.3544; [α]D 20 +2.5 (c 0.08,
CHCl3). Spectroscopic data are consistent with that previously reported.415
(R)-4,4,4-Trichloro-3-hydroxy-3-methyl-1-morpholinobutan-1-one 428
To a solution of (R)-4-methyl-4-(trichloromethyl)oxetan-2-one 171 (0.230 g, 1.13
mmol) in THF (2 mL) was added morpholine (0.200 mL, 2.26 mmol) and the solution
was heated to 70 °C for 25 minutes in a microwave reactor. After this time the solution
was washed with pH 2 buffer and the combined aqueous fractions were extracted with
Et2O. The organic layer was dried over Na2SO4 and the solvent was removed in vacuo
to yield product as a white solid (0.304 g, 93%). ν (cm-1); 3191 (br, O-H stretch), 1601
(C=O stretch), 1115 (C-O stretch), 801 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 
6.50 (1H, s, OH), 3.77-3.51 (8H, m, CH2), 3.14 (1H, d, J 15.5, CHHCO), 2.78 (1H, d,
J 15.5, CHHCO), 1.70 (3H, s, CH3); 13C NMR (CDCl3, 125 MHz) δ 170.4 (CO), 107.9 
(CCl3), 82.1 (C(OH)), 66.8 (CH2), 66.6 (CH2), 46.6 (CH2), 42.3 (CH2), 36.0 (CH2CO),
24.5 (CH3); HRMS (ESI) m/z: calcd. for C9H1435Cl3NNaO3 [M+Na]+ 311.9931, found
311.9937; m.p = 120-121 °C; [α]D 20 +30.0 (c 0.76, CHCl3).
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3-Chloro-2-ethyl-1-morpholinopentane-1,4-dione 434
4,5-Diethyl-5-methylfuran-2(5H)-one 435
The compounds were isolated as side products in the following reaction. To a solution
of (R)-4,4,4-trichloro-3-hydroxy-3-methyl-1-morpholinobutan-1-one 428 (0.345 g,
1.19 mmol) in dry THF (5 mL) was added ethylmagnesium bromide (1.19 mL, 2M in
THF, 2.38 mmol) at 0 °C, under nitrogen. The solution was warmed to reflux
temperature and stirred for 14 hours. The reaction was quenched with 10% AcOH
(aq.), extracted with Et2O and washed with water and brine. The combined organic
fractions were dried over Na2SO4 and the solvent was removed in vacuo. Column
chromatography (3:1 petroleum ether/EtOAc) isolated the side product 434 as a single
diastereoisomer (5 mg, 1.7%) ν (cm-1); 1725 (ketone C=O stretch), 1628 (amide C=O
stretch), 1114 (C-O stretch), 777 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 4.65 
(1H, d, J 10, CHCl), 3.85-3.78 (1H, m, CH2), 3.74-3.62 (6H, m, CH2), 3.57-3.45 (1H,
m, CH2), 3.17 (1H, ddd, J 11.5, 7.5, 4, CHCH2), 2.34 (3H, s, COCH3), 1.90-1.76 (2H,
m, CH2CH3), 0.94 (3H, t, J 7.5, CH2CH3); 13C NMR (CDCl3, 125 MHz) δ 202.1 
(COCH3), 171.9 (CON), 67.1, 66.8 (CH2), 61.8 (CHCl), 46.8 (CH2), 44.3 (CHCH2),
42.3 (CH2), 28.0 (COCH3), 22.6 (CH2CH3), 10.2 (CH2CH3); HRMS (ESI) m/z: calcd.
for C11H1835ClNNaO3 [M+Na]+ 270.0867, found 270.0868.
Lactone 435 was isolated from the same mixture (7 mg, 3.8%) as a colourless oil. Only
1H and 13 NMR data were obtained for this compound. 1H NMR (CDCl3, 500 MHz) δ 
5.77-5.74 (1H, m, COCH), 2.30-2.12 (2H, m, C5-CH2), 1.89 (1H, quin, J 7.5, C4-
CHH), 1.65 (1H, quin, J 7.5, C4-CHH), 1.42 (3H, s, C5-CH3), 1.23 (3H, t, J 7.5,
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CH2CH3), 0.78 (3H, t, J 7.5, CH2CH3); 13C NMR (CDCl3, 125 MHz) δ 177.8 (C3),
172.7 (CO), 114.8 (C2), 89.8 (C4), 30.3 (C4-CH2), 24.0 (C5-CH3), 20.5 (C5-CH2), 11.1
(CH2CH3), 7.5 (CH2CH3).
1-Morpholinobutane-1,3-dione 440
To a solution of (R)-4,4,4-trichloro-3-hydroxy-3-methyl-1-morpholinobutan-1-one
428 (0.349 g, 1.21 mmol) in THF (5 mL) was added KOt-Bu (0.136 g, 1.21 mmol) at
0 °C, under nitrogen. The mixture was stirred at room temperature for 16 hours, then
the reaction was quenched with MeOH and the solvent was removed in vacuo. The
crude residue was purified by column chromatography (100% EtOAc to 95:5
EtOAc/MeOH) to yield product as a colourless amorphous solid (0.108 g, 52%). ν 
(cm-1); 1717 (ketone C=O stretch), 1630 (amide C=O stretch); 1H NMR (CDCl3, 500
MHz) δ keto/enol 1:0.18; keto: 3.73-3.61 (6H, m, CH2), 3.56 (2H, s, COCH2), 3.45-
3.38 (2H, m, CH2), 2.28 (3H, s, CH3); enol: 14.6 (1H, s, OH), 5.10 (1H, s, COCH),
3.73-3.61 (8H, m, CH2), 1.96 (3H, s, CH3); 13C NMR (CDCl3, 125 MHz) δ keto: 202.4
(CO), 165.1 (CO), 66.9 (CH2), 66.7 (CH2), 50.0 (COCH2), 47.0 (CH2), 42.3 (CH2),
30.5 (CH3); enol: 175.3 (C(OH)), 171.0 (CO), 86.3 (COCH), 66.9 (CH2), 66.7 (CH2),
47.0 (CH2), 42.3 (CH2), 22.2 (CH3); LRMS (ESI) m/z: calcd. for C8H13NaNO3
[M+Na]+ 194.1, found 194.1. Spectroscopic data are consistent with that previously
reported.443
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Benzyl-(R)-2-(4,4,4-trichloro-3-hydroxy-3-methylbutanoyl)hydrazine-1-
carboxylate 444
To a solution of (R)-4-methyl-4-(trichloromethyl)oxetan-2-one 171 (0.398 g, 1.96
mmol) in THF (5 mL) was added benzyl hydrazinecarboxylate (0.440 g, 2.70 mmol)
443 and the solution was heated to 60 °C for 72 hours. After cooling to room
temperature, the mixture was diluted with Et2O and the organic layer was washed with
saturated Na2CO3 (aq.) and pH 2 buffer. The organic layer was dried over Na2SO4 and
the solvent was removed in vacuo. The crude residue was purified by column
chromatography (6:4 petroleum ether/EtOAc) to yield product as a white solid (657
mg, 92%). ν (cm-1); 3341 (br, O-H stretch), 1730 (C=O stretch), 1678 (C=O stretch),
1216 and 1038 (C-O stretch), 729 and 692 (Ar-H bend); 1H NMR (CDCl3, 500 MHz)
δ 9.81 (1H, s, NH), 9.26 (1H, s, NH), 7.42-7.29 (5H, m, Ph-H), 6.40 (1H, s, OH), 5.09 
(1H, s, OCH2), 2.76 (1H, d, J 13, CHHCO), 2.65 (1H, d, J 13, CHHCO), 1.63 (3H, s,
CH3); 13C NMR (CDCl3, 125 MHz) δ 168.5 (COCH2), 156.0 (CO2), 136.6 (Ph-C),
128.4 (Ph-C), 128.0 (Ph-C), 127.9 (Ph-C), 109.6 (CCl3), 81.2 (C(OH)), 65.9 (OCH2),
40.2 (CH2), 21.5 (CH3); HRMS (ESI) m/z: calcd. for C13H1535Cl3N2NaO4 [M+Na]+
390.9990, found 390.9993; m.p = 147-148 °C; [α]D 20 -30.0 (c 0.03, CHCl3).
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Compound 445 or 446
To a solution of benzyl (R)-2-(4,4,4-trichloro-3-hydroxy-3-
methylbutanoyl)hydrazine-1-carboxylate 444 (0.270 g, 0.738 mmol) in THF (4 mL)
was added 2M NaOH (aq.) (1.48 mL, 2.95 mmol) under nitrogen, and the solution was
stirred at room temperature overnight. The solvent was removed in vacuo and the
residue dissolved in EtOAc. This solution was acidified to pH 2, washed three times
with pH 2 buffer and the organic fractions were dried over Na2SO4. The solvent was
removed in vacuo to give the product as a colourless oil (0.100 g, 49%). This
compound was difficult to purify so it was used directly in the next step as a crude
mixture.
448 or 449 (X = Cl)
To a solution of crude unknown cyclic acid 445 or 446 (0.220 g, 0.791 mmol) from
the previous step in dry THF (5 mL) was added EDCI.HCl (0.303 g, 1.58 mmol),
DMAP (0.193 g, 1.58 mmol) and p-chlorobenzylamine (0.190 mL, 1.58 mmol) and
stirred at room temperature under nitrogen overnight. The mixture was then
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partitioned between EtOAc and pH 2 buffer and the organic layer was washed with
pH 2 buffer three times. The organic fractions were dried over Na2SO4 and the solvent
was removed in vacuo. The crude product was purified by column chromatography
(9:1 to 8:2 to 1:1 petroleum ether/EtOAc) to yield product as a colourless oil (70 mg,
28%). ν (cm-1); 3263 (br, N-H stretch), 1787 (C=O stretch), 1718 (C=O stretch), 1649
(C=O stretch), 1244 and 1041 (C-O stretch), 733 (C-Cl stretch); 1H NMR (CDCl3, 500
MHz) δ 9.04 (1H, s, NHN), 7.81 (1H, s, CH2NH), 7.43-7.09 (9H, m, Ar-H), 5.15 (1H,
d, J 12, CHHO), 5.05 (1H, d, J 11.5, CHHO), 4.45-4.31 (2H, m, CH2NH), 3.00 (1H,
d, J 15, CHHCO), 2.77 (1H, d, J 15, CHHCO), 1.61 (3H, s, CH3); 13C NMR (CDCl3,
125 MHz) δ 171.1 (CONH), 168.3 (CH2CO), 157.1 (OCONH), 136.6, 134.7, 133.3,
129.3, 129.0, 128.9, 128.8, 128.5 (Ar-C), 68.9 (CH2O), 65.6 (C(CH3)), 47.8 (CH2CO),
42.9 (CH2NH), 13.7 (C(CH3)); HRMS (ESI) m/z: calcd. for C20H2035ClN3NaO4
[M+Na]+ 424.1035, found 424.1037; [α]D 20 -115 (c 0.45, CHCl3).
448 or 449 (X = Br)
To a solution of crude unknown cyclic acid 445 or 446 (0.115 g, 0.414 mmol) from
the previous step in dry THF (3 mL) was added EDCI.HCl (0.159 g, 0.828 mmol),
DMAP (0.101 g, 0.828 mmol) and p-bromobenzylamine (0.100 mL, 0.828 mmol) and
stirred at room temperature under nitrogen overnight. The mixture was then
partitioned between EtOAc and pH 2 buffer and the organic layer was washed with
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pH 2 buffer three times. The organic fractions were dried over Na2SO4 and the solvent
was removed in vacuo. The crude product was purified by column chromatography
(4:6 to 3:7 petroleum ether/EtOAc) to yield the product as a colourless oil (24 mg,
13%). ν (cm-1); 3265 (br, N-H stretch), 1789 (C=O stretch), 1720 (C=O stretch), 1653
(C=O stretch), 1248 and 1043 (C-O stretch), 748 (C-Br stretch); 1H NMR (CDCl3, 500
MHz) δ 9.00 (1H, s, NHN), 7.47-7.27 (9H, m, Ar-H), 7.15 (1H, d, J 7.5, CH2NH),
5.15 (1H, d, J 12, CHHO), 5.06 (1H, d, J 12, CHHO), 4.43-4.31 (2H, m, CH2NH),
3.01 (1H, d, J 15, CHHCO), 2.79 (1H, d, J 15, CHHCO), 1.62 (3H, s, CH3); 13C NMR
(CDCl3, 125 MHz) δ 170.9 (CONH), 168.0 (CH2CO), 156.9 (OCONH), 137.1, 134.5,
131.7, 129.6, 128.9, 128.8, 128.5, 121.3 (Ar-C), 68.9 (CH2O), 65.5 (C(CH3)), 47.8
(CH2CO), 42.9 (CH2NH), 18.4 (C(CH3)); HRMS (ESI) m/z: calcd. for
C20H2079BrN3NaO4 [M+Na]+ 468.0529, found 468.0525; [α]D 20 -101 (c 0.42, CHCl3).
448 or 449 (X = NO2)
To a solution of crude unknown cyclic acid 445 or 446 (0.150 g, 0.540 mmol) from
the previous step in dry THF (3 mL) was added EDCI.HCl (0.207 g, 1.08 mmol),
DMAP (0.132 g, 1.08 mmol), p-nitrobenzylamine hydrochloride (0.203 g, 1.08
mmol), trimethylamine (0.300 mL, 2.16 mmol) and stirred at room temperature under
nitrogen overnight. The mixture was then partitioned between EtOAc and pH 2 buffer
and the organic layer was washed with pH 2 buffer three times. The organic fractions
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were dried over Na2SO4 and the solvent was removed in vacuo. The crude product
was purified by column chromatography (100% EtOAc) to yield product as a
colourless oil (38 mg, 17%). ν (cm-1); 3260 (br, N-H stretch), 1784 (C=O stretch),
1715 (C=O stretch), 1651 (C=O stretch), 1249 and 1040 (C-O stretch), 1H NMR
(CDCl3, 500 MHz) δ 9.20 (1H, s, NHN), 8.21-8.19 (2H, m, Ar-H), 7.46-7.28 (7H, m, 
Ar-H), 7.07 (1H, s, CH2NH), 5.19 (1H, d, J 12, CHHO), 5.13 (1H, d, J 12, CHHO),
4.59-4.45 (2H, m, CH2NH), 3.06 (1H, d, J 15, CHHCO), 2.86 (1H, d, J 15, CHHCO),
1.66 (3H, s, CH3); 13C NMR (CDCl3, 125 MHz) δ 171.1 (CONH), 167.7 (CH2CO),
157.0 (OCONH), 147.3, 145.5, 134.4, 129.0, 128.8, 128.44, 128.41, 123.9 (Ar-C),
69.1 (CH2O), 65.4 (C(CH3)), 48.1 (CH2CO), 42.9 (CH2NH), 18.4 (C(CH3)); HRMS
(ESI) m/z: calcd. for C20H20N4NaO6 [M+Na]+ 435.1275, found 435.1274; [α]D 20 -97.7
(c 0.26, CHCl3).
(R)-N,N-Dibenzyl-4,4,4-trichloro-3-hydroxy-3-methylbutanamide 453
To a solution of (R)-4-methyl-4-(trichloromethyl)oxetan-2-one 171 (0.243 g, 1.20
mmol) in THF (5 mL) was added dibenzylamine (0.460 mL, 2.40 mmol), and the
solution was stirred at 60 °C for 88 hours. The solvent was removed in vacuo and the
residue was passed through a short plug of silica eluting with 85:15 petroleum
ether/EtOAc, to yield product as a white solid (0.337 g, 64%). ν (cm-1); 3272 (br, O-
H stretch), 1624 (C=O stretch), 1216 (C-O stretch), 758 (C-Cl stretch); 1H NMR
(CDCl3, 500 MHz) δ 7.64-7.46 (8H, m, Ph-H), 7.41-7.36 (2H, m, Ph-H), 5.09 (1H, d, 
J 14.5, CHHN), 4.79 (1H, d, J 17, CHHN), 4.70 (1H, d, J 14.5, CHHN), 4.67 (1H, d,
J 17, CHHN), 3.98 (1H, d, J 15.5, CHHC(OH)), 3.09 (1H, d, J 15.5, CHHC(OH)),
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1.86 (3H, s, CH3); 13C NMR (CDCl3, 125 MHz) δ 172.9 (CO), 136.4, 135.8, 129.3, 
129.0, 128.7, 128.2, 128.0, 126.5 (Ar-C), 107.7 (CCl3), 82.1 (C(OH)), 50.6, 49.1
(CH2N), 36.4 (CH2CO), 24.6 (CH3); HRMS (ESI) m/z: calcd. for C19H2135Cl3NO2
[M+H]+ 400.0632, found 400.0632; m.p = 113-114 °C; [α]D 25 -14.7 (c 0.38, CHCl3).
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Chapter 3
Given our success using (R)-4-methyl-4-(trichloromethyl)oxetan-2-one (171) in the
synthesis of both α- and γ-tocopherol, we decided to explore further transformations 
of this somewhat underused chiral building block. The only other reports in the
literature using this lactone in synthesis were discussed previously in section 2.1.
3.1 (R)-4-(Trichloromethyl)-oxetanone 254a
There are more reports in the literature detailing the use of lactone 254a as an
enantiomerically enriched starting material. Song et al. used lactone 254a in the
synthesis of ester 455, a key intermediate in the synthesis of (R)-carnitine (Scheme
145).444
Scheme 145. Reagents and conditions: TsOH (2.0 mol%), EtOH, reflux, 25 h; n-Bu3SnH (2.1 equiv.),
THF, reflux, 28 h.
The ethanolysis of 254a had previously been reported by Wynberg and Staring445 and
no racemisation is observed during the reaction. Selective bis-dechlorination was
strongly dependent on the temperature – at room temperature the sole product was the
singly dechlorinated compound. Conversion of ester 455 into (R)-carnitine had been
previously reported.446
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In addition to their work on the Fridel-Crafts ring opening of 254a, Fujisawa et al. also
demonstrated that the lactone could be readily opened by ester enolates (Scheme
146).357
Scheme 146. Reagents and conditions: 456 (5.0 equiv.), THF, -78 °C, 3 h; Et3B (1.1 equiv.), NaBH4
(1.1 equiv.), -100 °C, 6 h; TFA (100 equiv.), CH2Cl2, 0 °C to rt, 12 h; 0.1M HCl (cat.), 4Å molecular
sieves, 50 °C, 24 h.
The enolate adduct 457 was elaborated into the β-hydroxy-γ-valerolactone 460, a
useful precursor to Compactin 461 and Mevinolin 462. Schulz et al. used similar
methodology in their synthesis of Sigillin A 463.447
Romo and Liu used (R)-lactone 254a as part of a synthesis of Schulzeine B (Scheme
147). The tetrahydroisoquinoline 466 was obtained as a separable mixture of
diastereoisomers from the Pictet-Spengler reaction448 of 465 and eventually subjected
to modified Corey-Link conditions to yield the δ-lactam 467.
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Scheme 147. Synthesis of Schulzeine B.
3.2 The Synthesis of (R)-dihydrocitronellol
We were most interested in reports that lactone 254a could be directly reduced using
LiAlH4 (Wynberg et al.)445 or using DIBAL-H (Fujisawa et al.),358 to yield the diol
322 (Scheme 148).
Scheme 148. Direct reduction of lactone 254a.
Both Wynberg and Fujisawa reported that the high enantiomeric excess of 254a was
unchanged by the reduction.
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During the course of this research, Snowden et al. published the one-carbon
homologation of aldehydes 470, using a Jocic reaction with a hydride nucleophile
(Scheme 149).350
Scheme 149. One-carbon homologation of trichlorocarbinols. Reagents and conditions: LiBH4 (4.0
equiv.), NaOH (3.0 equiv.), IPA, 40 °C, 16-24 h.
Given that the authors only used secondary trichloroalcohol substrates they could not
study the stereochemical outcome of the reaction. We imagined that lactone 171 could
be reduced in the same way as lactone 254a, to yield an enantiomerically enriched,
tertiary trichlorocarbinol 473 (Scheme 150).
Scheme 150. Proposed reduction of lactone 171.
It was expected that the diol 473 would undergo the same Jocic reaction when
subjected to the conditions described by Snowden et al. to yield an isoprenoid
compound, potentially in high enantiomeric excess. Table 32 shows a brief
optimisation study for the direct reduction of lactone 171.
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entry reductant solvent temperature (°C) time (h) yield (%)
1 LiAlH4 THF 0 1 85
2 DIBAL-H CH2Cl2 23 16 55
3 NaBH4 MeOH 23 16 0
4 LiBH4 THF 0 1 67
5 LiBH4 THF 0 0.5 99
Table 32. Optimisation of conditions for the reduction of lactone 171. 3.0 Equivalents of the
reductant were used in each entry.
Using LiAlH4 as described by Wynberg (entry 1) gave the diol 473 in good yield.
However, unidentified side products were present in the crude mixture so the
compound required purification by column chromatography. We imagined that there
should be conditions that would yield diol 473 without the need for extra purification,
so alternative reductants were screened. The use of DIBAL-H (entry 2) gave a less
satisfactory yield of the diol. The reaction with NaBH4 yielded unreacted starting
materials only. LiBH4 yielded diol 473 after 30 minutes at 0 °C, in essentially
quantitative yield without the need for further purification (entry 5). Gram-quantities
of the diol were accessible using this procedure.
With the diol 473 in hand, we first wondered if it would undergo a Jocic
reaction/lactonisation like that reported by Romo et al. (Scheme 151).354
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Scheme 151. Attempted synthesis of α-disubstituted γ-lactones.  
p-Methoxyphenol was chosen as the nucleophile, since it had been previously reported
by Corey to take part in Jocic reactions of the type in scheme 151.435 Unfortunately,
under the conditions described by Romo et al. an unidentifiable mixture was obtained.
In order to prevent side reactions in the homologation reaction of 473, the primary
alcohol was selectively protected with triisopropylsilyl chloride. This group is known
to be stable to alkaline conditions.449 The monoprotected diol 474 was then subjected
to the conditions developed by Snowden et al. (Scheme 152).
Scheme 152. One-carbon homologation of a tertiary trichlorocarbinol.
The desired alcohol (R)-475 was isolated in 64% yield under the conditions described
by Snowden. However, also present in the crude reaction mixture was the secondary
alcohol 476. It was not possible to establish the ratio of 475:476 from the crude 1H
NMR spectrum since the peaks were overlapping (Figure 19). The formation of 476
can be rationalised using the following mechanistic pathway (Scheme 153).
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Figure 19. 1H NMR of crude reaction mixture. Inset: magnified region showing α-CH protons. 
Scheme 153. Reaction pathways leading to the formation of alcohols (R)-475 and 476.
The predominant pathway must be path a, following the accepted Jocic reaction
mechanism to yield the primary alcohol 475. The formation of secondary alcohol 476
is presumably due to initial elimination of CHCl3 from the trichlorocarbinol (R)-473
to give ketone 479, which is reduced by LiBH4. Snowden et al. reported no such side
PPM 3.90 3.80 3.70 3.60 3.50 3.40 3.30
PPM 4.0 3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2 1.0 0.8 0.6
475 α-CH2OH
476 α-CHOH
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products, since there will not be as great a driving force for elimination of CHCl3 in
the corresponding secondary trichlorocarbinols.
Luckily, the primary alcohol (R)-475 was separable from the side product alcohol 476
by column chromatography. In order to measure the e.e. of the primary alcohol we
first attempted to use the (R)- and (S)-Mosher’s ester derivatives. Unfortunately, the
diastereomeric esters showed no difference by 1H NMR spectroscopy. We therefore
turned to HPLC analysis. Scheme 154 describes the racemic synthesis of (±)-475. An
aldol condensation between ethyl acetate enolate and 1,1,1-trichloroacetone 480
yielded the adduct 481 in moderate yield. The use of LiAlH4 in place of LiBH4 in the
following reduction gave a poor yield (34%) of the diol (±)-473. Monoprotection of
the diol with triisopropylsilyl chloride was carried out in the same manner as for the
enantiomerically enriched compound.
Scheme 154. Synthesis of racemic monoprotected diol (±)-475.
The reaction of trichlorocarbinol (±)-474 with NaOH/LiBH4 yielded the alcohol (±)-
475 in comparable yield, along with 476 which was separated by column
chromatography. Both the racemate and the enantiomerically enriched alcohols 475
were then converted into the diphenylphosphinate esters (R)-482 and (±)-482 (Scheme
155).
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Scheme 155. Synthesis of phosphonate esters.
Benzoate esters are commonly used for the HPLC analysis of compounds with no
chromophore, however other members of the group have had success in separating
enantiomers using the phosphonate ester group.
Figure 20. HPLC trace of (±)-482.
Figure 21. HPLC trace of (R)-482. Conditions: Daicel Chiralcel AD-H column, 2-propanol : hexane
= 98 : 2, 1 mL/min, 225 nm, (S) isomer 32.49 min, (R)-isomer 36.84 min.
The e.e. of phosphonate ester (R)-482 was measured to be 92% (Figures 20 and 21),
and the absolute configuration of the alcohol 475 was established as (R) by comparison
of the measured optical rotation to the literature value. This corresponds to an expected
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inversion of configuration during the Jocic reaction. Given that the ring-opening of
the gem-dichloroepoxide 477 is known to be highly stereospecific, the racemisation
must be taking elsewhere in the reaction mechanism. Snowden et al. reported that
isopropyl esters such as 483 were intermediates in the reaction pathway (Scheme 156).
Scheme 156. Formation of an isopropyl ester intermediate 483.
This intermediate was also identified during our work. Both the acid chloride 478 and
the ester 483 will be prone to enolisation under the alkaline conditions due to the α-
protons in each compound, so it seems likely that this is the source of the racemisation
taking place in the reaction.
A search in the literature revealed alcohol (S)-484 to be a key intermediate in a
stereoselective synthesis of (3R,7R)-hexahydrofarnesol 32 by Matsueda et al. (Scheme
157).450 We envisaged that the same sequence of reactions using (S)- rather than (R)-
475 should yield (R)-dihydrocitronellol 487, and eventually (3R,7R)-
hexahydrofarnesol 32. We decided to keep triisopropylsilane as the protecting group
since we imagined that it should not behave differently to tert-butyldimethylsilane
(TBDMS) under the reaction conditions shown in scheme 157.
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Scheme 157. Synthesis of (3R,7R)-hexahydrofarnesol 32 by Matsueda et al. Reagents and conditions:
I2 (1.3 equiv.), PPh3 (1.2 equiv.), imidazole (1.3 equiv.), CH2Cl2, rt, 16 h; 486 (2.0 equiv.), CuCl2 (3.0
mol%), 1-phenyl-1-propyne (0.15 equiv.), THF, rt, 2 h; TBAF (2.0 equiv.), THF, rt, 3 h.
Scheme 158 shows the synthesis of (R)-dihydrocitronellol 487. The same sequence of
reactions previously developed were used to synthesise (S)-alcohol 475, starting from
the (S)-enantiomer of lactone 171. The conversion of (S)-475 into (R)-
dihydrocitronellol 487 was then carried out according to Matsueda et al.
Scheme 158. Synthesis of (R)-dihydrocitronellol 487.
It was imagined that the racemisation observed during the Jocic reaction to form
alcohol (S)-475 might be suppressed by lowering the reaction temperature.
Accordingly, when the reaction was carried out at 0 – 2 °C no racemisation was
observed by chiral HPLC (Figure 23). However, the reaction was extremely sluggish
and only went to 25% conversion after four days. The reaction was similarly slow at
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10 °C. When the reaction was carried out at room temperature the e.e. appears to
increase and none of the (R)-enantiomer could be observed (Figure 24). An increased
reaction time (24 hours) was required to ensure full conversion. An attempt was made
to convert (±)-dihydrocitronellol 487 into its phosphonate ester for a direct
measurement of the stereochemical purity of the (R)-dihydrocitronellol 487 product,
but the enantiomers were inseparable by chiral HPLC.
Scheme 159. Synthesis of phosphonate ester (S)-482.
Figure 22. HPLC trace of the phosphonate ester (±)-482.
Figure 23. HPLC trace of the phosphonate ester (S)-482 (0 °C reaction temperature).
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Figure 24. HPLC trace of the phosphonate ester (S)-482 (room temperature reaction). Conditions:
Daicel Chiracel AD-H column, 2-propanol : hexane 98 : 2, 1 mL/min, 225 nm, (S) isomer 33.78 min,
(R) isomer 38.80 min.
Using this successive Grignard coupling strategy, all four stereoisomers of
hexahydrofarnesol ought to be accessible in high e.e. and d.e. (Scheme 160). This
strategy was previously used by Barner et al. where the source of chirality was a
natural γ-lactone.168, 170
Scheme 160. Potential stereoselective synthesis of all four stereoisomers of hexahydrofarnesol.
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In this way, (R)-dihydrocitronellol 487 was converted into (3R,7R)-hexahydrofarnesol
32 (Scheme 161). Unfortunately, the second Grignard coupling step was low yielding
and the desired hexahydrofarnesol 32 was contaminated with inseparable side
products. Further attempts, preferably on a larger scale, would be required to optimise
this step. Nevertheless, this work further demonstrates the usefulness of
trichlorolactones such as 171 as chiral building blocks.
Scheme 161. Completion of the hexahydrofarnesol synthesis.
3.3 Scope of the Reductive Jocic Reaction
We established that the Jocic reaction with a hydride nucleophile developed by
Snowden et al. produced alcohols in high e.e. when enantiomerically pure, tertiary
trichlorocarbinols were used as substrates. We were therefore interested to explore the
potential generality of the homologation reaction.
3.3.1 The Synthesis of Tertiary Trichlorocarbinols
Whilst the synthesis of secondary trichlorocarbinols from aldehydes is well
established,235-237, 261 the synthesis of tertiary trichlorocarbinols from ketones is more
difficult. This is primarily due to competing enolisation when strong bases are used.
Li et al. reported the use of organotitanium reagents to prepare tertiary
trichlorocarbinols, and high yields were obtained from readily enolisable ketones
(Scheme 162). 238
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Scheme 162. Reagents and conditions: CHCl3 (5.0 equiv.), n-BuLi (5.0 equiv.), TiCl(OiPr)3 (2.0
equiv.), THF, -60 °C, 4 h. R1 = aryl, vinyl; R2 = alkyl.
This seemed to be a potential general procedure. Unfortunately, in this project when
the simple ketones 494 and 496 were subjected to the reported conditions the reaction
either failed or was low yielding (Scheme 163). Alternative procedures were therefore
sought.
Scheme 163. Attempted synthesis of tertiary trichlorocarbinols.
Henegar and Lira developed a protocol for in situ generation of TMS-CCl3 and
addition to carbonyl compounds (Scheme 164).256, 379
Scheme 164. Synthesis of trichlorocarbinols using in situ generated TMS-CCl3. R1 = aryl, alkyl; R2 =
H, alkyl.
In addition, they showed that using the bulky TMS-CCl3 nucleophile gave good
diastereoselectivity for substituted cyclohexanone substrates (Scheme 165).
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Scheme 165. Diastereoselective synthesis of trichlorocarbinol 503.
As expected, the CCl3 group preferentially added anti to the 2-phenyl substituent.
Because a variety of substituted cyclohexanone compounds are commercially
available, we imagined this method might provide a route to diastereomerically
enriched trichlorocarbinols such as 503, as well as general racemic compounds, in
order to establish the scope of the Jocic reaction.
The use of identical conditions to those shown in schemes 164 and 165 failed to give
any trace of product when 496 was used as the ketone; however, addition of LiHMDS
to a solution of ketone 496 and CHCl3 in THF yielded the desired trichlorocarbinol
497 in an acceptable yield of 63% (Scheme 166).
Scheme 166. Synthesis of tertiary trichlorocarbinol 497.
In this way a variety of alkyl trichlorocarbinols were synthesised (Figure 25). Aryl
ketones were not considered suitable substrates at this point due to their low yielding
conversion into trichlorocarbinols by this method. The yields for compounds 505a-i
ranged from moderate to good. The method of Aggarwal236 used for compound 505f
failed when applied to any other substrate.
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Figure 25. Synthesis of tertiary trichlorocarbinols. a This compound was synthesised using the
method of Aggarwal et al.: CHCl3 (2.0 equiv.), DBU (1.0 equiv.), rt, 16 h.
3.3.2 Jocic Reation using Hydride Nucleophile
With the trichlorocarbinols 505a-i in hand, we subjected them to the reductive Jocic
reaction conditions we had previously developed. The results are shown in Table 33.
Unfortunately, most of the substrates were inseparable from the secondary alcohol 507
side product. The low crude yield of 506a is likely due to the volatility of the low
molecular weight alcohol. None of the linear alkyl substrates (a-e) tested could be
separated from the secondary alcohol side product. The increased steric hindrance of
505e is presumably responsible for the higher proportion of side product, due to a
greater driving force for elimination of CHCl3. Smaller rings (cyclopentyl, 505f and
cyclohexyl, 505g) gave more favourable ratios than the larger rings (cyclooctanyl,
505h and cyclododecanyl, 505i). However, it was possible to isolate the primary
alcohol 506i cleanly in 49% yield.
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entry ratio 506:507a 506 yield (%) entry ratio 506:507a 506 yield (%)
a 70:30 14b f 95:5 70c
b 82:18 69b g 73:17 76b
c 77:23 65b h 21:79 82b
d 82:18 90b i 66:34 49
e 45:55 90b
Table 33. Reagents and conditions: LiBH4 (4.0 equiv.), NaOH (3.0 equiv.), IPA, rt, 24 h.
a Determined by analysis of the 1H NMR spectrum of the crude material. b Crude yield: compound 506
was inseparable from compound 507. c Crude yield: compound was difficult to isolate due to its
volatility.
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Figure 26. Top: 1H NMR spectrum of entry a crude mixture. Bottom: 1H NMR spectrum of entry h
crude mixture.
CH2OH
CH2OH
CHOH
CHOH
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3.4 Dichlorocarbinols as Alternative Substrates
We established that hydride could take part in a Jocic reaction with tertiary
trichlorocarbinols to yield various branched alcohols, in an overall one-carbon
homologation from the starting material ketone. However, the main drawback
appeared to be the formation of a secondary alcohol which was often inseparable from
the desired primary alcohol. The ratio of the two products was also found to be in
favour of the secondary alcohol for the more hindered substrates. We imagined that
using the corresponding dichlorocarbinols might provide a solution to this issue, since
the elimination of dichloromethane from the compound will be much less favourable
and therefore slower than the elimination of chloroform.
3.4.1 Literature Syntheses and Reactions of Dichlorocarbinols
Methods for the synthesis of tertiary dichlorocarbinols in the literature are scarce.
Ohshiro et al. used diethyl phosphonate-triethylamine to reduce trichlorocarbinol 508
to the corresponding dichlorocarbinol 509 (Scheme 167).451
Scheme 167. Reagents and conditions: diethyl phosphonate (4.0 equiv.), NEt3 (3.0 equiv.), 80 °C,
12 h.
The trichloromethyl group can also be electrochemically reduced selectively to the
dichloromethyl group (Scheme 168).452
Scheme 168. Electrochemical reduction of trichloromethyl group. Mercury cathode, -1.6V working
potential versus saturated calomel electrode.
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Fechtel et al. synthesised 511 in this way and used it in a Jocic-type reaction, with a
phenoxide nucleophile (Scheme 169).336
Scheme 169. Synthesis of α-aryloxy-aldehydes. 
Although this reaction was carried out on a secondary substrate, and we were
interested in tertiary substrates, we still felt it was promising for our proposal.
Additionally, the authors managed to isolate the chloroepoxide 512, which provides
further evidence for these epoxides as intermediates in the general Jocic reaction
mechanism.
Probably the most straightforward method for the synthesis of dichlorocarbinols is the
addition of dichloromethyl anion, much like the procedures discussed in Chapter 1 for
the synthesis of trichlorocarbinols. Taguchi et al. described a practical synthesis of
polyhalomethyl-lithium adducts (Scheme 170).453, 454
Scheme 170. Reagents and conditions: Lithium dicyclohexylamide (2.0 equiv.), CH2Cl2, -78 °C, 1 h.
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The lesser acidity of dichloromethane compared to chloroform requires that a stronger
base than LiHMDS be used. Lithium dicyclohexylamide, lithium diisopropylamide
and lithium 2,2,6,6-tetramethylpiperidine all gave similar results. The steric bulk of
these bases and the low temperature used helps to minimise enolisation side reactions.
In addition to dichloromethane, the authors found that dibromomethane,
diiodomethane and bromoform all gave the adducts in useful yields.
Deloisy et al. used this procedure to synthesise a sugar-derived dichlorocarbinol in
stereoselective fashion, which then underwent a Jocic reaction with sodium azide
(Scheme 171).455
Scheme 171. Stereoselective synthesis of α-azido aldehyde 520a and 520b. Reagents and conditions:
LDA (4.0 equiv.), CH2Cl2 (4.0 equiv.), THF, -78 °C to rt; NaN3 (10 equiv.), DMPU (5.0 equiv.), 15-
crown-5 (0.1 equiv.), 70 °C. DMPU = 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone.
The addition of dichloromethyllithium to the ketone 518a took place selectively to
yield dichlorocarbinol 519a, which in turn was converted into the α-azido aldehyde 
520a by treatment with sodium azide. The same reaction sequence with R = Bn yielded
520b as a 2:1 mixture of diastereoisomers isomeric at C-5.
Shiozaki and Nakamura used similar chemistry as part of a synthesis of Sphingofungin
E (525, Scheme 172).456
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Scheme 172. Synthesis of Sphingofungin E.
Addition of dichloromethyllithium to the pyranose 521 took place
diastereoselectively, due to steric hindrance from the anomeric axial allyl group. None
of the C-2 epimer was observed.
Yoshikawa et al. described a similar strategy during the synthesis of the structurally
similar antifungal compound Myriocin (529, Scheme 173).457
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Scheme 173. Reagents and conditions: LDA (2.0 equiv.), CH2Cl2 (10 equiv.), -78 °C, 15 min; NaN3
(5.0 equiv.), 15-crown-5 (0.5 equiv.), HMPA, 100 °C, 2 h.
The observed diastereoselectivity of dichloromethyllithium addition in this example
arises due to steric hindrance from the bulky 1,3-benzylidene group at the C-4 position.
Masaki et al. reported that dichlorocarbene, generated from a CHCl3/ aq. NaOH/ phase
transfer catalyst system, took part in a C-H insertion reaction with chiral secondary
alcohols (Scheme 174).458, 459
Scheme 174. Insertion of dichlorocarbene. CTAC = cetyltrimethylammonium chloride. R = n-C6H13,
CH2Ph, Ph
This report particularly interested us since the authors claimed that the insertion was
completely stereospecific, allowing the synthesis of enantiomerically pure
dichlorocarbinol compounds 532 which were previously inaccessible. The authors
then demonstrated that these compounds would undergo a Jocic reaction with either
sodium azide or sodium cyanide, in stereospecific fashion (Scheme 175).
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Scheme 175. Reagents and conditions: K2CO3 (5.0 equiv.), MeOH, rt, 10 min; NaN3 (3.0 equiv.), 15-
crown-5 (1.0 equiv.), THF, rt, 12 h; KCN (3.0 equiv.), 18-crown-6, THF, rt, 12 h; NaBH4 (5.0 equiv.),
MeOH, rt, 10 min.
In this way compounds 534 and 536 were obtained in > 98% e.e. The reaction of
chloroepoxide 533 with cyanide first yielded the cyanohydrin 535 as a mixture of
diastereoisomers, which was reduced to the primary alcohol 536. Interestingly, when
phenyl dichlorocarbinol (R = Ph) was used as the substrate the opposite enantiomer of
compounds 534 and 536 was observed. An intramolecular chloride 1,2-shift is one
explanation for this double inversion, and the α-chloro-aldehyde 537 was indeed
isolated (Scheme 176). An alternative mechanism where the chloroepoxide 533 is
opened by chloride nucleophile, then substituted by azide in SN2 fashion, would also
explain this double inversion.
Scheme 176. Observed double inversion of phenyl substrate 532.
The products of the substitution reaction of aldehyde 537 with azide or cyanide still
retained > 98% e.e. The absolute configuration of all the compounds was determined
by conversion to the known carboxylic acids and comparison of optical rotations.
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3.4.2 Synthesis of Dichlorocarbinol Substrates
The stereospecific synthesis of dichlorocarbinols (Scheme 174) seemed desirable to
us, since the corresponding racemic substrates ought to be readily synthesised using
the well-established LDA/CH2Cl2 method. Therefore, we first attempted the carbene
insertion reaction reported by Masaki et al., using racemic 2-octanol. Unfortunately,
the highest conversion achieved was 12%, over a period of four days at 80 °C using
benzyltriethylammonium chloride as the phase transfer catalyst (Scheme 177). This
was despite the report claiming an overall yield (after TMS deprotection) of 39% after
18 hours. Alternative phase transfer catalysts tetra-n-butylammonium chloride and
cetyltrimethylammonium chloride gave even lower conversions.
Scheme 177. Attempted synthesis of dichlorocarbinols by carbene insertion.
Despite this, dichloromethyllithium readily added to a range of general ketones at
-78 °C, in moderate to good yields (Figure 27). LDA was chosen as the base as there
was little difference when lithium dicyclohexylamide was employed, and LDA is
generally used more in organic synthesis. The use of less basic amide base LiHMDS
gave poor conversion as expected, due to the decreased acidity of dichloromethane.
It was found that by washing the organic layer several times with pH 2 buffer during
the work up all traces of diisopropylamine could be removed. In some cases this
allowed the dichlorocarbinol to be used without any further purification, which
represents an improvement on the original protocol. A low temperature was vital
because at higher reaction temperatures (e.g. 0 °C) the LDA began to degrade,
resulting in a lower yield.
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Figure 27. Synthesis of dichlorocarbinols. Reagents and conditions: LDA (2.0 equiv.), CH2Cl2, -78
°C, 0.5 h. Yields shown for 542i-k and 542n are the combined yield of both diastereoisomers. a Crude
yield.
Linear, unbranched alkyl ketones (541a-c) gave good yields of the dichloromethyl
adduct. The branched substrates 541h and 541l gave slightly lower yields, with the
tert-butyl substrate 541d significantly lower yielding, presumably due to steric
hindrance. The cyclic dichlorocarbinols 542e-g were obtained in similar yields to the
trichloromethylation reaction. Compound 542i was obtained as a 1.6:1 ratio of
diastereoisomers, which were readily separated by column chromatography (Figure
28).
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Figure 28. 1H NMR spectrum obtained from crude mixture of 542i. Inset: CHCl2 peaks used to
determine diastereomeric ratio.
Compound 542j was obtained as an increased 5.8:1 ratio of diastereoisomers (Figure
29), although these were inseparable by column chromatography. The greater
selectivity is due to the proximity of the methyl substituent. The bulkier cyclohexyl
group provided an even higher selectivity of 11:1 (542k, Figure 30), and the
diastereoisomers were separable by column chromatography.
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Figure 29. 1H NMR spectrum obtained from crude mixture of 542j. Inset: CHCl2 peaks used to
determine diastereomeric ratio.
Figure 30. 1H NMR spectrum obtained from crude mixture of 542k. Inset: CHCl2 peaks used to
determine diastereomeric ratio.
The reaction of dichloromethyllithium with (R)-pulegone resulted in a selectivity of
13.3:1 (Figure 31), which was the highest observed. These diastereoisomers were also
readily separable by column chromatography. The reaction with ketone 541m did not
reach full conversion even using extended reaction times. In addition, the product
appeared to degrade on silica gel to the ketone starting material, so it was not tested as
2
542j
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a substrate in the reductive Jocic reaction. An attempted reaction using (S)-camphor
failed to give a satisfactory yield of dichlorocarbinol under the optimised conditions.
Figure 31. 1H NMR spectrum obtained from crude mixture of 542n. Inset: CHCl2 peaks used to
measure diastereomeric ratio
3.4.3 Jocic Reaction using Hydride Nucleophile
With dichlorocarbinols 542a-n in hand, we then looked to subject them to the same
reduction conditions previously developed (section 3.3.2) and in doing so make some
comparison to the use of trichlorocarbinol analogues.
3.4.4 Results
Table 34 shows our results. The linear, alkyl substrates b and c gave the best results
in terms of yield, with minimal secondary alcohol 544 being identified by inspection
of the crude 1H NMR spectrum (Figure 32). The lower isolated yield of compound
543a may be due to its volatility. All three entries represent an improvement on the
trichloro- analogues in both isolated yield and the ratio of 543:544. Dichlorocarbinol
542d failed to undergo the expected reaction, and no identifiable products were
observed. This is likely due to the large steric hindrance of the tert-butyl group.
PPM 6.36 6.32 6.28 6.24 6.20 6.16 6.12 6.08 6.04 6.00
PPM 6.8 6.4 6.0 5.6 5.2 4.8 4.4 4.0 3.6 3.2 2.8 2.4 2.0 1.6 1.2 0.8
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entry ratio 543:544a 543 yield (%) entry ratio 543:544a 543 yield (%)
a 96:4 30 cis-i 100:0 61
b 100:0 75 trans-i 100:0 28
c 100:0 66 j 100:0 59
d - -b kd 98:2 39
e 100:0 31 l 100:0 46
f 100:0 91c n - -b
g 94:6 56
h 100:0 65
Table 34. Reactions and conditions: LiBH4 (4.0 equiv.), NaOH (3.0 equiv.), IPA, rt, 16 h. a Ratio
determined by examination of the crude 1H NMR spectrum. b Neither product 543 or 544 was
observed in the crude mixture. c Crude yield: product 543 could not be isolated cleanly. d Major
diastereomer was used as the substrate as the minor diastereoisomer was inseparable from impurities.
Compound 543e was isolated in a lower yield, although no trace of side product 544e
was observed. The medium-sized and large rings (entries f and g) were less suitable
substrates, behaviour which was observed for the trichloro-analogues. The reaction
with dichlorocarbinol 542f, although yielding no trace of secondary alcohol side
product, gave an alkene side product not observed in any other entries. The proposed
mechanistic justification for this will be discussed in section 3.4.5. The reaction with
dichlorocarbinol 542g showed the lowest 543:544 ratio of all the entries, although it
still represents a seven-fold improvement over the trichloro- analogue. Notably, the
corresponding trichlorocarbinol for entry h gave the secondary alcohol in almost a 1:1
ratio. The reactions with single diastereoisomers (cis-542i, trans-542i, 542k) and a
mixture of diastereoisomers (542j) will be discussed more fully in section 3.4.6.
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Dichlorocarbinol 542l gave a moderate yield of the desired primary alcohol, with none
of the secondary alcohol being observed. The reaction with 542n yielded none of the
desired product, although peaks consistent with SN2’ addition of hydride to the alkene
were observed in 1H NMR spectrum of the crude mixture.
Figure 32. Top 1H NMR spectrum: obtained from the crude mixture of 543b. Bottom 1H NMR
spectrum: 2-nonanol.
3.4.5 Mechanism Considerations
The potential mechanism by which the secondary alcohol 544 is formed is shown in
scheme 178. It is clear from our results that the elimination of CH2Cl2 from compound
542 to form the ketone 547 (path b) must be slower than the corresponding elimination
of CHCl3. This would be expected due to the increased acidity of CHCl3 compared to
CH2Cl2. For many of the substrates reaction pathway b became negligible.
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Scheme 178. Formation of alcohols 543 and 544.
From the reaction of dichlorocarbinol 542f the allylic alcohol 548 was formed, and it
was inseparable from the desired primary alcohol 543f (Scheme 179).
Scheme 179. Possible mechanism for the formation of an allylic alcohol side product.
It was interesting to note that in none of the experiments run was any ring opening at
the non-chlorinated carbon of the intermediate chloroepoxide observed. For the
analogous dichloroepoxide this might be expected mainly on the grounds of
electronics, since the epoxide ring opening likely involves a “late” SN2 transition state.
Lengthening of the C-O bond causes a build-up of positive charge on the carbon atom,
and the chlorine atoms will raise the energy of TS2 relative to TS1 (Figure 33).
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Figure 33. Illustration of possible transition states in the ring opening of gem-dichloroepoxides.
Evidently, one chlorine atom is enough to sufficiently raise the energy barrier for this
pathway to still be negligible. Comparison of the 1H NMR spectra of the independently
synthesised tertiary alcohol 549 with that of the crude reaction mixture obtained from
dichlorocarbinol 542c illustrates this (Figure 34). Tertiary alcohol 549 was synthesised
by addition of MeMgBr to 2-decanone (Scheme 180).
Figure 34. Top 1H NMR spectrum: crude reaction mixture of 543c. Bottom 1H NMR spectrum:
tertiary alcohol 549.
Scheme 180. Synthesis of tertiary alcohol 549.
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As can be seen in figure 34, no tertiary alcohol was observed in the Jocic reaction of
dichlorocarbinol 542c, corresponding to complete regioselectivity for the non-
chlorinated carbon. Non-chlorinated epoxides will generally react with a hydride
nucleophile at the less hindered end. For example, epoxide 550 (synthesised
independently using a Corey-Chaykovsky reaction,460 scheme 181) was subjected to
our reduction conditions (Scheme 182) and the crude 1H NMR spectrum was
examined (Figure 35).
Scheme 181. Synthesis of epoxide 550 using a Corey-Chaykovsky reaction.
Scheme 182. Reaction of epoxide 550 with LiBH4 and NaOH.
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Figure 35. 1H NMR spectra from top to bottom: starting material epoxide 550; tertiary alcohol 549;
primary alcohol 543c; crude reaction mixture of epoxide 550 subjected to our Jocic reduction
conditions.
As can be seen from the 1H NMR spectra, under our Jocic reaction conditions the
epoxide 550 undergoes ring opening at the less hindered end, and the reaction only
reached ~75% conversion. No trace of the primary alcohol resulting from attack at the
more hindered end of the epoxide was observed.
3.4.6 Stereochemistry
The separation by column chromatography of the cis and trans diastereoisomers of
dichlorocarbinol 542i allowed us to gain some insight into the stereochemistry of the
Jocic reaction under these conditions. Therefore, each single isolated diastereoisomer
and a mixture of the two diastereoisomers was reacted under the same conditions and
the reaction mixtures were analysed by 1H NMR spectroscopy (Figure 36).
249
Figure 36. Top 1H NMR spectrum: obtained from the reaction of a mixture of both 542i
diastereoisomers. Middle 1H NMR spectrum: obtained from the reaction of the more polar
diastereoisomer of 542i. Bottom 1H NMR spectrum: obtained from the reaction of the less polar
diastereoisomer of 542i.
Figure 37. Magnification of α-CH peaks.  
cis-CH2OH trans-CH2OH
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Note that the relative configuration was not known prior to carrying out the Jocic
reaction. Each diastereoisomer was crystalline but unfortunately we were not able to
grow suitable crystals for X-ray crystallography.
Although the relative stereochemistry of each diastereoisomer of 542i was not known
beforehand, the Jocic reaction is known to go with inversion. The cis- and trans-
alcohols 543i were known in the literature,461, 462 so by identifying the relative
stereochemistry of the primary alcohol products we were able to tentatively assign the
stereochemistry of the starting materials (Scheme 183). In this way, the less polar
diastereoisomer of 542i was assigned as cis, and the more polar diasteroisomer was
assigned as trans. The 1H NMR spectra established that none of the opposite
diastereoisomer was present in each reaction. This indicates that the reaction is highly
stereospecific, and that no epimerisation of the C-1 stereocentre is taking place during
the reaction.
Scheme 183. Inversion of configuration at the C-1 centre during the Jocic reaction.
Compound 542k was reacted as the major diastereoisomer only, since the minor
diastereoisomer could not be isolated cleanly. NMR data for the resulting 2-
cyclohexylcyclohexyl methanol product 543k was not available, which made analysis
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of the reaction stereochemistry difficult, although there appeared to be only a single
diastereoisomer with a negligible presence of the secondary alcohol (Figure 38).
Figure 38. 1H NMR spectrum of the crude mixture from the Jocic reaction of dichlorocarbinol 542k.
However, the melting point (56-57 °C) agreed reasonably well with the literature for
the cis diastereoisomer (lit. 62-63 °C463). The melting point of the trans
diastereoisomer was reported to be 160-162 °C from the same reference. Thus, the
major diastereoisomer of dichlorocarbinol 542k can tentatively be assigned as cis,
which is as expected due to attack of dichloromethyllithium at the less hindered face
of the cyclohexanone ring.
Compound 542j was reacted as an inseparable 5.8:1 mixture of diastereoisomers. The
1H NMR spectrum of the crude mixture (Figure 39) suggested an increased 33:1 ratio
of diastereoisomers, with the major isomer agreeing with literature data for the cis
configured alcohol 543j.464 This suggests a cis-configuration for the major
diastereoisomer of the dichlorocarbinol 542j. The diastereoisomers of the product
alcohol 543j were separable by column chromatography.
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Figure 39. 1H NMR spectrum of the crude mixture from the Jocic reaction with dichlorocarbinol
542j. Inset: CH3CH doublets used to determine the diastereomeric ratio.
3.5 Other Nucleophiles
Phenoxide had previously been shown by Fechtel et al. to participate in a Jocic
reaction with secondary dichlorocarbinols to yield α-substituted aldehydes. However, 
we found that treatment of the tertiary dichlorocarbinol 542c with p-methoxyphenol
and NaOH yielded a mixture of products 551 and 552, from the Cannizzaro reaction
of the α-substituted aldehyde (Scheme 184). 
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Scheme 184. Attempted Jocic reaction with a phenoxide nucleophile. R = p-OCH3C6H4.
We imagined that the use of a strong, non-nucleophilic organic base would prevent
the aldehyde product from undergoing a Cannizzaro reaction. Accordingly, treatment
of dichlorocarbinol 542c with triazabicyclodecene (TBD) and p-methoxyphenol in
IPA solvent yielded the α-disubstituted aldehyde 553 smoothly (Scheme 185).
Scheme 185. Synthesis of α-aryloxyaldehyde 553. R = p-OCH3C6H4.
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3.6 Conclusions and Future Work
The Jocic reaction with a hydride nucleophile, as first described by Snowden et al. for
secondary trichlorocarbinols, was applied to tertiary trichlorocarbinol substrates for
the first time. With tertiary trichlorocarbinols, elimination of CHCl3 was observed
which ultimately led to the formation of significant quantities of a secondary alcohol
side product. This side product was often inseparable from the desired primary
alcohol, making purification difficult. In spite of this, the reaction was shown to be
highly stereospecific when an enantiomerically pure, tertiary trichlorocarbinol was
used as the substrate. This reaction ultimately led to the stereoselective synthesis of
(R)-dihydrocitronellol and (3R,7R)-hexahydrofarnesol.
The use of dichlorocarbinols, synthesised by straightforward addition of lithiated
dichloromethane to ketones, greatly improved the Jocic procedure and little to no side
products were observed in this reaction. Several cyclohexanones containing a
stereogenic centre could be dichloromethylated with good diastereoselectivity.
Moreover, the addition of hydride to these substrates was shown to be both highly
regioselective and highly stereospecific. No epimerisation of the newly generated
stereogenic centre was observed in the reaction.
Clearly, a more comprehensive study of the reaction using enantiomerically pure
substrates would be desirable. Currently no methods exist for the enantioselective
synthesis of tertiary dichlorocarbinols, bar the carbene insertion reported by Masaki et
al.,458, 459 which in our hands failed for alkyl secondary alcohols. For aryl substrates
more promising results have been obtained by another member of the group.
One additional nucleophile (phenoxide) was used in the Jocic reaction (Scheme 185).
Other nucleophiles could be explored – for example N-based nucleophiles or S-based
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nucelophiles. The use of bidentate nucleophiles could generate substituted cyclic
structures as has been shown by Perryman et al.361
Sugar-derived ketones have been shown to provide excellent selectivity for the
addition of both trichloromethide and dichloromethide.366, 370-372, 455-457 Subsequent
Jocic reactions on these stereochemically pure compounds has largely been restricted
to the use of azide nucleophiles. We envisage that the use of our developed conditions
could provide a highly stereospecific route to one-carbon homologated sugar
compounds. This approach would be especially versatile for glucose since the
hydroxyls at the C-2, C-3, C-4 and C-6 positions can be selectively protected.465
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3.7 Experimental Section
All the reagents and solvents used were purchased from Sigma-Aldrich, Alfa-Aesar,
TCI, Fluorochem or Acros Organics and were used as received unless stated
otherwise. Solvents were dried over 3Å or 4Å molecular sieves when necessary.
1H and 13C NMR spectra were recorded on a Bruker AVII-700 MHz, AVIII HD-500
MHz, AVIII HD-400 MHz, AVIII HD-300 MHz or AV-300 MHz Fourier transform
spectrometer, at room temperature unless stated otherwise. Chemical shifts are quoted
in parts per million (ppm) downfield from tetramethylsilane. Solvents were used as an
internal standard when assigning NMR spectra (δH: CDCl3 7.26 ppm, CD3OD 3.31
ppm, (CD3)2SO 2.50 ppm, D2O 4.79 ppm; δC: CDCl3 77.1 ppm, CD3OD 49.0 ppm,
(CD3)2SO 39.5 ppm). Coupling constants (J) are quoted in Hertz (Hz) and rounded to
the nearest 0.5 Hz. Abbreviations used in the descriptions of spectra are as follows; s
= singlet, d = doublet, t = triplet, q = quartet, quin. = quintet, m = multiplet, br = broad.
13C NMR spectra were recorded with proton decoupling and the spectra were assigned
on the basis of COSY, PENDANT, HSQC and HMBC experiments.
Infrared spectra were recorded on a Bruker ALPHA platinum ATR spectrometer using
OPUS software and are quoted in wavenumbers (cm-1).
HPLC data were obtained on a Varian Prostar 335LC detector using a Chiralcel Daicel
AD-H column (4.6 mm x 250 mm), with a solvent system of n-hexane:2-propanol.
Melting points for solid crystalline products were determined using a Stuart Scientific
SMP10 Digital Melting Point Apparatus, with a range given in °C and rounded to the
nearest degree. The melting points are uncorrected.
Gas chromatography mass spectrometry (GC/MS) data was recorded on a Varian
3800-4000 GC-MS machine.
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Thin Layer Chromatography (TLC) was carried out using silica coated (0.25 mm)
alumina plates, and the plates were visualised using UV light or by staining with
KMnO4.
(R)-4,4,4-Trichloro-3-methylbutane-1,3-diol 473
To a solution of (R)-4-methyl-4-(trichloromethyl)oxetan-2-one 171 (0.221 g, 1.02
mmol) in dry THF (5 mL) was added LiBH4 (66.0 mg, 3.00 mmol) at 0 °C under
nitrogen. The mixture was stirred at this temperature until the reaction was complete
by TLC, then quenched with water and filtered through celite with EtOAc. The solvent
was removed in vacuo to yield product as a white solid (0.204 g, 99%). The compound
was used without further purification. ν (cm-1); 3357 (br, O-H stretch), 1129 (C-O
stretch), 788 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 4.07-3.88 (2H, m, CH2OH),
3.49 (1H, s, OH), 2.47 (1H, dddd, J 15, 9.5, 4.5, 0.5, CHHCH2OH), 2.16 (1H, t, J 5,
OH), 2.09 (1H, ddd, J 15, 4.5, 3.5, CHHCH2OH), 1.68 (3H, s, CH3); 13C NMR (CDCl3,
125 MHz) δ 109.0 (CCl3), 83.5 (C(CH3)), 59.8 (CH2OH), 37.1 (CH2CH2OH), 22.6
(CH3); m.p = 64-65 °C; [α]D 25 -7.5 (c 1, CHCl3).
(R)-1,1,1-Trichloro-2-methyl-4-((triisopropylsilyl)oxy)butan-2-ol 474
To a solution of (R)-4,4,4-trichloro-3-methylbutane-1,3-diol 473 (0.204 g, 0.990
mmol) in DMF (2 mL) was added imidazole (0.135 g, 1.98 mmol) and triisopropylsilyl
chloride (0.250 mL, 1.19 mmol) under nitrogen, and the solution was stirred at room
temperature overnight. The reaction was quenched with saturated NaHCO3 (aq.) and
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extracted with CH2Cl2. The combined organic fractions were washed with pH 2 buffer,
water and brine and dried over Na2SO4. The solvent was removed in vacuo and the
residue was purified by column chromatography (40:1 petroleum ether/Et2O) to yield
product as a colourless oil (0.212 g, 59%). ν (cm-1); 3434 (br, O-H stretch), 2925 (C-
H stretch), 1106 (C-O stretch), 1085 (Si-O stretch), 797 (C-Cl stretch); 1H NMR
(CDCl3, 500 MHz) δ 4.99 (1H, s, OH), 4.14-4.04 (2H, m, CH2OSi), 2.48 (1H, ddd, J
14.5, 10, 4.5, CHHCH2OSi), 2.01 (1H, ddd, J 14.5, 4, 3, CHHCH2OSi), 1.66 (3H, s,
OC(CH3)), 1.19-1.06 (21H, m, Si(CH(CH3)2)3); 13C NMR (CDCl3, 125 MHz) δ 109.2 
(CCl3), 83.0 (OC(CH3)), 60.9 (CH2OSi), 37.1 (CH2CH2OSi), 27.8 (OC(CH3)), 18.1
(SiCHCH3), 11.8 (SiCHCH3); HRMS (ESI) m/z: calcd. for C14H2935Cl3NaO2Si
[M+Na]+ 385.0895, found 385.0892; [α]D 25 -20.7 (c 1.98, CHCl3).
(R)-2-Methyl-4-((triisopropylsilyl)oxy)butan-1-ol 475
To a solution of (R)-1,1,1-trichloro-2-methyl-4-((triisopropylsilyl)oxy)butan-2-ol 474
(0.210 g, 0.580 mmol) in dry propan-2-ol (2 mL) was added LiBH4 (51.0 mg, 2.32
mmol) and freshly powdered NaOH (70.0 mg, 1.74 mmol) under nitrogen. The
mixture was stirred at 40 °C until the reaction was complete by TLC (17 h), when it
was quenched with saturated NH4Cl (aq.) (5 mL). The aqueous phase was saturated
with solid NaCl and extracted with EtOAc. The combined organic fractions were dried
over Na2SO4 and the solvent was removed in vacuo. The residue was purified by
column chromatography (9:1 petroleum ether/EtOAc) to yield product as a colourless
oil (97.0 mg, 64%). ν (cm-1); 3342 (br, O-H stretch), 2941 (C-H stretch), 1095 (Si-O
stretch), 678 (Si-O stretch); 1H NMR (CDCl3, 500 MHz) δ 3.88-3.81 (1H, m, 
CHHOSi), 3.78-3.71 (1H, m, CHHOSi), 3.57-3.49 (1H, m, CHHOH), 3.43 (1H, ddd,
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J 16, 5, 2, CHHOH), 3.09 (1H, dd, J 7.5, 5.5, OH), 1.88-1.78 (1H, m, CHCH3), 1.60-
1.55 (2H, m, CH2CH2OSi), 1.17-1.04 (21H, m, Si(CH(CH3)2)3), 0.92 (3H, d, J 7,
CHCH3); 13C NMR (CDCl3, 125 MHz) δ 68.4 (CH2OH), 62.2 (CH2OSi), 37.9
(CH2CH2OSi), 34.8 (CHCH3), 18.1 (SiCHCH3), 17.6 (CHCH3), 12.0 (SiCHCH3);
LRMS (ESI) m/z: calcd. for C14H32NaO2Si [M+Na]+ 283.5, found 283.2; [α]D 20 +3.4
(c 0.36, CHCl3). 1H and 13C NMR data are consistent with the previously reported data
for the (S) isomer.295
Ethyl 4,4,4-trichloro-3-hydroxy-3-methylbutanoate 481
To a solution of diisopropylamine (0.78 mL, 5.5 mmol) in dry THF (5 mL) was added
n-BuLi (2.0 mL, 2.5M, 5.0 mmol), at 0 °C under nitrogen. The solution was then
cooled to -78 °C and stirred for one hour, after which time EtOAc (0.49 mL, 5.0 mmol)
was added. The solution was stirred for a further one hour at -78 °C and 1,1,1-
trichloroacetone (0.67 mL, 6.0 mmol) was added. The reaction was quenched with
saturated NH4Cl (aq.) after 10 minutes and poured into water. The aqueous layer was
extracted with Et2O and the combined organic fractions were washed with water and
brine. After drying over Na2SO4 the solvent was removed in vacuo and the residue
was purified by column chromatography (9:1 petroleum ether/EtOAc), to yield
product as a yellow oil (0.820 g, 66%). ν (cm-1); 3466 (br, O-H stretch), 1711 (C=O
stretch), 1204 and 1026 (C-O stretch), 789 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz)
δ 4.65 (1H, s, OH), 4.23 (2H, q, J 7, CH2CH3), 3.14 (1H, d, J 15.5, CHHCO), 2.86
(1H, d, J 15.5, CHHCO), 1.71 (3H, s, OC(CH3)), 1.31 (3H, t, J 7, CH2CH3); 13C NMR
(CDCl3, 125 MHz) δ 171.8 (CO), 107.3 (CCl3), 81.2 (OC(CH3)), 61.6 (CH2O), 40.2
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(CH2CO), 23.5 (OC(CH3)), 14.1 (CH2CH3); HRMS (ESI) m/z: calcd. for
C7H1135Cl3NaO3 [M+Na]+ 270.9666, found 270.9674.
4,4,4-Trichloro-3-methylbutane-1,3-diol (±)-473
To a solution of ethyl 4,4,4-trichloro-3-hydroxy-3-methylbutanoate 481 (0.296 g, 1.19
mmol) in dry THF (5 mL) was added LiBH4 (52.0 mg, 2.38 mmol) under nitrogen at
0 °C. The mixture was stirred at this temperature until the reaction was complete by
TLC (four hours). The reaction was quenched with water (2 mL) and saturated
NaHCO3 (aq.) (3 mL), filtered through celite and the solvent was removed in vacuo.
The residue was purified by column chromatography (6:4 petroleum ether/EtOAc) to
yield product as a white solid (0.177 g, 72%). ν (cm-1); 3358 (br, O-H stretch), 1128
(C-O stretch), 793 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 4.06-3.94 (2H, m, 
CH2OH), 3.48 (1H, s, OH), 2.47 (1H, dddd, J 15, 9.5, 4.5, 0.5, CHHCH2OH), 2.15
(1H, dd, J 6, 4, OH), 2.09 (1H, dt, J 15, 4.5, CHHCH2OH), 1.68 (3H, s, CH3); 13C
NMR (CDCl3, 125 MHz) δ 108.9 (CCl3), 83.4 (C(CH3)), 59.7 (CH2OH), 37.0
(CH2CH2OH), 22.5 (CH3); m.p = 98-99 °C.
1,1,1-Trichloro-2-methyl-4-((triisopropylsilyl)oxy)butan-2-ol (±)-474
To a solution of 4,4,4-trichloro-3-methylbutane-1,3-diol (±)-473 (0.222 g, 1.07 mmol)
in DMF (2 mL) was added imidazole (0.146 g, 2.15 mmol) and triisopropylsilyl
chloride (0.270 mL, 1.28 mmol) under nitrogen, and the solution was stirred at room
temperature overnight. The reaction was quenched with saturated NaHCO3 (aq.) and
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extracted with CH2Cl2. The combined organic fractions were washed with pH 2 buffer,
water and brine and dried over Na2SO4. The solvent was removed in vacuo and the
residue was purified by column chromatography (40:1 petroleum ether/Et2O) to yield
product as a colourless oil (0.272 g, 70%). ν (cm-1); 3443 (br, O-H stretch), 2940 (C-
H stretch), 1110 (C-O stretch), 884 (Si-O stretch), 797 (C-Cl stretch); 1H NMR
(CDCl3, 500 MHz) δ 5.00 (1H, s, OH), 4.14-4.04 (2H, m, CH2OSi), 2.47 (1H, ddd, J
15, 10, 5, CHHCH2OSi), 2.01 (1H, dt, J 14.5, 3, CHHCH2OSi), 1.66 (3H, s, OC(CH3)),
1.89-1.01 (21H, m, Si(CH(CH3)2)3); 13C NMR (CDCl3, 125 MHz) δ 109.2 (CCl3), 83.0
(C(OH)), 60.9 (CH2OSi), 37.1 (CH2CH2OSi), 22.7 (OC(CH3)), 18.1 (SiCHCH3), 11.8
(SiCHCH3); HRMS (ESI) m/z: calcd. for C14H2935Cl3NaO2Si [M+Na]+ 385.0895,
found 385.0893.
2-Methyl-4-((triisopropylsilyl)oxy)butan-1-ol (±)-475
To a solution of 1,1,1-trichloro-2-methyl-4-((triisopropylsilyl)oxy)butan-2-ol (±)-474
(0.210 g, 0.580 mmol) in dry propan-2-ol (2 mL) was added LiBH4 (51.0 mg, 2.32
mmol) and freshly powdered NaOH (70.0 mg, 1.74 mmol) under nitrogen. The
mixture was stirred at 40 °C until the reaction was complete by TLC (17 h), when it
was quenched with saturated NH4Cl (aq.) (5 mL). The aqueous phase was saturated
with solid NaCl and extracted with EtOAc. The combined organic fractions were dried
over Na2SO4 and the solvent was removed in vacuo. The residue was purified by
column chromatography (9:1 petroleum ether/EtOAc) to yield product as a colourless
oil (0.103 g, 56%). %). ν (cm-1); 3327 (br, O-H stretch), 2941 (C-H stretch), 1096 (Si-
O stretch), 680 (Si-O stretch); 1H NMR (CDCl3, 500 MHz) δ 3.88-3.81 (1H, m, 
CHHOSi), 3.77-3.70 (1H, m, CHHOSi), 3.56-3.49 (1H, m, CHHOH), 3.46-3.40 (1H,
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m, CHHOH), 3.09 (1H, dd, J 7.5, 5.5, OH), 1.90-1.77 (1H, m, CHCH3), 1.60-1.55
(2H, m, CH2CH2OSi), 1.17-1.03 (21H, m, Si(CH(CH3)2)3), 0.92 (3H, d, J 7, CHCH3);
13C NMR (CDCl3, 125 MHz) δ 68.4 (CH2OH), 62.2 (CH2OSi), 37.9 (CH2CH2OSi),
34.8 (CHCH3), 18.1 (SiCHCH3), 17.6 (CHCH3), 12.0 (SiCHCH3); HRMS (ESI) m/z:
calcd. for C14H32NaO2Si [M+Na]+ 283.2064, found 283.2062.
(R)-2-Methyl-4-((triisopropylsilyl)oxy)butyl diphenylphosphinate 482
To a solution of (R)-2-methyl-4-((triisopropylsilyl)oxy)butan-1-ol 475 (85.0 mg,
0.327 mmol) in dry CHCl3 (3 mL) was added NEt3 (0.135 mL, 0.981 mmol), DMAP
(40.0 mg, 0.327 mmol) and diphenylphosphinic chloride (0.100 mL, 0.490 mmol)
under nitrogen. The mixture was stirred at room temperature until complete by TLC,
quenched with saturated NaHCO3 (aq.) and extracted with CH2Cl2. The combined
organic fractions were washed with saturated NaHCO3 (aq.), dried over Na2SO4 and
the solvent was removed in vacuo. The residue was purified by column
chromatography (1:1 petroleum ether/EtOAc) to yield product as a colourless oil
(0.120 g, 80%, 92% e.e.). ν (cm-1); 2940 (C-H stretch), 1430 (P-Ph stretch), 1228 (P=O
stretch), 1099 (Si-O stretch), 692 (Si-O stretch); 1H NMR (CDCl3, 500 MHz) δ 7.84-
7.77 (4H, m, Ph-H), 7.54-7.49 (2H, m, Ph-H), 7.47-7.41 (4H, m, Ph-H), 3.94-3.81
(2H, m, CH2OP), 3.77-3.67 (2H, m, CH2OSi), 2.13-2.02 (1H, m, CHCH3), 1.78-1.69
(1H, m, CHHCH2OSi), 1.46-1.36 (1H, m, CHHCH2OSi), 1.09-0.97 (24H, m,
Si(CH(CH3)2)3 and CHCH3); 13C NMR (CDCl3, 125 MHz) δ 132.2 (2 x Ph-Cpara),
131.8 (d, J 10, 4 x Ph-Cmeta), 131.8 (d, J 137, 2 x Ph-Cipso), 128.6 (d, J 13, 4 x Ph-
Cortho), 69.6 (d, J 6, CH2OP), 61.2 (CH2OSi), 36.4 (CH2CH2OSi), 31.1 (d, J 7,
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CHCH3), 18.2 (SiCHCH3), 16.8 (CHCH3), 12.1(SiCHCH3); HRMS (ESI) m/z: calcd.
for C26H41NaO3PSi [M+Na]+ 483.2455, found 483.2457; [α]D 25 -1.3 (c 1.3, CHCl3).
Enantiomeric excess was determined by chiral HPLC analysis (Daicel Chiracel AD-
H column, 2-propanol : hexane = 2 : 98, 1 mL/min, 226 nm, (S) isomer 32.49 min, (R)
isomer 36.84 min).
2-Methyl-4-((triisopropylsilyl)oxy)butyl diphenylphosphinate (±)-482
To a solution of 2-methyl-4-((triisopropylsilyl)oxy)butan-1-ol (±)-475 (90.0 mg,
0.346 mmol) in dry CHCl3 (3 mL) was added NEt3 (0.140 mL, 1.04 mmol), DMAP
(42.0 mg, 0.346 mmol) and diphenyl phosphinic chloride (93.7 µL, 0.490 mmol) under
nitrogen. The mixture was stirred at room temperature until complete by TLC,
quenched with saturated NaHCO3 (aq.) and extracted with CH2Cl2. The combined
organic fractions were washed with saturated NaHCO3 (aq.), dried over Na2SO4 and
the solvent was removed in vacuo. The residue was purified by column
chromatography (1:1 petroleum ether/EtOAc) to yield product as a colourless oil
(0.129 g, 81%). ν (cm-1); 2940 (C-H stretch), 1439 (P-Ph stretch), 1229 (P=O stretch),
1099 (Si-O stretch), 693 (Si-O stretch); 1H NMR (CDCl3, 500 MHz) δ 7.84-7.77 (4H, 
m, Ph-H), 7.54-7.49 (2H, m, Ph-H), 7.47-7.41 (4H, m, Ph-H), 3.94-3.81 (2H, m,
CH2OP), 3.77-3.68 (2H, m, CH2OSi), 2.13-2.02 (1H, m, CHCH3), 1.78-1.69 (1H, m,
CHHCH2OSi), 1.46-1.36 (1H, m, CHHCH2OSi), 1.11-0.97 (24H, m, Si(CH(CH3)2)3
and CHCH3); 13C NMR (CDCl3, 125 MHz) δ 132.2 (2 x Ph-Cpara), 131.8 (d, J 10, 4 x
Ph-Cmeta), 131.8 (d, J 137, 2 x Ph-Cipso), 128.6 (d, J 13, 4 x Ph-Cortho), 69.6 (d, J 6,
CH2OP), 61.2 (CH2OSi), 36.4 (CH2CH2OSi), 31.2 (d, J 7, CHCH3), 18.2 (SiCHCH3),
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16.8 (CHCH3), 12.1(SiCHCH3); HRMS (ESI) m/z: calcd. for C26H41NaO3Psi [M+Na]+
483.2455, found 483.2453.
(S)-4,4,4-Trichloro-3-methylbutane-1,3-diol 473
To a solution of (S)-4-methyl-4-(trichloromethyl)oxetan-2-one 171 (1.02 g, 5.02
mmol) in dry THF (25 mL) was added LiBH4 (0.331 g, 15.06 mmol) at 0 °C under
nitrogen, and stirred at this temperature until the reaction was complete by TLC. The
reaction was quenched with water and filtered through celite with EtOAc. The solvent
was removed in vacuo to yield product as a white solid (0.949 g, 92%). ν (cm-1); 3355
(br, O-H stretch), 1127 (C-O stretch), 788 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz)
δ 4.06-3.94 (2H, m, CH2OH), 3.50 (1H, s, OH), 2.47 (1H, ddd, J 14.5, 9.5, 4.5,
CHHCH2OH), 2.16 (1H, dd, J 6, 4, OH), 2.09 (1H, dt, J 14.5, 4, CHHCH2OH), 1.68
(3H, s, CH3); 13C NMR (CDCl3, 125 MHz) δ 109.1 (CCl3), 83.4 (C(CH3)), 59.7
(CH2OH), 37.0 (CH2CH2OH), 22.5 (CH3); m.p = 46-47 °C; [α]D 25 +9.7 (c 0.16,
CHCl3).
(S)-1,1,1-Trichloro-2-methyl-4-((triisopropylsilyl)oxy)butan-2-ol 474
To a solution of (S)-4,4,4-trichloro-3-methylbutane-1,3-diol 473 (1.89 g, 9.13 mmol)
in DMF (18 mL) was added imidazole (0.746 g, 11.0 mmol) and triisopropylsilyl
chloride (2.35 mL, 11.0 mmol) under nitrogen, and the solution was stirred at room
temperature overnight. The reaction was quenched with saturated NaHCO3 (aq.) and
extracted with CH2Cl2. The combined organic fractions were washed with pH 2 buffer,
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water and brine and dried over Na2SO4. The solvent was removed in vacuo and the
residue was purified by column chromatography (40:1 petroleum ether/Et2O) to yield
product as a colourless oil (2.50 g, 76%). ν (cm-1); 3445 (br, O-H stretch), 2942 (C-H
stretch), 1107 (C-O stretch), 881 (Si-O stretch), 794 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 4.99 (1H, s, OH), 4.14-4.04 (2H, m, CH2OSi), 2.48 (1H, ddd, J 14.5, 10.5,
4.5, CHHCH2OSi), 2.01 (1H, ddd, J 14.5, 3.5, 3, CHHCH2OSi), 1.66 (3H, s,
OC(CH3)), 1.89-1.01 (21H, m, Si(CH(CH3)2)3); 13C NMR (CDCl3, 125 MHz) δ 109.1 
(CCl3), 83.0 (C(OH)), 60.9 (CH2OSi), 37.1 (CH2CH2OSi), 22.7 (OC(CH3)), 18.1
(SiCHCH3), 11.8 (SiCHCH3); HRMS (ESI) m/z: calcd. for C14H2935Cl3NaO2Si
[M+Na]+ 385.0895, found 385.0898; [α]D 25 +27.6 (c 0.31, CHCl3).
(S)-2-Methyl-4-((triisopropylsilyl)oxy)butan-1-ol 475
To a solution of (S)-1,1,1-trichloro-2-methyl-4-((triisopropylsilyl)oxy)butan-2-ol 474
(1.64 g, 4.53 mmol) in dry propan-2-ol (20 mL) was added LiBH4 (0.400 g, 18.1
mmol) and freshly powdered NaOH (0.544 g, 13.6 mmol) under nitrogen. The mixture
was stirred at room temperature until the reaction was complete by TLC (16 h), when
it was quenched with saturated NH4Cl (aq.) (5 mL). The aqueous phase was saturated
with solid NaCl and extracted with EtOAc. The combined organic fractions were dried
over Na2SO4 and the solvent was removed in vacuo. The residue was purified by
column chromatography (9:1 petroleum ether/EtOAc) to yield product as a colourless
oil (0.630 g, 54%) after column chromatography (9:1 petroleum ether/EtOAc). ν (cm-
1); 3338 (br, O-H stretch), 2923 (C-H stretch), 1095 (C-O stretch), 881 (Si-O stretch);
1H NMR (CDCl3, 500 MHz) δ 3.84 (1H, dt, J 10.5, 5, CHHOSi), 3.74 (1H, dt, J 10.5,
6, CHHOSi), 3.53 (1H, ddd, J 11, 7.5, 4.5, CHHOH), 3.43 (1H, ddd, J 11, 7, 5,
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CHHOH), 3.08 (1H, dd, J 7.5, 5, OH), 1.89-1.78 (1H, m, CHCH3), 1.61-1.55 (2H, m,
CH2CH2OSi), 1.17-1.03 (21H, m, Si(CH(CH3)2)3), 0.93 (3H, d, J 7, CHCH3); 13C
NMR (CDCl3, 125 MHz) δ 68.4 (CH2OH), 62.2 (CH2OSi), 37.9 (CH2CH2OSi), 34.8
(CHCH3), 18.1 (SiCHCH3), 17.6 (CHCH3), 12.0 (SiCHCH3); HRMS (ESI) m/z: calcd.
for C14H32NaO2Si [M+Na]+ 283.2064, found 283.2062; [α]D 25 -7.0 (c 0.57, CHCl3).
Spectroscopic data are consistent with that previously reported.295
(S)-2-Methyl-4-((triisopropylsilyl)oxy)butyl diphenylphosphinate 482
To a solution of (S)-2-methyl-4-((triisopropylsilyl)oxy)butan-1-ol 475 (36.5 mg, 0.140
mmol) in dry CHCl3 (2 mL) was added NEt3 (58.0 µL, 1.04 mmol), DMAP (17.0 mg,
0.140 mmol) and diphenyl phosphinic chloride (40.0 µL, 0.211 mmol) under nitrogen.
The mixture was stirred at room temperature until complete by TLC, quenched with
saturated NaHCO3 (aq.) and extracted with CH2Cl2. The combined organic fractions
were washed with saturated NaHCO3 (aq.), dried over Na2SO4 and the solvent was
removed in vacuo. The residue was purified by column chromatography (1:1
petroleum ether/EtOAc) to yield product as a colourless oil (53.0 mg, 82%, ≥ 98% 
e.e.) after column chromatography (7:3 petroleum ether/EtOAc). ν (cm-1); 2940 (C-H
stretch), 1438 (P-Ph stretch), 1229 (P=O stretch), 1099 (Si-O stretch), 690 (Si-O
stretch); 1H NMR (CDCl3, 500 MHz) δ 7.85-7.76 (4H, m, Ph-H), 7.54-7.48 (2H, m, 
Ph-H), 7.47-7.71 (4H, m, Ph-H), 3.91 (1H, dt, J 9.5, 5.5, CHHOP), 3.85 (1H, dt, J 9.5,
6, CHHOP), 3.76-3.68 (2H, m, CH2OSi), 2.13-2.03 (1H, m, CHCH3), 1.78-1.69 (1H,
m, CHHCH2OSi), 1.45-1.36 (1H, m, CHHCH2OSi), 1.10-0.96 (24H, m, -
Si(CH(CH3)2)3) and CHCH3); 13C NMR (CDCl3, 125 MHz) δ 132.2 (2 x Ar-Cpara),
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131.8 (d, J 10, 4 x Ar-Cmeta), 131.8 (d, J 137, 2 x Ar-Cipso), 128.6 (d, J 13, 4 x Ar-
Cortho), 69.6 (CH2OP), 61.2 (CH2OSi), 36.4 (CH2CH2OSi), 31.2 (CHCH3), 18.2
(SiCHCH3), 16.8 (CHCH3), 12.1 (SiCHCH3); HRMS (ESI) m/z: calcd. for
C26H41NaO3PSi [M+Na]+ 483.2455, found 483.2459; [α]D 25 +2.1 (c 0.52, CHCl3).
Enantiomeric excess was determined by chiral HPLC analysis (Daicel Chiracel AD-
H column, 2-propanol : hexane = 2 : 98, 1 mL/min, 226 nm, (S) isomer 33.81 min, (R)
isomer 38.80 min).
(S)-(4-Iodo-3-methylbutoxy)triisopropylsilane 488
To a solution of imidazole (48.0 mg, 0.703 mmol) and PPh3 (0.175 g, 0.670 mmol) in
CH2Cl2 (2 mL) was added I2 (0.179 g, 0.703 mmol) at 0 °C and the mixture was stirred
at this temperature for 15 minutes. (S)-2-Methyl-4-((triisopropylsilyl)oxy)butan-1-ol
475 (0.145 g, 0.558 mmol) in CH2Cl2 (1 mL) was then added dropwise and the mixture
was stirred at room temperature overnight. The reaction was quenched with saturated
Na2S2O3 (aq.), extracted with CH2Cl2 and the solvent was removed in vacuo.
Purification by column chromatography (100% petroleum ether) yielded product as
an orange oil (0.163 g, 81%). ν (cm-1); 2918 (C-H stretch), 1102 (Si-O stretch), 881
(Si-O stretch), 657 (C-I stretch); 1H NMR (CDCl3, 500 MHz) δ 3.77-3.68 (2H, m, 
CH2OSi), 3.30 (1H, dd, J 9.5, 4.5, CHHI), 3.22 (1H, dd, J 9.5, 6, CHHI), 1.73-1.66
(1H, m, CHCH3), 1.66-1.58 (1H, m, CHHCH2OSi), 1.49-1.41 (1H, m, CHHCH2OSi),
1.13-1.02 (21H, m, Si(CH(CH3)2)3), 1.00 (3H, d, J 6.5, CHCH3); 13C NMR (CDCl3,
125 MHz) δ 61.1 (CH2OSi), 39.5 (CH2CH2OSi), 31.5 (CHCH3), 20.9 (CHCH3), 18.5
(CH2I), 18.2 (SiCHCH3), 12.1 (SiCHCH3); HRMS (ESI) m/z: calcd. for C14H31INaOSi
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[M+Na]+ 393.1081, found 393.1067; [α]D 25 +6.7 (c 0.39, CHCl3). This compound was
reported previously but without spectroscopic data.466
(R)-Dihydrocitronellol 487
To a mixture of (S)-(4-iodo-3-methylbutoxy)triisopropylsilane 488 (0.486 g, 1.35
mmol), CuCl2 (5.50 mg, 0.0405 mmol) and 1-phenyl-1-propyne (26.0 µL, 0.205
mmol) in THF (4.5 mL) was added i-pentylmagnesium bromide 486 (1.37 mL, 2M in
THF, 2.74 mmol) at 0 °C. The reaction was stirred for two hours at this temperature
then quenched with saturated NH4Cl (aq.). The mixture was extracted with Et2O, dried
over Na2SO4 and the solvent was removed in vacuo. To a solution of this crude product
in THF (1.8 mL) was added TBAF (2.00 mL, 1M in THF, 2.00 mmol) at 0 °C under
nitrogen, then stirred at room temperature for three hours. The reaction was quenched
with ice water, extracted with Et2O, dried over Na2SO4 and the solvent was removed
in vacuo. The residue was purified by column chromatography (9:1 petroleum
ether/EtOAc) to yield product as a colourless oil (0.144 g, 68%). ν (cm-1); 3333 (br,
O-H stretch), 2924 (C-H stretch), 1052 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 
3.74-3.61 (2H, m, CH2OH), 1.65-1.06 (10H, m, CH2CH(CH2)3CH), 0.94-0.81 (9H,
overlapping d’s, CH3CH); 13C NMR (CDCl3, 125 MHz) δ 61.4 (CH2OH), 40.1, 39.4,
37.5 (CH2), 29.6, 28.1 (CH), 24.8 (CH2), 22.8, 22.7, 19.8 (CH3); GC/MS (CI, NH3):
176.1 [M+NH4]+. The spectroscopic data are consistent with that previously
reported.450, 467
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(R,R)-Hexahydrofarnesol 32
To a solution of (R)-dihydrocitronellol 487 (0.128 g, 0.810 mmol) in CH2Cl2 (8 mL)
was added PPh3 (0.255 g, 0.972 mmol), and the mixture was cooled to 0 °C. N-
bromosuccinimide (0.160 g, 0.899 mmol) was then added in portions over a period of
30 minutes, at 0 °C. The reaction was stirred for a further 20 minutes at room
temperature, then the solvent was removed under a flow of nitrogen. The residue was
passed through a short plug of silica eluting with n-pentane, to yield (R)-1-bromo-3,7-
dimethyloctane 489 (0.160 g, 89%) as a colourless oil. This compound was used
immediately in the next step. A solution of bromide 489 (0.136 g, 0.615 mmol) in dry
THF (0.5 mL) was added to magnesium turnings (22.0 mg, 0.923 mmol) in THF (0.5
mL), and the mixture was stirred at room temperature for 30 minutes then at reflux
temperature for two hours. A solution of this Grignard reagent 490 was then added to
a solution of iodide (S)-488 (0.111 g, 0.308 mmol), CuCl2 (4.00 mg, 0.0308 mmol)
and 1-phenyl-1-propyne (5.70 µL, 0.0462 mmol) in dry THF (1.5 mL), at 0 °C. The
resultant solution was stirred at 0 °C for 30 minutes then at room temperature for a
further two hours. The reaction was quenched with saturated NH4Cl (aq.), extracted
with Et2O, dried over Na2SO4 and the solvent was removed in vacuo. The protected
alcohol 491 was used directly in the next step as a crude material. To a solution of 491
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in THF (0.7 mL) was added TBAF (1M, 0.616 mL, 0.616 mmol) at 0 °C, under
nitrogen. The solution was warmed to room temperature and stirred until the reaction
was complete by TLC (three hours). The reaction was quenched with cold water,
extracted with Et2O, dried over Na2SO4 and the solvent was removed in vacuo. The
crude residue was purified by column chromatography (100% petroleum ether to 9:1
petroleum ether/EtOac to 85:15) to yield (R,R)-hexahydrofarnesol 32 as a colourless
oil (9 mg, 13% from iodide (S)-488). The title compound was inseparable from
impurities. Only 1H NMR and GC/MS (EI) data were obtained. 1H NMR (500 MHz,
CDCl3) 3.76-3.59 (2H, m, CH2OH), 1.67-0.99 (18H, m, CH2 and CH), 0.94-0.79 (12H,
m, CH3CH); GC/MS (EI): 210.0 [M-H2O]+. The 1H NMR data are consistent with that
previously reported.450
Preparation of lithium hexamethyldisilazide (LiHMDS)
A solution of 1M LiHMDS can be prepared by the following procedure. A solution of
hexamethyldisilazane (HMDS) (0.23 mL, 1.1 mmol) in dry THF (0.37 mL) was placed
under nitrogen and cooled to -78 °C. n-BuLi (2.5M in THF, 1.00 mmol, 0.40 mL) was
then added dropwise, and the solution was stirred at -78 °C for 30 minutes. After this
time the LiHMDS was used in the reactions shown below.
Synthesis of Trichloromethyl Carbinols: General Procedure 1
To a solution of ketone (1.00 equiv.) and dry CHCl3 (2.50 equiv.) in dry THF (4
mL/mmol ketone), was added freshly prepared LiHMDS (1.00 M in THF, 2.20 equiv.)
dropwise at -78 °C, under nitrogen. The mixture was stirred at -78 °C for one hour
then quenched with saturated NH4Cl (aq.). The product was extracted with Et2O, the
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combined organic fractions were washed with water and brine, dried over Na2SO4 and
the solvent was removed in vacuo. The residue was purified by column
chromatography (petroleum ether/EtOAc).
Synthesis of Trichloromethyl Carbinols: General Procedure 2
To a solution of ketone (1.00 equiv.) in dry CHCl3 (2.00 equiv.) was added DBU (1.00
equiv.) under nitrogen. The mixture was stirred at room temperature for 24 hours,
diluted with CH2Cl2 and washed with 1M HCl (aq.), water and brine. The solvent was
removed in vacuo and the residue was purified by column chromatography (petroleum
ether/EtOAc).
1,1,1-Trichloro-2,4-dimethylpentan-2-ol 505a
The compound was prepared according to General Procedure 1 (using 0.120 mL, 1.00
mmol 4-methylpentan-2-one 504a) to yield product as a yellow oil (0.138 g, 63%)
after column chromatography (95:5 petroleum ether/EtOAc). ν (cm-1); 3451 (br, O-H
stretch), 1131 (C-O stretch), 774 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 2.23 
(1H, s, OH), 1.98-1.88 (2H, m, CHHC(OH) and CH(CH3)2), 1.83-1.75 (1H, m,
CHHC(OH)), 1.60 (3H, s, OC(CH3)), 1.06 (3H, d, J 6.5, CH3CH), 1.01 (3H, d, J 6.5,
CH3CH); 13C NMR (CDCl3, 125 MHz) δ 110.6 (CCl3), 83.6 (C(OH)), 43.8 (CH2),
25.2, 25.1 (CH3CH), 23.9 (CH3CH), 21.5 (OC(CH3)); GC/MS (EI): 130.0, 132.0 [M-
Cl2H2O]+. This compound was previously reported without spectroscopic data.468
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1,1,1-Trichloro-2-methylheptan-2-ol 505b
The compound was prepared according to General Procedure 1 (using 0.290 mL, 2.00
mmol 2-heptanone 504b) to yield product as a colourless oil (0.429 g, 92%) after
column chromatography (95:5 petroleum ether/EtOAc). ν (cm-1); 3456 (br, O-H
stretch), 2925 (C-H stretch), 1139 (C-O stretch), 787 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 2.23 (1H, s, OH), 2.00-1.90 (2H, m, CH2C(OH)) 1.62-1.52 (1H, m,
CHHCH2C(OH)), 1.56 (3H, s, OC(CH3)), 1.50-1.40 (1H, m, CHHCH2C(OH)), 1.39-
1.29 (4H, m, CH2), 0.92 (3H, t, J 7, CH3CH2); 13C NMR (CDCl3, 125 MHz) δ 110.4 
(CCl3), 83.2 (C(OH)), 35.8 (CH2C(OH)), 32.3 (CH2), 24.2 (CH2CH2C(OH)), 22.8
(CH2), 21.3 (OC(CH3)), 14.2 (CH3CH2); GC/MS (EI): 143.2 [M-Cl2H2O]+. This
compound was previously reported without 1H and 13C NMR data.469, 470
1,1,1-Trichloro-2-methylnonan-2-ol 505c
The compound was prepared according to General Procedure 1 (using 0.35 mL, 2.00
mmol 2-nonanone 504c) to yield product as a colourless oil (0.376 g, 72%) after
column chromatography (95:5 petroleum ether/EtOAc). ν (cm-1); 3452 (br, O-H
stretch), 2955 (C-H stretch), 1139 (C-O stretch), 788 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 2.24 (1H, s, OH), 2.00-1.89 (2H, m, CH2C(OH)), 1.62-1.51 (1H, m,
CHHCH2C(OH)), 1.57 (3H, s, OC(CH3)), 1.49-1.39 (1H, m, CHHCH2C(OH)), 1.38-
1.22 (8H, m, CH2), 0.94-0.82 (3H, m, CH3CH2); 13C NMR (CDCl3, 125 MHz) δ 110.4 
(CCl3), 83.2 (C(OH)), 35.8 (CH2C(OH)), 31.9, 30.1, 29.4 (CH2), 24.5
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(CH2CH2C(OH)), 22.8 (CH2), 21.3 (OC(CH3)), 14.2 (CH3CH2); GC/MS (EI): 171.2
[M-Cl2H2O]+.
1,1,1-Trichloro-2-methyldecan-2-ol 505d
The compound was prepared according to General Procedure 1 (using 0.380 mL, 2.00
mmol 2-decanone 504d) to yield product as a colourless oil (0.380 g, 69%) after
column chromatography (95:5 petroleum ether/EtOAc). ν (cm-1); 3452 (br, O-H
stretch), 2924 (C-H stretch), 1105 (C-O stretch), 785 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 2.22 (1H, s, OH), 2.00-1.89 (2H, m, CH2C(OH)), 1.61-1.51 (1H, m,
CHHCH2C(OH)), 1.56 (3H, s, OC(CH3)), 1.49-1.39 (1H, m, CHHCH2C(OH)), 1.39-
1.22 (10H, m, CH2), 0.92-0.85 (3H, m, CH3CH2); 13C NMR (CDCl3, 125 MHz) δ 
110.4 (CCl3), 83.2 (C(OH)), 35.9 (CH2C(OH)), 32.0, 30.2, 29.7, 29.4 (CH2), 24.5
(CH2CH2C(OH)), 22.8 (CH2), 21.3 (OC(CH3)), 14.3 (CH3CH2); GC/MS (EI): 185.2
[M-Cl2H2O]+.
5-(Trichloromethyl)nonan-5-ol 505e
The compound was prepared according to General Procedure 1 (using 0.340 mL, 2.00
mmol 5-nonanone 504e) to yield product as a colourless oil (0.319 g, 61%) after
column chromatography (95:5 petroleum ether/EtOAc). ν (cm-1); 3473 (br, O-H
stretch), 2958 (C-H stretch), 1131 (C-O stretch), 776 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 2.26 (1H, s, OH), 2.05-1.87 (4H, m, CH2C(OH)), 1.52-1.42 (4H, m,
CH2CH2C(OH)), 1.41-1.31 (4H, m, CH3CH2), 0.95 (6H, t, J 7.5, CH3CH2); 13C NMR
(CDCl3, 125 MHz) δ 110.7 (CCl3), 83.9 (C(OH)), 35.2 (CH2C(OH)), 27.1
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(CH2CH2C(OH)), 23.6 (CH3CH2), 14.2 (CH3CH2); GC/MS (EI): 225 [M-37Cl]+, 189.2
[M-Cl2]+, 171.2 [M-Cl2H2O]+. This compound was previously reported without 1H or
13C NMR data.470
1-(Trichloromethyl)cyclopentan-1-ol 505f
The compound was prepared according to General Procedure 2 (using 0.890 mL, 10.0
mmol cyclopentanone 504f) to yield product as a white solid (0.872 g, 43%) after
column chromatography (9:1 petroleum ether/EtOAc). ν (cm-1); 3399 (br, O-H
stretch), 2964 (C-H stretch), 772 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 2.40 
(1H, s, OH), 2.39-2.30 (2H, m, CHHC(OH)), 2.00-1.90 (2H, m, CHHCH2C(OH)),
1.88-1.75 (4H, m, CHHC(OH) and CHHCH2C(OH)); 13C NMR (CDCl3, 125 MHz) δ 
107.5 (CCl3), 92.6 (C(OH)), 37.4 (CH2C(OH)), 25.6 (CH2CH2C(OH)); GC/MS (EI):
97 [M-Cl3]+; m.p = 35-36 °C. Spectroscopic data are consistent with that previously
reported.471
1-(Trichloromethyl)cyclohexan-1-ol 505g
The compound was prepared according to General Procedure 1 (using 0.210 mL, 2.00
mmol cyclohexanone 504g) to yield product as a white solid (0.241 g, 55%) after
column chromatography (92:8 petroleum ether/EtOAc). ν (cm-1); 3451 (br, O-H
stretch), 2936 (C-H stretch), 1159 (C-O stretch), 773 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 2.13-2.01 (3H, m, CHHC(OH) and OH), 1.90 (2H, td, J 13.5, 4,
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CHHC(OH)), 1.78-1.69 (3H, m, CHHCH2C(OH) and CHHCH2CH2), 1.63 (2H, qt, J
13, 3.5, CHHCH2C(OH)), 1.21-1.10 (1H, m, CHHCH2CH2); 13C NMR (CDCl3, 125
MHz) δ 110.5 (CCl3), 81.9 (C(OH)), 31.4 (CH2C(OH)), 25.1 (CH2CH2CH2), 22.0
(CH2CH2C(OH)); GC/MS (EI): 181.1 [M-35Cl]+, 163.2 [M-35ClH2O]+; m.p = 60-61
°C. Spectroscopic data are consistent with that previously reported.471
1-(Trichloromethyl)cyclooctan-1-ol 505h
The compound was prepared according to General Procedure 1 (using 0.252 g, 2.00
mmol cyclooctanone 504h) to yield product as a colourless oil (0.260 g, 53%) after
column chromatography (9:1 petroleum ether/Et2O). ν (cm-1); 3453 (br, O-H stretch),
2920 (C-H stretch), 1138 (C-O stretch), 757 (C-Cl stretch); 1H NMR (CDCl3, 500
MHz) δ 2.29-2.08 (4H, m, CH2C(OH)), 1.85-1.73 (4H, m, CH2CH2C(OH)), 1.72-1.59
(3H, m, CH2), 1.58-1.44 (3H, m, CH2); 13C NMR (CDCl3, 125 MHz) δ 111.4 (CCl3),
84.2 (C(OH)), 31.9 (CH2C(OH)), 27.8 (CH2), 24.6 (CH2), 22.4 (CH2CH2C(OH));
GC/MS (EI): 191.1 [M-37ClH2O]+, 155.2 [M-35Cl2H2O]+.
1-(Trichloromethyl)cyclododecan-1-ol 505i
The compound was prepared according to General Procedure 1 (using 0.354 g, 2.00
mmol cyclododecanone 504i) to yield product as a colourless oil (0.400 g, 67%) after
column chromatography (95:5 petroleum ether/EtOAc). ν (cm-1); 3453 (br, O-H
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stretch), 2927 (C-H stretch), 1067 (C-O stretch), 785 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 2.28 (1H, s, OH), 2.06-1.90 (4H, m, CH2C(OH)), 1.64-1.46 (4H, m,
CH2CH2C(OH)), 1.45-1.30 (14H, m, CH2); 13C NMR (CDCl3, 125 MHz) δ 109.9 
(CCl3), 84.8 (C(OH)), 31.6 (CH2C(OH)), 26.8 (CH2), 26.2 (CH2), 22.8 (CH2), 22.3
(CH2), 21.2 (CH2CH2C(OH)); GC/MS (EI): 229.3 [M-35Cl2]+.
Jocic Reaction: General Procedure 3
To a solution of trichloromethylcarbinol (1.00 equiv.) in dry propan-2-ol (4 mL/mmol
substrate) was added LiBH4 (4.00 equiv.) and NaOH (3.00 equiv.) under nitrogen, and
stirred for 16 hours at 40 °C. The reaction was quenched with saturated NH4Cl (aq.)
and brine was added. The product was extracted with EtOAc (5 x 10 mL), the
combined organic fractions were dried over Na2SO4 and the solvent was removed in
vacuo. The residue was purified by column chromatography (petroleum ether/EtOAc).
2,4-Dimethylpentan-1-ol 506a
The reaction was carried out according to General Procedure 3 (using 0.268 g, 1.22
mmol 1,1,1-trichloro-2,4-dimethylpentan-2-ol 505a) to yield crude product as a
colourless oil (20.0 mg, 14%). Integration of the peaks at 3.95-3.80 ppm472 (1H, m,
507-CHOH) and 3.45-3.33 ppm473 (1H, m, 506-CHHOH) in the 1H NMR spectrum
provided a ratio of 506:507 = 70:30. No further data were obtained for this crude
mixture.
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2-Methylheptan-1-ol 506b
The reaction was carried out according to General Procedure 3 (using 0.385 g, 1.65
mmol 1,1,1-trichloro-2-methylheptan-2-ol 505b) to yield crude product as a colourless
oil (0.147 g, 69%). Integration of the peaks at 3.88-3.73 ppm474 (1H, m, 507-CHOH)
and 3.47-3.36 ppm475 (1H, m, 506-CHHOH) in the 1H NMR spectrum provided a ratio
of 506:507 = 82:18. No further data were obtained for this crude mixture.
2-Methylnonan-1-ol 506c
The reaction was carried out according to General Procedure 3 (using 0.270 g, 1.03
mmol 1,1,1-trichloro-2-methylnonan-2-ol 505c) to yield crude product as a colourless
oil (97 mg, 65%). Integration of the peaks at 3.86-3.72 ppm476 (1H, m, 507-CHOH)
and 3.46-3.36 ppm (1H, m, 506-CHHOH) in the 1H NMR spectrum provided a ratio
of 506:507 = 77:23. No further data were obtained for this crude mixture.
2-Methyldecan-1-ol 506d
The reaction was carried out according to General Procedure 4 (using 0.140 g, 0.51
mmol 1,1,1-trichloro-2-methyldecan-2-ol 505d) to yield crude product as a colourless
oil (73.0 mg, 90%). Integration of the peaks at 3.86-3.75 ppm477 (1H, m, 507-CHOH)
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and 3.46-3.36 ppm478 (1H, m, 506-CHHOH) in the 1H NMR spectrum provided a ratio
of 506:507 = 82:18. No further data were obtained for this crude mixture.
2-Butylhexan-1-ol 506e
The reaction was carried out according to General Procedure 3 (using 0.266 g, 1.02
mmol 5-(trichloromethyl)nonan-5-ol 505e) to yield crude product as a colourless oil
(0.143 g, 90%). Integration of the peaks at 3.62-3.55 ppm479 (1H, m, 507-CHOH) and
3.53 ppm480 (2H, d, J 5.5, 506-CH2OH) provided an approximate ratio of 506:507 =
45:55 as the peaks were slightly overlapping. No further data were obtained for this
crude mixture.
Cyclopentylmethanol 506f
The reaction was carried out according to General Procedure 3 (using 98.0 mg, 0.484
mmol 1-(trichloromethyl)cyclopentan-1-ol 505f) to yield crude product as a colourless
oil (32.0 mg, 70%). Integration of the peaks at 4.37-4.30 ppm472 (1H, m, 507-CHOH)
and 3.51 ppm481 (2H, d, J 7, 506-CH2OH) provided a ratio of 506:507 = 95:5. No
further data were obtained for this crude mixture.
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Cyclohexylmethanol 506g
The reaction was carried out according to General Procedure 3 (using 0.190 g, 0.880
mmol 1-(trichloromethyl)cyclohexan-1-ol 505g) to yield crude product as a colourless
oil (85.0 mg, 76%). Integration of the relevant peaks at 3.67-3.54 ppm482 (1H, m, 507-
CHOH) and 3.44 ppm483 (2H, d, J 6, 506-CH2OH) provided a ratio of 506:507 = 73:17.
No further data were obtained for this crude mixture.
Cyclooctylmethanol 506h
The reaction was carried out according to General Procedure 3 (using 0.240 g, 0.980
mmol 1-(trichloromethyl)cyclooctan-1-ol 505h) to yield crude product as a colourless
oil (0.115 g, 82%). Integration of the relevant peaks at 3.85 ppm484 (1H, tt, J 8.5, 4,
507-CHOH) and 3.44-3.34478 (2H, m, 506-CH2OH) provided a ratio of 506:507 =
21:79. No further data were obtained for this crude mixture.
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Cyclododecylmethanol 506i
The reaction was carried out according to General Procedure 3 (using 0.342 g, 1.14
mmol 1-(trichloromethyl)cyclododecan-1-ol 505i) to yield crude product as a
colourless oil (0.214 g, 95%). Integration of the relevant peaks at 3.90-3.79 ppm485
(1H, m, 507-CHOH) and 3.49 ppm486 (2H, d, J 6, 506-CH2OH) provided a ratio of
506:507 = 66:34. The primary alcohol 506i could be separated cleanly (0.110 g, 49%)
by column chromatography (8:2 petroleum ether/EtOAc). ν (cm-1); 3329 (br, O-H
stretch), 2926 (C-H stretch), 1039 (C-O stretch); 1H NMR (CDCl3, 500 MHz) δ 3.49 
(2H, d, J 6.5, CH2OH), 1.69-1.62 (1H, m, CHCH2OH), 1.47-1.22 (22H, m, CH2); 13C
NMR (CDCl3, 125 MHz) δ 67.2 (CH2OH), 36.9 (CHCH2OH), 26.4, 24.5, 23.8, 23.6,
23.7, 22.2 (CH2); GC/MS (EI): 180.6 [M-H2O]+. Spectroscopic data are consistent
with that previously reported.486
General preparation of lithium diisopropylamide (LDA)
A 1M solution of LDA could be prepared using the following procedure. A solution
of diisopropylamine (0.16 mL, 1.1 mmol) in THF (0.44 mL) was placed under nitrogen
and cooled to -78 °C. n-BuLi (0.40 mL, 2.5M in THF, 1.00 mmol) was then added and
the solution was stirred at -78 °C for 30 minutes. After this time the LDA was used in
the reactions shown below.
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Dichloromethyllithium Addition: General Procedure 4
To a solution of ketone (1.0 equiv.) in dry CH2Cl2 (2 mL/mmol ketone) was added
freshly prepared LDA (2.0 equiv., 1M in THF) at -78 °C, under nitrogen. The reaction
was stirred for 30 minutes at this temperature unless specified otherwise, then
quenched with saturated NH4Cl (aq.) (3 mL). The product was extracted with Et2O
and the combined organic fractions were washed successively with pH 2 buffer and
water, then dried over Na2SO4. The solvent was removed in vacuo and the crude
product was purified by column chromatography where necessary.
1,1-Dichloro-2-methylheptan-2-ol 542a
The compound was prepared according to General Procedure 4 (using 0.140 mL, 1.00
mmol 2-heptanone 541a) to yield product as a yellow oil (0.176 g, 88%). ν (cm-1);
3437 (br, O-H stretch), 2955 (C-H stretch), 1155 (C-O stretch), 772 (C-Cl stretch); 1H
NMR (CDCl3, 500 MHz) δ 5.68 (1H, s, CHCl2), 2.04 (1H, s, OH), 1.77-1.63 (2H, m,
CH2C(OH)), 1.45-1.38 (2H, m, CH2CH2C(OH)), 1.38 (3H, s, OC(CH3)), 1.37-1.24
(4H, m, CH2), 0.90 (3H, t, J 7, CH3CH2); 13C NMR (CDCl3, 125 MHz) δ 81.0 (CHCl2),
76.6 (C(OH)), 37.5 (CH2C(OH)), 32.3 (CH3CH2), 23.0, 22.7 (CH2), 22.1 (OC(CH3)),
14.1 (CH3CH2); GC/MS (EI): 163.2, 165.2 [M-Cl]+, 145.1, 147.1 [M-ClH2O]+, 127.1
[M-Cl2]+, 109.2 [M-Cl2H2O]+.
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1,1-Dichloro-2-methylnonan-2-ol 542b
The compound was prepared according to General Procedure 4 (using 0.170 mL, 1.00
mmol 2-nonanone 541b) to yield product as a colourless oil (0.206 g, 91%). ν (cm-1);
3400 (br, O-H stretch), 2925 (C-H stretch), 1145 (C-O stretch), 772 (C-Cl stretch); 1H
NMR (CDCl3, 500 MHz) δ 5.68 (1H, s, CHCl2), 2.05 (1H, s, OH), 1.77-1.63 (2H, m,
CH2C(OH)), 1.44-1.37 (2H, m, CH2CH2C(OH)), 1.37 (3H, s, OC(CH3)), 1.35-1.23
(8H, m, CH2), 0.88 (3H, t, J 7, CH3CH2); 13C NMR (CDCl3, 125 MHz) δ 81.0 (CHCl2),
76.5 (C(OH)), 37.5 (CH2C(OH)), 31.9 (CH3CH2), 30.1, 29.3, 23.3, 22.8 (CH2), 22.1
(OC(CH3)), 14.2 (CH3CH2); GC/MS (EI): 191.1, 193.1 [M-Cl]+, 137.1
[M-Cl2H2O]+.
1,1-Dichloro-2-methyldecan-2-ol 542c
The compound was prepared according to General Procedure 4 (using 0.190 mL, 1.00
mmol 2-decanone 541c) to yield product as a colourless oil (0.226 g, 94%). ν (cm-1);
3437 (br, O-H stretch), 2924 (C-H stretch), 1143 (C-O stretch), 773 (C-Cl stretch); 1H
NMR (CDCl3, 500 MHz) δ 5.68 (1H, s, CHCl2), 2.04 (1H, s, OH), 1.77-1.63 (2H, m,
CH2C(OH)), 1.44-1.38 (2H, m, CH2CH2C(OH)), 1.38 (3H, s, OC(CH3)), 1.35-1.22
(12H, m, CH2), 0.88 (3H, t, J 7, CH3CH2); 13C NMR (CDCl3, 125 MHz) δ 81.0 
(CHCl2), 76.6 (C(OH)), 37.5 (CH2C(OH)), 32.0 (CH3CH2), 30.1, 29.6, 29.4, 23.3, 22.8
(CH2), 22.1 (OC(CH3)), 14.3 (CH3CH2); GC/MS (EI): 205.1, 207.1 [M-Cl]+, 169.1
[M-Cl2]+, 151 [M-Cl2H2O]+.
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1,1-Dichloro-2,3,3-trimethylbutan-2-ol 542d
The compound was prepared according to General Procedure 4 (using 0.120 mL, 1.00
mmol 3,3-dimethylbutan-2-one 541d) to yield product as a colourless oil (60.7 mg,
33%) after column chromatography (100% petroleum ether to 95:5 petroleum
ether/Et2O). ν (cm-1); 3585 (br, O-H stretch), 2959 (C-H stretch), 1110 (C-O stretch),
787 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 5.97 (1H, s, CHCl2), 2.11-2.06 (1H,
m, OH), 1.42 (3H, s, OC(CH3)), 1.10 (9H, s, C(CH3)3); 13C NMR (CDCl3, 125 MHz)
δ 79.8 (CHCl2), 79.3 (C(OH)), 38.3 (C(CH3)3), 26.9 (C(CH3)3), 17.3 (OC(CH3));
GC/MS (EI): 149.2, 150.9 [M-Cl]+, 131.0, 133.0 [M-ClH2O]+, 113.1 [M-Cl2]+, 95.2
[M-Cl2H2O]+. Spectroscopic data are consistent with that previously reported.487
1-(Dichloromethyl)cyclohexan-1-ol 542e
The compound was prepared according to General Procedure 4 (using 0.100 mL, 1.00
mmol cyclohexanone 541e) to yield product as a colourless oil (0.113 g, 62%) after
column chromatography (9:1 petroleum ether/Et2O). ν (cm-1); 3428 (br, O-H stretch),
2934 (C-H stretch), 1150 (C-O stretch), 751 (C-Cl stretch); 1H NMR (CDCl3, 500
MHz) δ 5.62 (1H, s, CHCl2), 1.89 (1H, s, OH), 1.82-1.73 (2H, m, CHHC(OH)), 1.71-
1.58 (7H, m, CHHC(OH) and CH2CH2C(OH) and CHHCH2CH2), 1.24-1.14 (1H, m,
CHHCH2CH2); 13C NMR (CDCl3, 125 MHz) δ 81.9 (CHCl2), 75.2 (C(OH)), 32.7
(CH2C(OH)), 25.5 (CH2CH2CH2), 21.6 (CH2CH2C(OH)); GC/MS (EI): 147.1, 149.1
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[M-Cl]+, 129.1, 131.1 [M-35ClH2O]+, 111.2 [M-Cl2]+, 93.3 [M-Cl2H2O]+.
Spectroscopic data are consistent with that previously reported.454, 471
1-(Dichloromethyl)cyclooctan-1-ol 542f
The compound was prepared according to General Procedure 4 (using 0.126 g, 1.00
mmol cyclooctanone 541f) to yield product as a colourless oil (0.118 g, 56%) after
column chromatography (85:15 petroleum ether/Et2O). ν (cm-1); 3440 (br, O-H
stretch), 2919 (C-H stretch), 1135 (C-O stretch), 751 (C-Cl stretch); 1H NMR (CDCl3,
500 MHz) δ 5.67 (1H, s, CHCl2), 2.01-1.93 (2H, m, CHHC(OH)), 1.88-1.81 (2H, m,
CHHC(OH)), 1.75-1.59 (7H, m, CH2), 1.48-1.36 (3H, m, CH2); 13C NMR (CDCl3,
125 MHz) δ 82.1 (CHCl2), 77.8 (C(OH)), 33.1 (CH2C(OH)), 28.1, 24.8, 22.0 (CH2);
GC/MS (EI): 175.1, 177.1 [M-Cl]+, 157.1, 159.1 [M-ClH2O]+, 139.1 [M-Cl2]+, 121.2
[M-Cl2H2O]+. This compound was previously reported without spectroscopic data.488
1-(Dichloromethyl)cyclododecan-1-ol 542g
The compound was prepared according to General Procedure 4 (using 0.182 g, 1.00
mmol cyclododecanone 541g) to yield product as a colourless oil (0.190 g, 71%) after
column chromatography (9:1 petroleum ether/Et2O). ν (cm-1); 3375 (br, O-H stretch),
2927 (C-H stretch), 1081 (C-O stretch), 744 (C-Cl stretch); 1H NMR (CDCl3, 500
MHz) δ 5.67 (1H, s, CHCl2), 1.95 (1H, s, OH), 1.89-1.80 (2H, m, CHHC(OH)), 1.63-
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1.56 (2H, m, CHHC(OH)), 1.52-1.22 (18H, m, CH2); 13C NMR (CDCl3, 125 MHz) δ 
81.3 (CHCl2), 78.7 (C(OH)), 32.0 (CH2C(OH)), 26.4, 26.1, 22.6, 22.1, 20.0 (CH2);
GC/MS (EI): 231.2, 233.2 [M-Cl]+, 211.3 [M-Cl2H2O]+, 195.3 [M-Cl2]+; m.p = 58-59
°C.
5-(Dichloromethyl)nonan-5-ol 542h
The compound was prepared according to General Procedure 4 (using 0.170 mL, 1.00
mmol 5-nonanone 541h) to yield product as a colourless oil (0.177 g, 78%) after
column chromatography (9:1 petroleum ether/Et2O). ν (cm-1); 3468 (br, O-H stretch),
2956 (C-H stretch), 1145 (C-O stretch), 771 (C-Cl stretch); 1H NMR (CDCl3, 500
MHz) δ 5.79 (1H, s, CHCl2), 1.90 (1H, s, OH), 1.78-1.66 (4H, m, CH2C(OH)), 1.39-
1.28 (8H, m, CH2CH2CH3), 0.93 (6H, t, J 7, CH3); 13C NMR (CDCl3, 125 MHz) δ 
80.5 (CHCl2), 77.8 (C(OH)), 34.8 (CH2C(OH)), 25.3, 23.3 (CH2), 14.1 (CH3); GC/MS
(EI): 191.2, 193.1 [M-Cl]+, 155.2 [M-Cl2]+, 137.4 [M-Cl2H2O]+.
cis-4-(tert-Butyl)-1-(dichloromethyl)cyclohexan-1-ol 542i
The compound was prepared according to General Procedure 4 (using 0.154 g, 1.00
mmol 4-tert-butylcyclohexanone 541i) to yield product as a white solid (0.106 g, 44%)
after column chromatography to separate the 1.6:1 mixture of diastereoisomers (8:2
petroleum ether/Et2O). ν (cm-1); 3501 (br, O-H stretch), 2957 (C-H stretch), 1017 (C-
O stretch), 747 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 5.59 (CHCl2), 1.90-1.82
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(2H, m, CHHC(OH)), 1.83 (1H, s, OH), 1.72-1.66 (2H, m, CHHCH), 1.64-1.56 (2H,
m, CHHC(OH)), 1.44-1.34 (2H, m, CHHCH), 1.00-0.93 (1H, m, CHC(CH3)3), 0.88
(9H, s, C(CH3)3); 13C NMR (CDCl3, 125 MHz) δ 82.0 (CHCl2), 74.9 (C(OH)), 47.6
(CHC(CH3)3), 33.0 (CH2C(OH)), 32.5 (C(CH3)3), 27.7 (C(CH3)3), 22.4 (CH2CH);
GC/MS (EI): 185.2, 187.2 [M-ClH2O]+, 167.1 [M-Cl2]+, 149.3 [M-Cl2H2O]+; m.p =
60-61 °C.
trans-4-(tert-Butyl)-1-(dichloromethyl)cyclohexan-1-ol 542i
The compound was isolated from the same reaction mixture as above, to yield product
as a white solid (61 mg, 26%) after column chromatography to separate the
diastereoisomers (8:2 petroleum ether/Et2O). ν (cm-1); 3490 (br, O-H stretch), 2962
(C-H stretch), 1075 (C-O stretch), 755 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 
6.08 (1H, s, CHCl2), 2.28-2.18 (2H, m, CHHC(OH)), 1.80-1.73 (2H, m, CHHCH),
1.60-1.52 (2H, m, CHHC(OH)), 1.16-1.08 (1H, m, CHC(CH3)3), 1.04-0.94 (2H, m,
CHHCH), 0.87 (9H, s, C(CH3)3); 13C NMR (CDCl3, 125 MHz) δ 78.9 (CHCl2), 74.8
(C(OH)), 47.2 (CHC(CH3)3), 36.0 (CH2C(OH)), 32.4 (C(CH3)3), 27.8 (C(CH3)3), 23.7
(CH2CH); GC/MS (EI): 185.2, 187.2 [M-ClH2O]+, 167.1 [M-Cl2]+, 149.3 [M-
Cl2H2O]+; m.p = 97-98 °C.
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1-(Dichloromethyl)-2-methylcyclohexan-1-ol 542j
The compound was prepared according to General Procedure 4 (using 0.120 mL, 1.00
mmol 2-methylcyclohexanone 541j) to yield product as a white solid (0.139 g, 71%,
inseparable 5.8:1 mixture of diastereoisomers) after column chromatography (9:1
petroleum ether/Et2O). ν (cm-1); 3475 (br, O-H stretch), 2934 (C-H stretch), 1146 (C-
O stretch), 737 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ major diastereoisomer:
5.91 (1H, s, CHCl2), 2.00-1.86 (2H, m, CHHC(OH) and CHCH3), 1.76-1.19 (7H, m,
CHHC(OH) and CH2), 0.90 (3H, d, J 7, CHCH3); minor diastereoisomer: 5.72 (1H, s,
CHCl2), 2.15-2.09 (1H, m, CHCH3), 2.00-1.86 (1H, m, CHHC(OH)), 1.76-1.19 (7H,
m, CHHC(OH) and CH2), 0.90 (3H, d, J 7, CHCH3); 13C NMR (CDCl3, 125 MHz) δ 
major diastereoisomer: 79.8 (CHCl2), 76.6 (C(OH)), 35.9 (CHCH3), 30.7, 29.2, 25.6,
20.9 (CH2), 14.2 (CHCH3); minor diastereoisomer: 81.7 (CHCl2), 76.6 (C(OH)), 35.6
(CHCH3), 29.6, 28.9, 21.5, 19.2 (CH2), 14.7 (CHCH3); GC/MS (EI): 161.2, 163.1 [M-
Cl]+, 143.1, 145.1 [M-ClH2O]+, 126.1 [M-Cl2]+.
cis-2-(Dichloromethyl)-[1,1'-bi(cyclohexan)]-2-ol 542k
The compound was prepared according to General Procedure 4 (using 0.190 mL, 1.00
mmol 2-cyclohexylcyclohexanone 541k) to yield product as a colourless oil (145 mg,
55%) after column chromatography to separate the 11:1 mixture of diastereoisomers
(40:1 petroleum ether/Et2O). ν (cm-1); 3577 (br, O-H stretch), 2922 (C-H stretch), 1139
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(C-O stretch), 788 (C-Cl stretch); 1H NMR (CDCl3, 500 MHz) δ 6.09 (1H, s, CHCl2),
1.97-1.84 (2H, m, CH2C(OH)), 1.82-0.94 (18H, m, CH2 and CH); 13C NMR (CDCl3,
125 MHz) δ 80.5 (CHCl2), 78.7 (C(OH)), 46.9 (CHC(OH)), 37.0 (CHCHC(OH)), 33.1
(CH2), 30.7 (CH2C(OH)), 28.8, 27.5, 27.0, 26.6, 26.4, 22.7, 21.2 (CH2); GC/MS (EI):
211.2, 213.0 [M-ClH2O]+, 176.4 [M-Cl2H2O]+. Data shown is for the major cis-
diastereoisomer only, the minor trans diastereoisomer could not be isolated cleanly.
1,1-Dichloro-2-cyclohexylpropan-2-ol 542l
The compound was prepared according to General Procedure 4 (using 0.140 mL, 1.00
mmol 1-cyclohexylethan-1-one 541l) to yield product as a colourless oil (0.166 g,
79%) after column chromatography (9:1 petroleum ether/Et2O). ν (cm-1); 3468 (br, O-
H stretch), 2929 (C-H stretch), 1067 (C-O stretch), 757 (C-Cl stretch); 1H NMR
(CDCl3, 500 MHz) δ 5.85 (CHCl2), 1.93 (1H, s, OH), 1.88-1.74 (4H, m, CH and CH2),
1.73-1.64 (2H, m, CH2), 1.32 (3H, s, CH3), 1.30-1.07 (5H, m, CH2); 13C NMR (CDCl3,
125 MHz) δ 80.3 (CHCl2), 77.9 (C(OH)), 44.2 (CHC(OH)), 27.5, 26.6, 26.5, 26.4
(CH2), 19.5 (CH3), one carbon missing due to overlapping peaks; GC/MS (EI): 211.2,
213.1 [M+H]+, 192.0, 194.1 [M-H2O]+, 157.2, 159.2 [M-ClH2O]+.
(5R)-1-(Dichloromethyl)-5-methyl-2-(propan-2-ylidene)cyclohexan-1-ol 542n
The compound was prepared according to General Procedure 4 (using 0.160 mL, 1.00
mmol (R)-pulegone 541n) to yield product as a yellow oil (0.162 g, 69%) after column
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chromatography to separate the 13.3:1 mixture of diastereoisomers (95:5 petroleum
ether/Et2O). ν (cm-1); 3569 (br, O-H stretch), 2952 (C-H stretch), 777 (C-Cl stretch);
1H NMR (CDCl3, 500 MHz) δ 6.22 (1H, s, CHCl2), 2.82-2.74 (1H, m, CHHCH2), 2.29
(1H, s, OH), 2.19-2.13 (1H, m, CHHC(OH)), 2.08 (3H, s, C=C(CH3)), 1.78-1.71 (1H,
m, CHHCHCH3), 1.74 (3H, s, C=C(CH3)), 1.70-1.57 (2H, m, CHCH3, CHHCH2), 1.35
(1H, t, J 13, CHHC(OH)), 0.99-0.88 (1H, m, CHHCHCH3), 0.92 (3H, d, J 6.5,
CH3CH); 13C NMR (CDCl3, 125 MHz) δ 130.3 (C=C(CH3)2), 128.3 (C=C(CH3)2),
81.2 (C(OH)), 79.7 (CHCl2), 47.6 (CH2C(OH)), 35.0 (CH2CHCH3), 30.0 (CHCH3),
29.0 (CH2CH2CH), 24.3, 22.6 (C=C(CH3)2), 22.1 (CHCH3); GC/MS (EI): 236.4 [M]+,
165.2 [M-Cl2]+. Data shown is for the major diastereoisomer only, the minor
diastereoisomer could not be isolated cleanly. The configuration of the C-1 centre is
not known.
Jocic Reaction: General Procedure 5
To a solution of dichloromethylcarbinol (1.00 equiv.) in dry propan-2-ol (4 mL/mmol
substrate) was added LiBH4 (4.00 equiv.) and NaOH (3.00 equiv.) under nitrogen, and
stirred for 16 hours at room temperature. The reaction was quenched with saturated
NH4Cl (aq.) and brine was added. The product was extracted with EtOAc (5 x 10 mL),
the combined organic fractions were dried over Na2SO4 and the solvent was removed
in vacuo. The residue was purified by column chromatography (petroleum
ether/EtOAc).
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2-Methylheptan-1-ol 543a
The compound was prepared according to General Procedure 5 (using 0.109 g, 0.548
mmol 1,1-dichloro-2-methylheptan-2-ol 542a) to yield product as a colourless oil (21
mg, 30%) after column chromatography (7:3 petroleum ether/Et2O). ν (cm-1); 3347
(br, O-H stretch), 2925 (C-H stretch), 1032 (C-O stretch); 1H NMR (CDCl3, 500 MHz)
δ 3.54-3.39 (2H, m, CH2OH), 1.65-1.55 (1H, m, CHCH3), 1.44-1.21 (7H, m,
CHHCHCH3 and CH2), 1.15-1.05 (1H, m, CHHCHCH3), 0.91 (3H, d, J 6.5, CHCH3),
0.89 (3H, t, J 7, CH3CH2); 13C NMR (CDCl3, 125 MHz) δ 68.6 (CH2OH), 35.9
(CHCH3), 33.2 (CH2CHCH3), 32.3, 26.8, 22.8 (CH2), 16.8 (CHCH3), 14.2 (CH3CH2);
GC/MS (EI): 111.7 [M-H2O]+, 97.1 [C7H14]+, 83.1 [C6H12]+, 69.2 [C5H10]+.
Spectroscopic data are consistent with that previously reported.475
2-Methylnonan-1-ol 543b
The compound was prepared according to General Procedure 5 (using 0.148 g, 0.655
mmol 1,1-dichloro-2-methylnonan-2-ol 542b) to yield product as a colourless oil (72.0
mg, 75%) after column chromatography (7:3 petroleum ether/Et2O). ν (cm-1); 3315
(br, O-H stretch), 2922 (C-H stretch), 1036 (C-O stretch); 1H NMR (CDCl3, 500 MHz)
δ 3.51 (1H, dd, J 10.5, 5.5, CHHOH), 3.42 (1H, dd, J 10.5, 6.5, CHHOH), 1.65-1.51
(1H, m, CHCH3), 1.53-1.43 (11H, m, CHHCHCH3 and CH2), 1.15-1.03 (1H, m,
CHHCHCH3), 0.91 (3H, d, J 6.5, CHCH3), 0.88 (3H, t, J 6.5, CH3CH2); 13C NMR
(CDCl3, 125 MHz) δ 68.6 (CH2OH), 35.9 (CHCH3), 33.3 (CH2CHCH3), 32.0, 30.1,
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29.5, 27.2, 22.8 (CH2), 16.7 (CHCH3), 14.3 (CH3CH2); GC/MS (EI): 158.2 [M]+,
140.2 [M-H2O]+. Spectroscopic data are consistent with that previously reported.489
2-Methyldecan-1-ol 543c
The compound was prepared according to General Procedure 5 (using 0.121 g, 0.502
mmol 1,1-dichloro-2-methyldecan-2-ol 542c) to yield product as a colourless oil (58.0
mg, 66%) after column chromatography (7:3 petroleum ether/Et2O). ν (cm-1); 3328
(br, O-H stretch), 2921 (C-H stretch), 1036 (C-O stretch); 1H NMR (CDCl3, 500 MHz)
δ 3.51 (1H, dd, J 10.5, 6, CHHOH), 3.41 (1H, dd, J 10.5, 6.5, CHHOH), 1.65-1.54
(1H, m, CHCH3), 1.43-1.15 (13H, m, CHHCHCH3 and CH2), 1.14-1.05 (1H, m,
CHHCHCH3), 0.91 (3H, d, J 6.5, CHCH3), 0.88 (3H, t, J 6.5, CH3CH2); 13C NMR
(CDCl3, 125 MHz) δ 68.6 (CH2OH), 35.9 (CHCH3), 33.3 (CH2CHCH3), 32.0, 30.1,
29.8, 29.5, 27.1, 22.8 (CH2), 16.7 (CHCH3), 14.3 (CH3CH2); GC/MS (EI): 154.3 [M-
H2O]+, 125.0 [C9H18]+, 112.0 [C8H16]+, 98.0 [C7H14]+. Spectroscopic data are
consistent with that previously reported.490
Cyclohexylmethanol 543e
The compound was prepared according to General Procedure 5 (using 98.0 mg, 0.536
mmol 1-(dichloromethyl)cyclohexan-1-ol 542e) to yield product as a colourless oil
(19.0 mg, 31%) after column chromatography (6:4 petroleum ether/Et2O). ν (cm-1);
3330 (br, O-H stretch), 2919 (C-H stretch), 1023 (C-O stretch); 1H NMR (CDCl3, 500
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MHz) δ 3.44 (2H, d, J 6.5, CH2OH), 1.79-1.71 (4H, m, CHHCHCH2OH and
CHHCH2CH), 1.70-1.64 (1H, m, CHHCH2CH2), 1.53-1.42 (1H, m, CHCH2OH),
1.31-1.11 (3H, m, CHHCH2CH and CHHCH2CH2), 0.98-0.88 (2H, m,
CHHCHCH2OH); 13C NMR (CDCl3, 125 MHz) δ 69.0 (CH2OH), 40.6 (CH), 30.0
(CH2CH), 26.7 (CH2CH2CH2CH), 26.0 (CH2CH2CH); GC/MS (EI): 96.1 [M-H2O]+,
83.2 [C6H11]+. Spectroscopic data are consistent with that previously reported.491
Cyclooctylmethanol 543f
The reaction was carried out according to General Procedure 5 (using 0.103 g, 0.489
mmol 1-(dichloromethyl)cyclooctan-1-ol 524f) to yield a mixture of 543f and 548 as
a colourless oil (63.0 mg). Peaks at 5.68-5.55 ppm (1H, m, CH=CH2), 4.04 ppm (2H,
s, CH2OH) and 2.24-2.02 ppm (4H, m, allylic) in the crude 1H NMR spectrum suggest
the presence of 548 by comparison to the literature.492
Cyclododecylmethanol 543g
The reaction was carried out according to General Procedure 5 (using 0.138 g, 0.517
mmol 1-(dichloromethyl)cyclododecan-1-ol 542g) to yield a crude mixture as a
colourless oil (90.0 mg, 88%). Integration of the relevant peaks at 3.90-3.79 ppm485
(1H, m, 544-CHOH) and 3.49 ppm486 (2H, d, J 6, 543-CH2OH) provided a ratio of
543:544 = 96:4. Compound 543g could be isolated as a colourless oil (57.6 mg, 56%)
293
after column chromatography (7:3 petroleum ether/Et2O), and was fully characterised
previously.
2-Butylhexan-1-ol 543 h
The compound was prepared according to General Procedure 5 (using 0.111 g, 0.491
mmol 5-(dichloromethyl)decan-5-ol 542h) to yield product as a colourless oil (50.0
mg, 65%) after column chromatography (7:3 petroleum ether/Et2O). ν (cm-1); 3328
(br, O-H stretch), 2924 (C-H stretch), 1043 (C-O stretch); 1H NMR (CDCl3, 500 MHz)
δ 3.54 (2H, d, J 5.5, CH2OH), 1.49-1.41 (1H, m, CHCH2OH), 1.38-1.22 (12H, m,
CH2), 1.18 (1H, br s, OH), 0.90 (6H, t, J 6.5, CH3); 13C NMR (CDCl3, 125 MHz) δ 
65.9 (CH2OH), 40.7 (CHCH2OH), 30.8, 29.3, 23.3 (CH2), 14.2 (CH3); GC/MS (EI):
158.0 M+, 140.2 [M-H2O]+, 112.1 [C8H16]+, 98.0 [C7H14]+. Spectroscopic data are
consistent with that previously reported.480
cis-4-(tert-Butyl)cyclohexyl)methanol 543i
The compound was prepared according to General Procedure 4 (using 0.150 g, 0.628
mmol cis-4-(tert-butyl)-1-(dichloromethyl)cyclohexan-1-ol 542i) to yield product as
a white solid (61.0 mg, 26%) after column chromatography (8:2 petroleum
ether/Et2O). ν (cm-1); 3248 (br, O-H stretch), 2932 (C-H stretch), 1031 (C-O stretch);
1H NMR (CDCl3, 500 MHz) δ 3.67-3.61 (2H, m, CH2OH), 1.87-1.76 (3H, m,
CHCH2OH and CHHCHCH2OH), 1.57-1.51 (2H, m, CHHCHC(CH3)3), 1.50-1.41
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(2H, m, CHHCHCH2OH), 1.19-1.15 (1H, m, OH), 1.10-0.94 (3H, m, CHC(CH3)3 and
CHHCHC(CH3)3), 0.83 (9H, s, C(CH3)3); 13C NMR (CDCl3, 125 MHz) δ 63.9 
(CH2OH), 48.5 (CHC(CH3)3), 35.5 (CHCH2OH), 32.7 (C(CH3)3), 27.60 (C(CH3)3),
27.59 (CH2CHCH2OH), 22.2 (CH2CHC(CH3)3); GC/MS (EI): 170.3 [M]+; m.p = 62-
63 °C. Spectroscopic data are consistent with that previously reported.461, 462
trans-4-(tert-Butyl)cyclohexyl)methanol 543i
The compound was prepared according to General Procedure 4 (using 94.0 mg, 0.393
mmol trans-4-(tert-butyl)-1-(dichloromethyl)cyclohexan-1-ol 542i) to yield product
as a colourless oil (19.0 mg, 29%) after column chromatography (6:4 petroleum
ether/Et2O). ν (cm-1); 3324 (br, O-H stretch), 2938 (C-H stretch), 1033 (C-O stretch);
1H NMR (CDCl3, 500 MHz) δ 3.44 (2H, d, J 6.5, CH2OH), 1.87-1.76 (4H, m, CH2),
1.45-1.27 (1H, m, CHCH2OH), 1.27 (1H, br s, OH), 1.04-0.88 (5H, m, CH2 and
CHC(CH3)3), 0.84 (9H, s, C(CH3)3); 13C NMR (CDCl3, 125 MHz) δ 67.0 (CH2OH),
48.4 (CHC(CH3)3), 40.7 (CHCH2OH), 32.4 (C(CH3)3), 30.1 (CH2), 27.7 (C(CH3)3),
26.9 (CH2); GC/MS (EI): 152.1 [M-H2O]+, 113.1 [C7H13]+. Spectroscopic data are
consistent with that previously reported.461, 462
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(±)-cis-2-Methylcyclohexyl)methanol 543j
The compound was prepared according to General Procedure 4 (using 93.6 mg, 0.475
mmol 1-(dichloromethyl)-2-methylcyclohexan-1-ol 542j, 5.8:1 ratio of
diastereoisomers) to yield product as a colourless oil (36.0 mg, 59%) after column
chromatography to separate the 33:1 ratio of diastereoisomers (1:1 petroleum
ether/Et2O). ν (cm-1); 3313 (br, O-H stretch), 2920 (C-H stretch), 1030 (C-O stretch);
1H NMR (CDCl3, 500 MHz) δ 3.57-3.44 (2H, m, CH2OH), 2.00-1.91 (1H, m, CHCH3),
1.73-1.66 (1H, m, CHCH2OH), 1.65-1.12 (8H, m, CH2), 0.86 (3H, d, J 7, CH3); 13C
NMR (CDCl3, 125 MHz) δ 65.3 (CH2OH), 42.9 (CHCH3), 32.8 (CH2), 30.0
(CHCH2OH), 25.1, 24.5, 22.0 (CH2), 13.9 (CH3); GC/MS (EI): 128.2 [M]+, 110.1 [M-
H2O]+, 97.2 [C7H13]+, 82.2 [C6H10]+. This compound was previously reported in the
literature without 1H or 13C NMR data.493
(±)-cis-[1,1'-bi(Cyclohexan)]-2-yl)methanol 543k
The compound was prepared according to General Procedure 4 (using 0.145 g, 0.547
mmol cis-2-(dichloromethyl)-[1,1'-bi(cyclohexan)]-2-ol 542k) to yield product as a
white solid (42.0 mg, 39%) after column chromatography (7:3 petroleum ether/Et2O).
ν (cm-1); 3322 (br, O-H stretch), 2915 (C-H stretch), 1027 (C-O stretch); 1H NMR
(CDCl3, 500 MHz) δ 3.76-3.69 (2H, m, CH2OH), 2.08-2.00 (1H, m, CHCH2OH),
1.99-0.70 (20H, m, CH2 and CH); 13C NMR (CDCl3, 125 MHz) δ 59.9 (CH2OH), 45.4
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(CH), 39.2 (CH), 37.4 (CHCH2OH), 31.6, 30.8, 27.6, 27.0, 26.8, 26.65, 26.63, 25.5,
20.8 (CH2); GC/MS (EI): 178.2 [M-H2O]+, 165.2 [C12H22]+; m.p = 56-57 °C. This
compound was previously reported without 1H or 13C NMR data.463
2-Cyclohexylpropan-1-ol 543l
The compound was prepared according to General Procedure 4 (using 96.0 mg, 0.455
mmol 1,1-dichloro-2-cyclohexylpropan-2-ol 542l) to yield product as a colourless oil
(30.0 mg, 46%) after column chromatography (7:3 petroleum ether/Et2O). ν (cm-1);
3345 (br, O-H stretch), 2921 (C-H stretch), 1018 (C-O stretch); 1H NMR (CDCl3, 500
MHz) δ 3.65-3.58 (1H, m, CHHOH), 3.50-3.43 (1H, m, CHHOH), 1.78-1.60 (5H, m,
CH2), 1.54-1.44 (1H, m, CHCH3), 1.38-1.29 (1H, m, CHCHCH3), 1.27-0.93 (5H, m,
CH2), 0.89 (3H, d, J 7, CHCH3); 13C NMR (CDCl3, 125 MHz) δ 66.5 (CH2OH), 41.1
(CHCH2OH), 39.5 (CHCHCH3), 31.1, 29.0, 26.90, 26.85, 26.80 (CH2), 13.5 (CH3);
GC/MS (EI): 124.3 [M-H2O]+. Spectroscopic data are consistent with that previously
reported.494
2-Methylnonan-2-ol 549
To a solution of 2-decanone 541c (0.380 mL, 2.00 mmol) in dry Et2O (5 mL) was
added methylmagnesium bromide (2.00 mL, 3M in THF, 6.00 mmol) dropwise, at 0
°C. The mixture was heated at reflux temperature for two hours, then cooled to 0 °C
and quenched with saturated NH4Cl (aq.). The mixture was extracted with Et2O,
washed with water, dried over Na2SO4 and the solvent was removed in vacuo. The
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compound was a colourless oil (0.309 g, 90%) and was used without further
purification. ν (cm-1); 3361 (br, O-H stretch), 2925 (C-H stretch), 1150 (C-O stretch);
1H NMR (CDCl3, 500 MHz) δ 1.48-1.43 (2H, m, CH2C(OH)), 1.37-1.23 (12H, m,
CH2), 1.21 (6H, s, (CH3)2C(OH)), 0.88 (3H, t, J 6.5, CH3CH2); 13C NMR (CDCl3, 125
MHz) δ 71.2 (C(OH)), 44.2 (CH2C(OH)), 32.0, 30.3, 29.8, 29.4 (CH2), 29.3
((CH3)2C(OH)), 24.5, 22.8 (CH2), 14.3 (CH3CH2); GC/MS (EI): 173.1 [M+H]+, 157.1
[C10H21O]+, 153.9 [M-H2O]+. Spectroscopic data are consistent with that previously
reported.495
2-Heptyl-2-methyloxirane 550
A round-bottomed flask was charged with NaH (60% dispersion in mineral oil, 0.40
g, 10 mmol), and the NaH was washed with petroleum ether. Trimethylsulfoxonium
iodide (2.2 g, 10 mmol) was then added, followed by DMSO (5 mL), at 0 °C. The
mixture was stirred for 20 minutes at room temperature, then a solution of 2-decanone
541c (0.95 mL, 5.0 mmol) in DMSO (5 mL) was added. The reaction was stirred at
room temperature for a further 22 hours then cooled to 0 °C and water was added. The
mixture was extracted with 1:1 petroleum ether/Et2O, the combined organic fractions
were washed with water and brine, dried over Na2SO4 and the solvent was removed in
vacuo. The compound was a colourless oil (0.62 g, 73%) and was used without further
purification. ν (cm-1); 2923 (C-H stretch), 901, 798 (C-O stretch); 1H NMR (CDCl3,
500 MHz) δ 2.60 (1H, d, J 5, CHHO), 2.57 (1H, d, J 5, CHHO), 1.62-1.55 (1H, m,
CHHC(O)), 1.51-1.44 (1H, m, CHHC(O)), 1.42-1.34 (2H, m, CH2CH2C(O)), 1.32-
1.19 (10H, m, CH2), 1.30 (3H, s, CH3C(O)), 0.88 (3H, t, J 6.5, CH3CH2); 13C NMR
(CDCl3, 125 MHz) δ 57.2 (CO), 54.1 (CH2O), 36.9 (CH2C(O)), 32.0, 29.8, 29.7, 29.4
298
(CH2), 25.4 (CH2CH2C(O)), 22.8 (CH2), 21.0 (CH3C(O)), 14.2 (CH3CH2); GC/MS
(EI): 170.2 [M]+. Spectroscopic data are consistent with that previously reported.496
2-(4-Methoxyphenoxy)-2-methyldecanal 553
To a solution of 1,1-dichloro-2-methyldecan-2-ol 542c (0.241 g, 1.00 mmol) and 4-
methoxyphenol (0.472 g, 3.00 mmol) in dry 2-propanol (4 mL) was added TBD (1.12
g, 8.00 mmol), and the reaction was stirred at room temperature for 15 hours. Saturated
NH4Cl (aq.) was added and the mixture was extracted with EtOAc. The combined
organic fractions were washed with pH 2 buffer and water, dried over Na2SO4 and the
solvent was removed in vacuo. The residue was purified by column chromatography
(95:5 to 8:2 petroleum ether/EtOAc) to yield product as a colourless oil (0.147 g,
50%). ν (cm-1); 2924 (C-H stretch), 1734 (C=O stretch), 1505 (C=C stretch), 1214 (C-
O stretch), 841 (Ar-H bend); 1H NMR (CDCl3, 500 MHz) δ 9.85 (1H, s, CHO), 6.84-
6.76 (4H, m, Ph-H), 3.77 (3H, s, CH3O), 1.83-1.75 (1H, m, CHHC(CHO)), 1.73-1.65
(1H, m, CHHC(CHO)), 1.48-1.34 (2H, m, CH2CH2C(CHO)), 1.33-1.20 (10H, m,
CH2), 1.27 (3H, s, CH3C(CHO)), 0.88 (3H, t, J 6.5, CH3CH2); 13C NMR (CDCl3, 125
MHz) δ 204.4 (CHO), 155.7 (Ar-Cpara), 148.7 (Ar-Cipso), 122.1, 114.6 (Ar-C), 85.9
(C(CHO)), 55.7 (CH3O), 36.4 (CH2C(CHO)), 32.0, 30.1, 29.5, 29.3 (CH2), 23.0
(CH2CH2C(CHO)), 22.8 (CH2), 18.7 (CH3C(CHO)), 14.2 (CH3CH2); HRMS (ESI)
m/z: calcd. for C18H28NaO3 [M+Na]+ 315.1931, found 315.1927.
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